patient_id,superpopulation,n_variants_carried,primary_gene,severity_score,severity_category,predicted_progression,all_genes,pathway_Proteostasis,pathway_Proteostasis_score,pathway_Proteostasis_genes,pathway_Proteostasis_mechanisms,pathway_RNA_Metabolism,pathway_RNA_Metabolism_score,pathway_RNA_Metabolism_genes,pathway_RNA_Metabolism_mechanisms,pathway_Cytoskeletal_Axonal_Transport,pathway_Cytoskeletal_Axonal_Transport_score,pathway_Cytoskeletal_Axonal_Transport_genes,pathway_Cytoskeletal_Axonal_Transport_mechanisms,pathway_Mitochondrial,pathway_Mitochondrial_score,pathway_Mitochondrial_genes,pathway_Mitochondrial_mechanisms,pathway_Excitotoxicity,pathway_Excitotoxicity_score,pathway_Excitotoxicity_genes,pathway_Excitotoxicity_mechanisms,pathway_Vesicle_Trafficking,pathway_Vesicle_Trafficking_score,pathway_Vesicle_Trafficking_genes,pathway_Vesicle_Trafficking_mechanisms,pathway_DNA_Damage,pathway_DNA_Damage_score,pathway_DNA_Damage_genes,pathway_DNA_Damage_mechanisms,n_pathways_affected,primary_pathway,all_mechanisms,primary_gene_mechanism
AFR_00000,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00001,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00002,AFR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AFR_00003,AFR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00004,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00005,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00006,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00007,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00008,AFR,2,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Cytoskeletal_Axonal_Transport,SIGMAR1: MAM calcium dysregulation | TUBA4A: Microtubule destabilization,MAM calcium dysregulation
AFR_00009,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00010,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00011,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00012,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00013,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00014,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00015,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00016,AFR,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; SETX,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00017,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00018,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00019,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00020,AFR,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00021,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00022,AFR,3,VCP,7.7,Moderate,Slow Progression,SLC52A3; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00023,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00024,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00025,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00026,AFR,2,VCP,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00027,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00028,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00029,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00030,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00031,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00032,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00033,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00034,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00035,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00036,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00037,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00038,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00039,AFR,2,FIG4,8.4,Severe,Fast Progression,FIG4; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,FIG4; SPG11,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosomal biogenesis failure
AFR_00040,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00041,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00042,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00043,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00044,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00045,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00046,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00047,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00048,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00049,AFR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00050,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00051,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00052,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00053,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00054,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00055,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00056,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00057,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00058,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00059,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00060,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00061,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00062,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00063,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00064,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00065,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00066,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00067,AFR,2,SQSTM1,7.8,Moderate,Fast Progression,HNRNPA1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA1: Stress granule dysregulation | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00068,AFR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AFR_00069,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00070,AFR,1,LOC130001681,9.2,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00071,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00072,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00073,AFR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00074,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00075,AFR,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00076,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00077,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00078,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00079,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00080,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00081,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00082,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00083,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00084,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00085,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00086,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00087,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00088,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00089,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00090,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00091,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00092,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00093,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00094,AFR,1,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00095,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00096,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00097,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00098,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00099,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00100,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00101,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00102,AFR,2,KIF5A,6.6,Moderate,Slow Progression,DCTN1; KIF5A,0,0,,,0,0,,,1,2,DCTN1; KIF5A,DCTN1: Retrograde transport failure | KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | KIF5A: Anterograde transport failure,Anterograde transport failure
AFR_00103,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00104,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00105,AFR,1,SETX,4.6,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00106,AFR,2,VCP,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00107,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00108,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00109,AFR,2,LOC108903148,9.2,Severe,Fast Progression,ALS2; LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_00110,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00111,AFR,1,VCP,9.1,Severe,Fast Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00112,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00113,AFR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AFR_00114,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00115,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00116,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00117,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00118,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00119,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00120,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00121,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00122,AFR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AFR_00123,AFR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00124,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00125,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00126,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00127,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00128,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00129,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00130,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00131,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00132,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; SETX,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00133,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00134,AFR,2,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00135,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00136,AFR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Endosome-lysosome fusion failure
AFR_00137,AFR,2,FUS,9.9,Severe,Slow Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00138,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00139,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00140,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00141,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00142,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00143,AFR,2,OPTN,7.8,Moderate,Slow Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00144,AFR,3,TBK1,10.0,Severe,Fast Progression,C9orf72; SIGMAR1; TBK1,1,2,C9ORF72; TBK1,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | TBK1: Autophagy initiation kinase deficiency,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,4,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00145,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00146,AFR,2,FIG4,9.2,Severe,Fast Progression,FIG4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AFR_00147,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00148,AFR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AFR_00149,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00150,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00151,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_00152,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00153,AFR,1,LOC130003372,6.6,Moderate,Asymptomatic/Low Penetrance,LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00154,AFR,3,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_00155,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00156,AFR,3,LOC108903148,9.2,Severe,Fast Progression,ALS2; FUS; LOC108903148,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
AFR_00157,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00158,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00159,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00160,AFR,2,TARDBP,7.0,Moderate,Slow Progression,ERBB4; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00161,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00162,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00163,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00164,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00165,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00166,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00167,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00168,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00169,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00170,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00171,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00172,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00173,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00174,AFR,2,OPTN,9.2,Severe,Slow Progression,OPTN; TUBA4A,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | TUBA4A: Microtubule destabilization,Autophagy receptor dysfunction
AFR_00175,AFR,2,VCP,7.7,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00176,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00177,AFR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00178,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00179,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00180,AFR,3,UBQLN2,7.7,Moderate,Slow Progression,TARDBP; UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Ubiquitin-proteasome clearance failure
AFR_00181,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00182,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00183,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00184,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00185,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00186,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00187,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00188,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00189,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00190,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00191,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00192,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00193,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00194,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00195,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00196,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00197,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00198,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00199,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00200,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00201,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00202,AFR,2,TBK1,9.8,Severe,Fast Progression,TBK1; UNC13A,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,2,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UNC13A: Synaptic transmission defects,Autophagy initiation kinase deficiency
AFR_00203,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00204,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00205,AFR,2,LOC108903148,7.8,Moderate,Fast Progression,KIF5A; LOC108903148,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Unknown mechanism
AFR_00206,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00207,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00208,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00209,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00210,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00211,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00212,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00213,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00214,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00215,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00216,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00217,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00218,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00219,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00220,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00221,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00222,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00223,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00224,AFR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00225,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00226,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00227,AFR,1,SETX,5.2,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00228,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00229,AFR,2,TARDBP,7.0,Moderate,Slow Progression,SETX; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00230,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00231,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00232,AFR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00233,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00234,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00235,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00236,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00237,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00238,AFR,2,UBQLN2,7.0,Moderate,Slow Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00239,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00240,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00241,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00242,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00243,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00244,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00245,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00246,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00247,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00248,AFR,3,SOD1,7.7,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00249,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00250,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00251,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00252,AFR,2,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
AFR_00253,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00254,AFR,1,KIF5A,9.2,Severe,Fast Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AFR_00255,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00256,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00257,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00258,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00259,AFR,4,FUS,10.0,Severe,Fast Progression,FUS; HNRNPA2B1; SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,FUS; HNRNPA2B1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA2B1: Stress granule dysregulation,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA2B1: Stress granule dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00260,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00261,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00262,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00263,AFR,1,LOC108903148,6.6,Moderate,Asymptomatic/Low Penetrance,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00264,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00265,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00266,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00267,AFR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00268,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00269,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00270,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00271,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00272,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00273,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
AFR_00274,AFR,2,TBK1,10.0,Severe,Fast Progression,LOC108903148; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00275,AFR,1,C9orf72,8.8,Severe,Fast Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AFR_00276,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00277,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00278,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00279,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00280,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00281,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00282,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00283,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00284,AFR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AFR_00285,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00286,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00287,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00288,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00289,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00290,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00291,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00292,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00293,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00294,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00295,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00296,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00297,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
AFR_00298,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00299,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00300,AFR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00301,AFR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00302,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00303,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00304,AFR,4,TBK1,9.1,Severe,Fast Progression,ALS2; SQSTM1; TBK1; VCP,1,3,SQSTM1; TBK1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_00305,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00306,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00307,AFR,3,DCTN1,7.0,Moderate,Slow Progression,ALS2; DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Retrograde transport failure
AFR_00308,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00309,AFR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00310,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00311,AFR,3,FIG4,8.4,Severe,Fast Progression,FIG4; LOC124629354; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AFR_00312,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00313,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00314,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00315,AFR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00316,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00317,AFR,2,OPTN,7.8,Moderate,Slow Progression,OPTN; UBQLN2,1,2,OPTN; UBQLN2,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
AFR_00318,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00319,AFR,2,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00320,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00321,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00322,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00323,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00324,AFR,1,SQSTM1,9.2,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00325,AFR,2,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00326,AFR,2,FIG4,7.8,Moderate,Fast Progression,FIG4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AFR_00327,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00328,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00329,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00330,AFR,2,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_00331,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00332,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00333,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00334,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00335,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00336,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00337,AFR,2,SPG11,7.0,Moderate,Slow Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00338,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00339,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00340,AFR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00341,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00342,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00343,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00344,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00345,AFR,2,SPG11,7.0,Moderate,Fast Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
AFR_00346,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00347,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00348,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00349,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00350,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00351,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00352,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00353,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00354,AFR,3,LOC130001681,9.2,Severe,Fast Progression,ALS2; LOC130001681; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_00355,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00356,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00357,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00358,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00359,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00360,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00361,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00362,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00363,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_00364,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00365,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00366,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00367,AFR,1,OPTN,9.2,Severe,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00368,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00369,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00370,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00371,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00372,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00373,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00374,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00375,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00376,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00377,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00378,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00379,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00380,AFR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_00381,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00382,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00383,AFR,2,SOD1,7.0,Moderate,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00384,AFR,2,TUBA4A,6.0,Moderate,Slow Progression,ALS2; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00385,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00386,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00387,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00388,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00389,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00390,AFR,2,FIG4,7.8,Moderate,Fast Progression,FIG4; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,FIG4; SPG11,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosomal biogenesis failure
AFR_00391,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00392,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00393,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00394,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00395,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00396,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00397,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00398,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00399,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00400,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00401,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00402,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00403,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00404,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00405,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00406,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00407,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00408,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00409,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00410,AFR,4,FUS,10.0,Severe,Fast Progression,FUS; OPTN; SIGMAR1; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00411,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00412,AFR,2,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Unknown mechanism
AFR_00413,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00414,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00415,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00416,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00417,AFR,5,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1; SPG11; SQSTM1; TARDBP,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,6,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62) | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00418,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00419,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00420,AFR,2,KIF5A,7.8,Moderate,Fast Progression,KIF5A; SETX,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure | SETX: R-loop accumulation; genomic instability,Anterograde transport failure
AFR_00421,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00422,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00423,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00424,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00425,AFR,2,LOC108903148,9.2,Severe,Slow Progression,LOC108903148; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,Unknown mechanism
AFR_00426,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00427,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_00428,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00429,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00430,AFR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00431,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00432,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00433,AFR,1,ANG,6.0,Moderate,Slow Progression,ANG,0,0,,,1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,ANG: Ribosomal biogenesis impairment,Ribosomal biogenesis impairment
AFR_00434,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00435,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00436,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00437,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00438,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
AFR_00439,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00440,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00441,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00442,AFR,2,TBK1,9.1,Severe,Fast Progression,KIF5A; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,KIF5A: Anterograde transport failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00443,AFR,2,SPG11,7.0,Moderate,Fast Progression,FUS; SPG11,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00444,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00445,AFR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00446,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00447,AFR,2,TARDBP,7.0,Moderate,Slow Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00448,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00449,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00450,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00451,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00452,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00453,AFR,2,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Ubiquitin-proteasome clearance failure
AFR_00454,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00455,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00456,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00457,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00458,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00459,AFR,2,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Unknown mechanism
AFR_00460,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00461,AFR,2,SOD1,7.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00462,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00463,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00464,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00465,AFR,2,SOD1,7.0,Moderate,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00466,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00467,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00468,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00469,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00470,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00471,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00472,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00473,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00474,AFR,3,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00475,AFR,1,LOC108903148,6.6,Moderate,Asymptomatic/Low Penetrance,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00476,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00477,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00478,AFR,2,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00479,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00480,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00481,AFR,2,SOD1,7.0,Moderate,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00482,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
AFR_00483,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00484,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00485,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00486,AFR,1,SIGMAR1,7.7,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00487,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00488,AFR,2,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00489,AFR,2,TBK1,9.1,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00490,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00491,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00492,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00493,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00494,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00495,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00496,AFR,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00497,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00498,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00499,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00500,AFR,2,FIG4,9.2,Severe,Fast Progression,FIG4; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Mitochondrial,FIG4: Lysosomal biogenesis failure | SIGMAR1: MAM calcium dysregulation,Lysosomal biogenesis failure
AFR_00501,AFR,3,SQSTM1,8.4,Severe,Fast Progression,SOD1; SPG11; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00502,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00503,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00504,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00505,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00506,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00507,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00508,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00509,AFR,2,VCP,7.7,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00510,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00511,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00512,AFR,2,FIG4,8.4,Severe,Fast Progression,ALS2; FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; FIG4,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_00513,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00514,AFR,2,VCP,7.7,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00515,AFR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00516,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00517,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00518,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00519,AFR,1,SQSTM1,8.6,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00520,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00521,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00522,AFR,2,SOD1,7.7,Moderate,Fast Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00523,AFR,2,TBK1,9.1,Severe,Fast Progression,CHMP2B; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00524,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00525,AFR,3,SPG11,7.0,Moderate,Slow Progression,FUS; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,6,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00526,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00527,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00528,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00529,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00530,AFR,2,SETX,6.2,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,R-loop accumulation; genomic instability
AFR_00531,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00532,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00533,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00534,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00535,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00536,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00537,AFR,1,UBQLN2,7.7,Moderate,Fast Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00538,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00539,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00540,AFR,2,UBQLN2,7.0,Moderate,Slow Progression,SETX; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00541,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00542,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00543,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00544,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00545,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00546,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00547,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00548,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00549,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00550,AFR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00551,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00552,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00553,AFR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00554,AFR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00555,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00556,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00557,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00558,AFR,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00559,AFR,5,TBK1,7.0,Moderate,Slow Progression,ALS2; SOD1; TBK1; UNC13A,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | UNC13A: Synaptic transmission defects,Autophagy initiation kinase deficiency
AFR_00560,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00561,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00562,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00563,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00564,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00565,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00566,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00567,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00568,AFR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00569,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00570,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00571,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00572,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00573,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00574,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00575,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00576,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00577,AFR,2,TBK1,10.0,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00578,AFR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AFR_00579,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00580,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00581,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00582,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00583,AFR,2,SETX,5.2,Mild,Slow Progression,ERBB4; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00584,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00585,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00586,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00587,AFR,2,TBK1,9.8,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00588,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_00589,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00590,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00591,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00592,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00593,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00594,AFR,2,VCP,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00595,AFR,1,NEK1,9.2,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00596,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00597,AFR,1,SIGMAR1,5.0,Mild,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00598,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00599,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00600,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00601,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00602,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00603,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00604,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00605,AFR,3,FUS,9.9,Severe,Fast Progression,FUS; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00606,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00607,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00608,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00609,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00610,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00611,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00612,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00613,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00614,AFR,3,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00615,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00616,AFR,2,UBQLN2,7.0,Moderate,Slow Progression,ERBB4; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00617,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00618,AFR,4,VCP,9.1,Severe,Fast Progression,FUS; LOC130056973; TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00619,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00620,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00621,AFR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00622,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00623,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00624,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00625,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00626,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00627,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00628,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00629,AFR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00630,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00631,AFR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00632,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00633,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00634,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00635,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00636,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00637,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00638,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00639,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00640,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00641,AFR,2,FUS,9.9,Severe,Slow Progression,FUS; SIGMAR1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00642,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00643,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00644,AFR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AFR_00645,AFR,2,SOD1,7.7,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00646,AFR,2,SOD1,7.0,Moderate,Slow Progression,KIF5A; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,KIF5A: Anterograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00647,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00648,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00649,AFR,2,SOD1,7.0,Moderate,Fast Progression,PLEKHG5; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00650,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00651,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00652,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00653,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00654,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00655,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00656,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00657,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00658,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00659,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00660,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00661,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00662,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00663,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00664,AFR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00665,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00666,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00667,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction
AFR_00668,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00669,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00670,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00671,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00672,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00673,AFR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00674,AFR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_00675,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00676,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00677,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00678,AFR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AFR_00679,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00680,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00681,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00682,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00683,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00684,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00685,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00686,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00687,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00688,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00689,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00690,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00691,AFR,2,NEK1,8.4,Severe,Fast Progression,NEK1; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,DNA damage checkpoint failure
AFR_00692,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00693,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00694,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00695,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00696,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00697,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00698,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00699,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00700,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00701,AFR,4,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; SQSTM1; TARDBP; UBQLN2,1,2,SQSTM1; UBQLN2,SQSTM1: Autophagy receptor dysfunction (p62) | UBQLN2: Ubiquitin-proteasome clearance failure,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
AFR_00702,AFR,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00703,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00704,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00705,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00706,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00707,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00708,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00709,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; SETX,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00710,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00711,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00712,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00713,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00714,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00715,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00716,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00717,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00718,AFR,1,UBQLN2,7.0,Moderate,Asymptomatic/Low Penetrance,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00719,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00720,AFR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00721,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00722,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00723,AFR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_00724,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00725,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00726,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00727,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00728,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; TUBA4A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TUBA4A: Microtubule destabilization,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00729,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00730,AFR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00731,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00732,AFR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00733,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00734,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00735,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00736,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00737,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00738,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00739,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00740,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00741,AFR,1,DCTN1,9.1,Severe,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00742,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00743,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00744,AFR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00745,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00746,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00747,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00748,AFR,2,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_00749,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00750,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00751,AFR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00752,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00753,AFR,2,DCTN1,9.1,Severe,Slow Progression,DCTN1; SIGMAR1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | SIGMAR1: MAM calcium dysregulation,Retrograde transport failure
AFR_00754,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00755,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00756,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00757,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00758,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00759,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00760,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00761,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00762,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00763,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00764,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00765,AFR,4,OPTN,8.4,Severe,Fast Progression,ERBB4; OPTN; SOD1; UBQLN2,1,3,OPTN; SOD1; UBQLN2,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
AFR_00766,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00767,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00768,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00769,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00770,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00771,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00772,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00773,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00774,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00775,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00776,AFR,1,SQSTM1,9.2,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00777,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00778,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00779,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00780,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00781,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00782,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00783,AFR,2,LOC108903148,7.8,Moderate,Fast Progression,ALS2; LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_00784,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00785,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00786,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00787,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00788,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00789,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00790,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00791,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00792,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00793,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00794,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00795,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00796,AFR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_00797,AFR,1,SQSTM1,9.2,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00798,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00799,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00800,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00801,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00802,AFR,3,SPTLC1,6.9,Moderate,Fast Progression,OPTN; SPG11; SPTLC1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_00803,AFR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00804,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00805,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00806,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00807,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00808,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00809,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00810,AFR,3,NEK1,8.4,Severe,Slow Progression,ALS2; NEK1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,NEK1,NEK1: DNA damage checkpoint failure,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DNA damage checkpoint failure
AFR_00811,AFR,2,FUS,10.0,Severe,Fast Progression,CHRNA3; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00812,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00813,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00814,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00815,AFR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00816,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00817,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00818,AFR,3,TARDBP,7.7,Moderate,Slow Progression,ALS2; ANXA11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00819,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00820,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00821,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00822,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00823,AFR,2,FIG4,8.4,Severe,Fast Progression,FIG4; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_00824,AFR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00825,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00826,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00827,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00828,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00829,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00830,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00831,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00832,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00833,AFR,2,TARDBP,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_00834,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00835,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00836,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00837,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00838,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00839,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00840,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00841,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00842,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00843,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_00844,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00845,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00846,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00847,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00848,AFR,2,SOD1,7.7,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00849,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00850,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00851,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00852,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00853,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00854,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00855,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00856,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00857,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00858,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00859,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00860,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00861,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00862,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00863,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00864,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00865,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00866,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00867,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00868,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00869,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00870,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00871,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00872,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00873,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00874,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00875,AFR,2,SQSTM1,9.2,Severe,Fast Progression,SQSTM1; VCP,1,2,SQSTM1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction (p62)
AFR_00876,AFR,3,SOD1,7.0,Moderate,Slow Progression,CHCHD10; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,2,CHCHD10; SOD1,CHCHD10: Cristae disruption; mtDNA instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Mitochondrial,CHCHD10: Cristae disruption; mtDNA instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00877,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00878,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_00879,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00880,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00881,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00882,AFR,2,SQSTM1,9.2,Severe,Fast Progression,FUS; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00883,AFR,2,VCP,7.0,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00884,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00885,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00886,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00887,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00888,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00889,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00890,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00891,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00892,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00893,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00894,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00895,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00896,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00897,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00898,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00899,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_00900,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00901,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00902,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00903,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00904,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00905,AFR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00906,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00907,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00908,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00909,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00910,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00911,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00912,AFR,3,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Excitotoxicity,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00913,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00914,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00915,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00916,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00917,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00918,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00919,AFR,2,TBK1,10.0,Severe,Fast Progression,FIG4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00920,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00921,AFR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AFR_00922,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00923,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00924,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00925,AFR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00926,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00927,AFR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
AFR_00928,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00929,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_00930,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00931,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00932,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00933,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00934,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00935,AFR,2,FIG4,7.8,Moderate,Fast Progression,ALS2; FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; FIG4,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_00936,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00937,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00938,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00939,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00940,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00941,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00942,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00943,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00944,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00945,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00946,AFR,2,VCP,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00947,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00948,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00949,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00950,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00951,AFR,1,SQSTM1,9.2,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00952,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00953,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00954,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00955,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00956,AFR,2,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00957,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_00958,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00959,AFR,3,OPTN,8.4,Severe,Fast Progression,ALS2; OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AFR_00960,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00961,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00962,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00963,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00964,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00965,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00966,AFR,2,SPTLC1,6.9,Moderate,Slow Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_00967,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00968,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00969,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00970,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00971,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00972,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00973,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_00974,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00975,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00976,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00977,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00978,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00979,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00980,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_00981,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00982,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00983,AFR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_00984,AFR,2,SOD1,7.7,Moderate,Fast Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00985,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_00986,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00987,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00988,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00989,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00990,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00991,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_00992,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00993,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00994,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00995,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_00996,AFR,2,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_00997,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_00998,AFR,2,DCTN1,7.0,Moderate,Slow Progression,ALS2; DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_00999,AFR,4,TBK1,10.0,Severe,Fast Progression,SETX; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01000,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01001,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01002,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01003,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01004,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01005,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01006,AFR,2,VCP,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01007,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01008,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01009,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01010,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01011,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01012,AFR,3,VCP,7.7,Moderate,Slow Progression,ALS2; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01013,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01014,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01015,AFR,3,FUS,10.0,Severe,Fast Progression,FUS; NEK1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | NEK1: DNA damage checkpoint failure | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01016,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01017,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01018,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01019,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01020,AFR,1,SETX,5.7,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01021,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01022,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01023,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01024,AFR,2,SOD1,7.0,Moderate,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01025,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_01026,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01027,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01028,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01029,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01030,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01031,AFR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AFR_01032,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01033,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01034,AFR,1,ERBB4,5.0,Mild,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01035,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01036,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01037,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01038,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01039,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01040,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01041,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01042,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01043,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01044,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01045,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01046,AFR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01047,AFR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01048,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01049,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01050,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01051,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01052,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01053,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01054,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01055,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01056,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01057,AFR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01058,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01059,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01060,AFR,2,SOD1,7.7,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01061,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01062,AFR,3,VCP,7.7,Moderate,Slow Progression,CHMP2B; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01063,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01064,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01065,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01066,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01067,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01068,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01069,AFR,2,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01070,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01071,AFR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_01072,AFR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01073,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01074,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01075,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01076,AFR,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01077,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01078,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01079,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01080,AFR,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01081,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01082,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01083,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01084,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01085,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01086,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01087,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01088,AFR,2,UBQLN2,7.0,Moderate,Slow Progression,SETX; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01089,AFR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01090,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01091,AFR,3,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01092,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01093,AFR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01094,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01095,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01096,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01097,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_01098,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01099,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01100,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01101,AFR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01102,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01103,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01104,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01105,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01106,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01107,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01108,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01109,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01110,AFR,2,SQSTM1,9.2,Severe,Fast Progression,CHMP2B; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01111,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01112,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01113,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01114,AFR,2,SYNE1,9.2,Severe,Fast Progression,SETX; SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,Unknown mechanism
AFR_01115,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01116,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01117,AFR,2,TBK1,9.8,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01118,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01119,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01120,AFR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01121,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01122,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01123,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01124,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01125,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01126,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01127,AFR,2,DCTN1,7.7,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Retrograde transport failure
AFR_01128,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01129,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01130,AFR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01131,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01132,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01133,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01134,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01135,AFR,2,VCP,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01136,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01137,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01138,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01139,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01140,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01141,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01142,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01143,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01144,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01145,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01146,AFR,2,TBK1,9.1,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01147,AFR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Lysosome reformation failure; DNA repair defects
AFR_01148,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01149,AFR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01150,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01151,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01152,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01153,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01154,AFR,3,TARDBP,7.7,Moderate,Fast Progression,ALS2; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01155,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01156,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01157,AFR,4,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1; TBK1,1,3,OPTN; SOD1; TBK1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction
AFR_01158,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01159,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01160,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01161,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01162,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01163,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01164,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01165,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01166,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01167,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01168,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01169,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01170,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01171,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01172,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01173,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01174,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01175,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01176,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01177,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01178,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01179,AFR,2,SQSTM1,8.4,Severe,Fast Progression,DCTN1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01180,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01181,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01182,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01183,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01184,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01185,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01186,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01187,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01188,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01189,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01190,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01191,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01192,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; UBQLN2,1,2,OPTN; UBQLN2,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
AFR_01193,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01194,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01195,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01196,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01197,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01198,AFR,2,LOC130001681,9.2,Severe,Fast Progression,LOC130001681; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_01199,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01200,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01201,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01202,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01203,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01204,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01205,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01206,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01207,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01208,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01209,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01210,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01211,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01212,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01213,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01214,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01215,AFR,3,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01216,AFR,3,TUBA4A,6.0,Moderate,Slow Progression,NEK1; SOD1; TUBA4A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,5,Proteostasis,NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_01217,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01218,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01219,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01220,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01221,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01222,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01223,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01224,AFR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01225,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01226,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01227,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01228,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01229,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01230,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01231,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01232,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01233,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01234,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01235,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01236,AFR,2,SQSTM1,8.4,Severe,Fast Progression,ANG; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,ANG: Ribosomal biogenesis impairment | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01237,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01238,AFR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01239,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01240,AFR,2,OPTN,8.4,Severe,Fast Progression,LOC130001681; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01241,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01242,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01243,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01244,AFR,1,DCTN1,9.1,Severe,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01245,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01246,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01247,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; SLC52A3,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01248,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01249,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01250,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01251,AFR,2,PRPH,7.8,Moderate,Fast Progression,PRPH; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_01252,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01253,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01254,AFR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01255,AFR,3,ANXA11,8.6,Severe,Slow Progression,ANXA11; NEK1; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_01256,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01257,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01258,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01259,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01260,AFR,3,OPTN,7.8,Moderate,Fast Progression,OPTN; TBK1; UBQLN2,1,3,OPTN; TBK1; UBQLN2,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
AFR_01261,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01262,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01263,AFR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AFR_01264,AFR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01265,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AFR_01266,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01267,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01268,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01269,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01270,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01271,AFR,1,SIGMAR1,7.7,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01272,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01273,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01274,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01275,AFR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01276,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01277,AFR,3,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; TARDBP; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
AFR_01278,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | UBQLN2: Ubiquitin-proteasome clearance failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01279,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01280,AFR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01281,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01282,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01283,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01284,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01285,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01286,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01287,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01288,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01289,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01290,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01291,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01292,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01293,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01294,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01295,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01296,AFR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01297,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01298,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01299,AFR,2,TBK1,9.8,Severe,Fast Progression,ERBB4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01300,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01301,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01302,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01303,AFR,2,TBK1,10.0,Severe,Fast Progression,TARDBP; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01304,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01305,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01306,AFR,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01307,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01308,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01309,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01310,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01311,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01312,AFR,2,VCP,7.7,Moderate,Slow Progression,LOC108903148; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01313,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01314,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01315,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01316,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01317,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01318,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01319,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01320,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01321,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01322,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01323,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01324,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01325,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01326,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01327,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01328,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01329,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01330,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01331,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01332,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01333,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01334,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01335,AFR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01336,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01337,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01338,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01339,AFR,3,FUS,9.9,Severe,Fast Progression,FUS; HNRNPA2B1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,2,FUS; HNRNPA2B1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA2B1: Stress granule dysregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA2B1: Stress granule dysregulation | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01340,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01341,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01342,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01343,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01344,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01345,AFR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01346,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01347,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01348,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01349,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01350,AFR,2,VCP,7.0,Moderate,Slow Progression,UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01351,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01352,AFR,4,SOD1,7.0,Moderate,Slow Progression,FUS; SETX; SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,3,FUS; SIGMAR1; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability | SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01353,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01354,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01355,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01356,AFR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01357,AFR,2,TARDBP,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01358,AFR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01359,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01360,AFR,3,SPG11,7.0,Moderate,Slow Progression,ALS2; SLC52A3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01361,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01362,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01363,AFR,3,OPTN,7.8,Moderate,Fast Progression,OPTN; SIGMAR1; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01364,AFR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01365,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01366,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01367,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01368,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01369,AFR,2,SPG11,7.0,Moderate,Slow Progression,SETX; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01370,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01371,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01372,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01373,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01374,AFR,2,TARDBP,7.7,Moderate,Slow Progression,SETX; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01375,AFR,4,SLC52A3,9.2,Severe,Fast Progression,HNRNPA2B1; SIGMAR1; SLC52A3; SPG11,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation | SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_01376,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01377,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01378,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01379,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01380,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01381,AFR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | UNC13A: Synaptic transmission defects,Endosome-lysosome fusion failure
AFR_01382,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01383,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01384,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01385,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01386,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01387,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01388,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01389,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01390,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01391,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01392,AFR,2,LOC130001681,8.4,Severe,Fast Progression,ALS2; LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_01393,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01394,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01395,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01396,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01397,AFR,2,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_01398,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01399,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01400,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01401,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01402,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01403,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01404,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01405,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01406,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01407,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01408,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01409,AFR,3,SOD1,7.0,Moderate,Slow Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01410,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01411,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01412,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01413,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01414,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01415,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01416,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01417,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01418,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01419,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01420,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01421,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01422,AFR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AFR_01423,AFR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_01424,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01425,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01426,AFR,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01427,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01428,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01429,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01430,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01431,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01432,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01433,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01434,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01435,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01436,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01437,AFR,3,NEK1,8.4,Severe,Fast Progression,NEK1; SPG11; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,3,DNA_Damage,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects | UBQLN2: Ubiquitin-proteasome clearance failure,DNA damage checkpoint failure
AFR_01438,AFR,2,SOD1,7.0,Moderate,Slow Progression,SCAF4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01439,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01440,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01441,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01442,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01443,AFR,2,NEK1,8.4,Severe,Slow Progression,ALS2; NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_01444,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01445,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01446,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01447,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01448,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01449,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01450,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01451,AFR,1,SIGMAR1,7.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01452,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Endosome-lysosome fusion failure
AFR_01453,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01454,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01455,AFR,2,SOD1,7.0,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01456,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01457,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01458,AFR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01459,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01460,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01461,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01462,AFR,1,SPG11,7.7,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01463,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01464,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01465,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01466,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01467,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01468,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01469,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01470,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01471,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01472,AFR,2,SOD1,7.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01473,AFR,4,SQSTM1,7.8,Moderate,Fast Progression,ALS2; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01474,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01475,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01476,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01477,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01478,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01479,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01480,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01481,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01482,AFR,3,ALS2,7.0,Moderate,Slow Progression,ALS2; ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AFR_01483,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01484,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01485,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01486,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01487,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01488,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01489,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01490,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01491,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01492,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01493,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01494,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01495,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01496,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01497,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01498,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01499,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01500,AFR,2,SQSTM1,8.4,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction (p62)
AFR_01501,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01502,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01503,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01504,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01505,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01506,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01507,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01508,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01509,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01510,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01511,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01512,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01513,AFR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01514,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01515,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01516,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01517,AFR,2,DCTN1,7.7,Moderate,Slow Progression,DCTN1; SLC52A3,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01518,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01519,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01520,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01521,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01522,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01523,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01524,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01525,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01526,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01527,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01528,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01529,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction
AFR_01530,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01531,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01532,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01533,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01534,AFR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01535,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01536,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01537,AFR,2,VCP,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01538,AFR,2,SOD1,7.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01539,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01540,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_01541,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01542,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01543,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01544,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01545,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01546,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01547,AFR,3,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01548,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01549,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01550,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01551,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01552,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01553,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01554,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01555,AFR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01556,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01557,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01558,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01559,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01560,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01561,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01562,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01563,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01564,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01565,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01566,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01567,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01568,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01569,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01570,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01571,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01572,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01573,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01574,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01575,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01576,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01577,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01578,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01579,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01580,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01581,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01582,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01583,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01584,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01585,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01586,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01587,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01588,AFR,2,FUS,9.0,Severe,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01589,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01590,AFR,1,PARK7,7.7,Moderate,Slow Progression,PARK7,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01591,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01592,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01593,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01594,AFR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01595,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01596,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01597,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01598,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01599,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01600,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01601,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01602,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01603,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01604,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01605,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01606,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01607,AFR,2,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01608,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01609,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01610,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01611,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01612,AFR,3,TBK1,10.0,Severe,Fast Progression,SQSTM1; TBK1; VCP,1,3,SQSTM1; TBK1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_01613,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01614,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01615,AFR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01616,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01617,AFR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AFR_01618,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01619,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01620,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01621,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01622,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01623,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01624,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01625,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_01626,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01627,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01628,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01629,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01630,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01631,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01632,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01633,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01634,AFR,2,SOD1,7.0,Moderate,Fast Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01635,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01636,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01637,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01638,AFR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01639,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01640,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01641,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01642,AFR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01643,AFR,1,NEK1,7.8,Moderate,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_01644,AFR,2,SPG11,7.0,Moderate,Slow Progression,SLC52A3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01645,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01646,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01647,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01648,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01649,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01650,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01651,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01652,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01653,AFR,2,SETX,5.2,Mild,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01654,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01655,AFR,3,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01656,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01657,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01658,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01659,AFR,3,FUS,9.9,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01660,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01661,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01662,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01663,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01664,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01665,AFR,2,SIGMAR1,7.7,Moderate,Slow Progression,SETX; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Mitochondrial,SETX: R-loop accumulation; genomic instability | SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01666,AFR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01667,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01668,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01669,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01670,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01671,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01672,AFR,2,SOD1,7.0,Moderate,Fast Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01673,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01674,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01675,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01676,AFR,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01677,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01678,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01679,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01680,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01681,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01682,AFR,2,OPTN,9.2,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01683,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01684,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01685,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01686,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | TUBA4A: Microtubule destabilization,Endosome-lysosome fusion failure
AFR_01687,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01688,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01689,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01690,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01691,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01692,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01693,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01694,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01695,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01696,AFR,3,OPTN,6.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01697,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01698,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01699,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01700,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01701,AFR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_01702,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01703,AFR,2,TARDBP,7.7,Moderate,Slow Progression,ALS2; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01704,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01705,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01706,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01707,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01708,AFR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01709,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01710,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01711,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01712,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01713,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01714,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01715,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01716,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01717,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01718,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01719,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AFR_01720,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01721,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01722,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01723,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01724,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01725,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01726,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01727,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01728,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01729,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01730,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01731,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01732,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01733,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01734,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01735,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01736,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01737,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01738,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01739,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01740,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01741,AFR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01742,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01743,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01744,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_01745,AFR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01746,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01747,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01748,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01749,AFR,2,TBK1,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01750,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01751,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01752,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01753,AFR,2,UBQLN2,7.7,Moderate,Slow Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01754,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01755,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01756,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01757,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01758,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01759,AFR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01760,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01761,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01762,AFR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AFR_01763,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01764,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01765,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01766,AFR,3,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Unknown mechanism
AFR_01767,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01768,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01769,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01770,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01771,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01772,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01773,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01774,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01775,AFR,2,OPTN,8.4,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01776,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01777,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Endosome-lysosome fusion failure
AFR_01778,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01779,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01780,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01781,AFR,1,UBQLN2,7.0,Moderate,Asymptomatic/Low Penetrance,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_01782,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01783,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01784,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01785,AFR,3,TBK1,9.1,Severe,Fast Progression,OPTN; SIGMAR1; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01786,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01787,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01788,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01789,AFR,4,FUS,10.0,Severe,Fast Progression,ALS2; FUS; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,6,Mitochondrial,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01790,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01791,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01792,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01793,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01794,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01795,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01796,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01797,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01798,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01799,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01800,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01801,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01802,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01803,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01804,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01805,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01806,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01807,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01808,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01809,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01810,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01811,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01812,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01813,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01814,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01815,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01816,AFR,2,SQSTM1,9.2,Severe,Fast Progression,FUS; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01817,AFR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_01818,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01819,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01820,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01821,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01822,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01823,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01824,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01825,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01826,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01827,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01828,AFR,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01829,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01830,AFR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01831,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01832,AFR,2,TBK1,9.1,Severe,Fast Progression,CHMP2B; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01833,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01834,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01835,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01836,AFR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01837,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01838,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01839,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01840,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01841,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01842,AFR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01843,AFR,2,SQSTM1,8.4,Severe,Fast Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01844,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01845,AFR,2,TBK1,7.0,Moderate,Slow Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01846,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01847,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01848,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01849,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01850,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01851,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
AFR_01852,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01853,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01854,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01855,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01856,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01857,AFR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01858,AFR,2,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01859,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01860,AFR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01861,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01862,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01863,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01864,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01865,AFR,2,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Cytoskeletal_Axonal_Transport,SIGMAR1: MAM calcium dysregulation | TUBA4A: Microtubule destabilization,MAM calcium dysregulation
AFR_01866,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01867,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01868,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01869,AFR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01870,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01871,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01872,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01873,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01874,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01875,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01876,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01877,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01878,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01879,AFR,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AFR_01880,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01881,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01882,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01883,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01884,AFR,3,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Excitotoxicity,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01885,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01886,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01887,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01888,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01889,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01890,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01891,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01892,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01893,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01894,AFR,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01895,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01896,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01897,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01898,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01899,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01900,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01901,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01902,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01903,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01904,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01905,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01906,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01907,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01908,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01909,AFR,2,VCP,7.7,Moderate,Slow Progression,TUBA4A; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,TUBA4A: Microtubule destabilization | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01910,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01911,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01912,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01913,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01914,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01915,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01916,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01917,AFR,4,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN; SOD1; UNC13A,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,Autophagy receptor dysfunction
AFR_01918,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01919,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01920,AFR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01921,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01922,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01923,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01924,AFR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01925,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01926,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01927,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01928,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01929,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01930,AFR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_01931,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01932,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01933,AFR,2,TBK1,9.8,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01934,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01935,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01936,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01937,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01938,AFR,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_01939,AFR,2,VCP,7.0,Moderate,Slow Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01940,AFR,3,SPG11,7.0,Moderate,Slow Progression,SETX; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_01941,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_01942,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01943,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_01944,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01945,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01946,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01947,AFR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
AFR_01948,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01949,AFR,2,TBK1,7.0,Moderate,Slow Progression,TARDBP; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01950,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AFR_01951,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01952,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01953,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01954,AFR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01955,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01956,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01957,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01958,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01959,AFR,2,VCP,7.0,Moderate,Slow Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01960,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01961,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01962,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01963,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01964,AFR,1,DCTN1,9.1,Severe,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_01965,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01966,AFR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_01967,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01968,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01969,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01970,AFR,2,FUS,10.0,Severe,Fast Progression,FIG4; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,3,RNA_Metabolism,FIG4: Lysosomal biogenesis failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01971,AFR,3,FUS,9.9,Severe,Slow Progression,DCTN1; FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,DCTN1,DCTN1: Retrograde transport failure,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,5,Mitochondrial,DCTN1: Retrograde transport failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01972,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01973,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01974,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01975,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01976,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01977,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01978,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01979,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01980,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_01981,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01982,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01983,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01984,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01985,AFR,5,VCP,7.0,Moderate,Slow Progression,ALS2; CHRNA3; SETX; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_01986,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_01987,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01988,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_01989,AFR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
AFR_01990,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01991,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01992,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_01993,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_01994,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01995,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01996,AFR,2,TBK1,9.1,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_01997,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_01998,AFR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_01999,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02000,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02001,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02002,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02003,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02004,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02005,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02006,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02007,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02008,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02009,AFR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02010,AFR,2,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02011,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02012,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02013,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02014,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02015,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02016,AFR,2,SOD1,7.0,Moderate,Slow Progression,KIF5A; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,KIF5A: Anterograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02017,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02018,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02019,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02020,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02021,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02022,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02023,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02024,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02025,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02026,AFR,2,OPTN,7.8,Moderate,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02027,AFR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02028,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02029,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02030,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02031,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02032,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02033,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02034,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02035,AFR,1,SOD1,7.7,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02036,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02037,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02038,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02039,AFR,1,SPG11,6.5,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02040,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02041,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02042,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02043,AFR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02044,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02045,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02046,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02047,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02048,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02049,AFR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AFR_02050,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02051,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02052,AFR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02053,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02054,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_02055,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02056,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02057,AFR,4,SPG11,7.0,Moderate,Slow Progression,OPTN; SETX; SOD1; SPG11,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02058,AFR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02059,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02060,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02061,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02062,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02063,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02064,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02065,AFR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02066,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02067,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02068,AFR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02069,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02070,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02071,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02072,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02073,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02074,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02075,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02076,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02077,AFR,2,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_02078,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02079,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02080,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02081,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02082,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02083,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02084,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02085,AFR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02086,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02087,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02088,AFR,3,NEK1,8.4,Severe,Fast Progression,NEK1; OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,3,DNA_Damage,NEK1: DNA damage checkpoint failure | OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,DNA damage checkpoint failure
AFR_02089,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02090,AFR,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AFR_02091,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02092,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02093,AFR,2,NEK1,8.4,Severe,Fast Progression,NEK1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Proteostasis,NEK1: DNA damage checkpoint failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,DNA damage checkpoint failure
AFR_02094,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02095,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02096,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02097,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02098,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02099,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02100,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02101,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02102,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02103,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02104,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02105,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02106,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02107,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02108,AFR,2,OPTN,7.8,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_02109,AFR,3,FUS,9.9,Severe,Fast Progression,FUS; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02110,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02111,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02112,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02113,AFR,3,FUS,9.9,Severe,Fast Progression,FUS; SLC52A3; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02114,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02115,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02116,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02117,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02118,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02119,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02120,AFR,4,NEK1,8.4,Severe,Fast Progression,ALS2; NEK1; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,NEK1,NEK1: DNA damage checkpoint failure,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | NEK1: DNA damage checkpoint failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DNA damage checkpoint failure
AFR_02121,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02122,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02123,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02124,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02125,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02126,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02127,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02128,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02129,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02130,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02131,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02132,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02133,AFR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02134,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02135,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02136,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02137,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02138,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02139,AFR,3,FIG4,8.4,Severe,Fast Progression,FIG4; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AFR_02140,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02141,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02142,AFR,1,SLC52A3,6.6,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02143,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02144,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02145,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02146,AFR,2,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02147,AFR,1,FIG4,7.8,Moderate,Slow Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_02148,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02149,AFR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02150,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02151,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02152,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02153,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02154,AFR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02155,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02156,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02157,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02158,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02159,AFR,1,ALS2,6.3,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02160,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02161,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02162,AFR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AFR_02163,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02164,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02165,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02166,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02167,AFR,2,FUS,9.9,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02168,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02169,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02170,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02171,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02172,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02173,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02174,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02175,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02176,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02177,AFR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02178,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02179,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02180,AFR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02181,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02182,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02183,AFR,2,SOD1,7.7,Moderate,Slow Progression,LOC130003372; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02184,AFR,2,C9orf72,8.8,Severe,Slow Progression,C9orf72; SOD1,1,2,C9ORF72; SOD1,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,C9ORF72; SOD1,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DPR toxicity; RNA foci; AMPA receptor dysregulation
AFR_02185,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02186,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02187,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02188,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02189,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02190,AFR,2,FUS,9.0,Severe,Slow Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02191,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02192,AFR,1,SOD1,10.0,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02193,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02194,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02195,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02196,AFR,2,TBK1,9.1,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_02197,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02198,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02199,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02200,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02201,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02202,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02203,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02204,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02205,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02206,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02207,AFR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02208,AFR,1,VCP,7.7,Moderate,Asymptomatic/Low Penetrance,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02209,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02210,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02211,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02212,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02213,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02214,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02215,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02216,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02217,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02218,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02219,AFR,2,VCP,7.7,Moderate,Slow Progression,UNC13A; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,2,Proteostasis,UNC13A: Synaptic transmission defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02220,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_02221,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02222,AFR,2,SPG11,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02223,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02224,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02225,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02226,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02227,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02228,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02229,AFR,3,SOD1,7.0,Moderate,Slow Progression,ALS2; FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Mitochondrial,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02230,AFR,2,VCP,7.7,Moderate,Slow Progression,CHMP2B; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02231,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02232,AFR,3,TBK1,9.8,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02233,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02234,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02235,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02236,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02237,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02238,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02239,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02240,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02241,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02242,AFR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02243,AFR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02244,AFR,3,ALS2,6.5,Moderate,Slow Progression,ALS2; UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
AFR_02245,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02246,AFR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02247,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02248,AFR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02249,AFR,3,VCP,7.7,Moderate,Slow Progression,ALS2; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02250,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02251,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02252,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02253,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02254,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02255,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02256,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02257,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02258,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02259,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02260,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02261,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02262,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02263,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; HNRNPA1,0,0,,,1,2,FUS; HNRNPA1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA1: Stress granule dysregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA1: Stress granule dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02264,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02265,AFR,2,TBK1,9.8,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02266,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02267,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02268,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02269,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02270,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02271,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02272,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02273,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02274,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02275,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02276,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02277,AFR,1,LOC130003372,6.6,Moderate,Slow Progression,LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02278,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02279,AFR,1,SETX,4.6,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02280,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02281,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02282,AFR,1,NEK1,9.2,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02283,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02284,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02285,AFR,3,SQSTM1,9.2,Severe,Fast Progression,SETX; SLC52A3; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02286,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02287,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02288,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02289,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02290,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02291,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02292,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02293,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02294,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02295,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02296,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02297,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02298,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02299,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02300,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02301,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02302,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02303,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02304,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02305,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02306,AFR,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02307,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02308,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02309,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02310,AFR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02311,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02312,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02313,AFR,3,FUS,10.0,Severe,Fast Progression,FUS; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02314,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02315,AFR,2,TARDBP,7.0,Moderate,Fast Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02316,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02317,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02318,AFR,2,SQSTM1,9.2,Severe,Fast Progression,NEK1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Proteostasis,NEK1: DNA damage checkpoint failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02319,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02320,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02321,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02322,AFR,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02323,AFR,1,PLEKHG5,6.2,Moderate,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02324,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02325,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02326,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02327,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02328,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02329,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02330,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02331,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02332,AFR,2,UBQLN2,7.0,Moderate,Slow Progression,DCTN1; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02333,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02334,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02335,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_02336,AFR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02337,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02338,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02339,AFR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
AFR_02340,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02341,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02342,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02343,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02344,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02345,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02346,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02347,AFR,2,SOD1,7.0,Moderate,Slow Progression,HNRNPA1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,HNRNPA1: Stress granule dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02348,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02349,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02350,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02351,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02352,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02353,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02354,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_02355,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02356,AFR,1,ANXA11,8.6,Severe,Slow Progression,ANXA11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02357,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02358,AFR,2,ALS2,7.2,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
AFR_02359,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02360,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02361,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02362,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02363,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02364,AFR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02365,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02366,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02367,AFR,3,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02368,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02369,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02370,AFR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02371,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02372,AFR,2,TBK1,7.0,Moderate,Slow Progression,ERBB4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02373,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02374,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02375,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02376,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02377,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02378,AFR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02379,AFR,2,TBK1,9.1,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02380,AFR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02381,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02382,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02383,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02384,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02385,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02386,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02387,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02388,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02389,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02390,AFR,3,SPG11,7.0,Moderate,Fast Progression,ALS2; OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02391,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02392,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02393,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02394,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02395,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02396,AFR,2,TBK1,10.0,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
AFR_02397,AFR,3,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02398,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02399,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02400,AFR,2,TBK1,10.0,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02401,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02402,AFR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; UBQLN2,1,2,OPTN; UBQLN2,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
AFR_02403,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02404,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02405,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02406,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02407,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02408,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02409,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02410,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02411,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02412,AFR,3,FIG4,7.8,Moderate,Fast Progression,FIG4; HNRNPA1; TARDBP,0,0,,,1,2,HNRNPA1; TARDBP,HNRNPA1: Stress granule dysregulation | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,3,RNA_Metabolism,FIG4: Lysosomal biogenesis failure | HNRNPA1: Stress granule dysregulation | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosomal biogenesis failure
AFR_02413,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02414,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02415,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02416,AFR,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02417,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02418,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02419,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02420,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02421,AFR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
AFR_02422,AFR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02423,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02424,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02425,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02426,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02427,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02428,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02429,AFR,2,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02430,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02431,AFR,1,FIG4,7.8,Moderate,Asymptomatic/Low Penetrance,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_02432,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02433,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02434,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02435,AFR,2,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_02436,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02437,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02438,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02439,AFR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02440,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02441,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02442,AFR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02443,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02444,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02445,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02446,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02447,AFR,3,SQSTM1,8.4,Severe,Fast Progression,FUS; SETX; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02448,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02449,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02450,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02451,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02452,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02453,AFR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02454,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02455,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02456,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02457,AFR,2,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02458,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02459,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02460,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02461,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02462,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02463,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02464,AFR,3,SOD1,9.8,Severe,Fast Progression,SLC52A3; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02465,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02466,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02467,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02468,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02469,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02470,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02471,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; SPTLC1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02472,AFR,3,OPTN,9.2,Severe,Slow Progression,OPTN; SETX; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AFR_02473,AFR,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02474,AFR,2,OPTN,6.0,Moderate,Slow Progression,ERBB4; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02475,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02476,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02477,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02478,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02479,AFR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_02480,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02481,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02482,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02483,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02484,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02485,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02486,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02487,AFR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AFR_02488,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02489,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02490,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02491,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02492,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02493,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02494,AFR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02495,AFR,2,SOD1,7.0,Moderate,Slow Progression,HNRNPA2B1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,HNRNPA2B1: Stress granule dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02496,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02497,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02498,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02499,AFR,1,TARDBP,7.7,Moderate,Fast Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02500,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02501,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02502,AFR,2,LOC130001681,8.4,Severe,Fast Progression,LOC130001681; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Unknown mechanism
AFR_02503,AFR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02504,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02505,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02506,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02507,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02508,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02509,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02510,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02511,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02512,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02513,AFR,2,SOD1,9.8,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02514,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_02515,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02516,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02517,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02518,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02519,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02520,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02521,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02522,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02523,AFR,3,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Unknown mechanism
AFR_02524,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02525,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02526,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02527,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_02528,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02529,AFR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02530,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02531,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02532,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02533,AFR,3,VCP,7.7,Moderate,Slow Progression,SIGMAR1; TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02534,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02535,AFR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02536,AFR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02537,AFR,3,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AFR_02538,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02539,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02540,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02541,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02542,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02543,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02544,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02545,AFR,2,FIG4,8.4,Severe,Fast Progression,FIG4; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Mitochondrial,FIG4: Lysosomal biogenesis failure | SIGMAR1: MAM calcium dysregulation,Lysosomal biogenesis failure
AFR_02546,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02547,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02548,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02549,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02550,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02551,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02552,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02553,AFR,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02554,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02555,AFR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02556,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02557,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02558,AFR,2,SOD1,7.7,Moderate,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02559,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02560,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02561,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02562,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02563,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02564,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02565,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02566,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02567,AFR,1,VCP,7.7,Moderate,Asymptomatic/Low Penetrance,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02568,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02569,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02570,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02571,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02572,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02573,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02574,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02575,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02576,AFR,1,SETX,4.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02577,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02578,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02579,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02580,AFR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02581,AFR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02582,AFR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AFR_02583,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02584,AFR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02585,AFR,2,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02586,AFR,3,FUS,10.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02587,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02588,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02589,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02590,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02591,AFR,3,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02592,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02593,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02594,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02595,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02596,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02597,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02598,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02599,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02600,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02601,AFR,1,ALS2,5.0,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02602,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02603,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02604,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02605,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02606,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02607,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02608,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02609,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02610,AFR,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02611,AFR,2,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02612,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02613,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02614,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02615,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02616,AFR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02617,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02618,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02619,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02620,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02621,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02622,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02623,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02624,AFR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02625,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02626,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02627,AFR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02628,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02629,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02630,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02631,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02632,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02633,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02634,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02635,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02636,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02637,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02638,AFR,1,SPG11,6.5,Moderate,Asymptomatic/Low Penetrance,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02639,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02640,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02641,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02642,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02643,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02644,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02645,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02646,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02647,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02648,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02649,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02650,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02651,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02652,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02653,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02654,AFR,2,SOD1,7.0,Moderate,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02655,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02656,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02657,AFR,3,TBK1,10.0,Severe,Fast Progression,SOD1; TARDBP; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02658,AFR,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02659,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02660,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02661,AFR,2,FUS,9.9,Severe,Fast Progression,FUS; TARDBP,0,0,,,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02662,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02663,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02664,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02665,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02666,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02667,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02668,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02669,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02670,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02671,AFR,2,OPTN,8.4,Severe,Fast Progression,C9orf72; OPTN,1,2,C9ORF72; OPTN,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | OPTN: Autophagy receptor dysfunction,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02672,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02673,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02674,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02675,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02676,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02677,AFR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02678,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02679,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02680,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02681,AFR,2,SETX,6.2,Moderate,Slow Progression,DCTN1; SETX,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02682,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02683,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02684,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02685,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02686,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02687,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02688,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02689,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02690,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02691,AFR,2,FUS,9.9,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02692,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02693,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02694,AFR,3,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02695,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02696,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02697,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02698,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02699,AFR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_02700,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02701,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02702,AFR,3,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AFR_02703,AFR,3,ALS2,6.5,Moderate,Slow Progression,ALS2; ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AFR_02704,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02705,AFR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02706,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02707,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02708,AFR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
AFR_02709,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02710,AFR,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02711,AFR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02712,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02713,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02714,AFR,2,LOC108903148,9.2,Severe,Fast Progression,FUS; LOC108903148,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
AFR_02715,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02716,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02717,AFR,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02718,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02719,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02720,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02721,AFR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02722,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02723,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02724,AFR,2,CHRNA3,8.4,Severe,Fast Progression,ALS2; CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_02725,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02726,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02727,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02728,AFR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02729,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02730,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02731,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02732,AFR,2,SPG11,7.0,Moderate,Slow Progression,SETX; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02733,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02734,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02735,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02736,AFR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_02737,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02738,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02739,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02740,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02741,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02742,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02743,AFR,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02744,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02745,AFR,2,SOD1,7.0,Moderate,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02746,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02747,AFR,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02748,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02749,AFR,2,LOC124629354,8.4,Severe,Fast Progression,ALS2; LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AFR_02750,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02751,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02752,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02753,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02754,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02755,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02756,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02757,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02758,AFR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
AFR_02759,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02760,AFR,2,ALS2,7.2,Moderate,Slow Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Endosome-lysosome fusion failure
AFR_02761,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02762,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02763,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02764,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02765,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02766,AFR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02767,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02768,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02769,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02770,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02771,AFR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02772,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02773,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02774,AFR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02775,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02776,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02777,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02778,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02779,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02780,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02781,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02782,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02783,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02784,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02785,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02786,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02787,AFR,1,DCTN1,7.0,Moderate,Asymptomatic/Low Penetrance,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02788,AFR,2,SLC52A3,9.2,Severe,Fast Progression,PLEKHG5; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02789,AFR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02790,AFR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AFR_02791,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02792,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02793,AFR,2,SQSTM1,8.6,Severe,Slow Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02794,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02795,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02796,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02797,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02798,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02799,AFR,3,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02800,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02801,AFR,2,FUS,10.0,Severe,Fast Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02802,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02803,AFR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AFR_02804,AFR,2,SOD1,7.0,Moderate,Slow Progression,LOC108903148; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02805,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02806,AFR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02807,AFR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AFR_02808,AFR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02809,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02810,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02811,AFR,1,C9orf72,8.8,Severe,Fast Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AFR_02812,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02813,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02814,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02815,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02816,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02817,AFR,3,SOD1,7.7,Moderate,Slow Progression,ALS2; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02818,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02819,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02820,AFR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02821,AFR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02822,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02823,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02824,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02825,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02826,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02827,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02828,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02829,AFR,2,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02830,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02831,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02832,AFR,2,TBK1,10.0,Severe,Fast Progression,CHRNA3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02833,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02834,AFR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02835,AFR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02836,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02837,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02838,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02839,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02840,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02841,AFR,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02842,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02843,AFR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02844,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02845,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02846,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02847,AFR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02848,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02849,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02850,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02851,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02852,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02853,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02854,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02855,AFR,3,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02856,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02857,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02858,AFR,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AFR_02859,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02860,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02861,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02862,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02863,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02864,AFR,1,TBK1,7.7,Moderate,Asymptomatic/Low Penetrance,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02865,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02866,AFR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02867,AFR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AFR_02868,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02869,AFR,1,HNRNPA1,6.0,Moderate,Asymptomatic/Low Penetrance,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AFR_02870,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02871,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02872,AFR,3,OPTN,7.8,Moderate,Slow Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
AFR_02873,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02874,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02875,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02876,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02877,AFR,3,SOD1,7.7,Moderate,Fast Progression,SETX; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,5,DNA_Damage,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02878,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02879,AFR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02880,AFR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02881,AFR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02882,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02883,AFR,2,VCP,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02884,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02885,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02886,AFR,2,SOD1,7.0,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02887,AFR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AFR_02888,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02889,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02890,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02891,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02892,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02893,AFR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02894,AFR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02895,AFR,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02896,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02897,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02898,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02899,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02900,AFR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AFR_02901,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02902,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02903,AFR,2,TBK1,10.0,Severe,Fast Progression,CHRNA3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02904,AFR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02905,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02906,AFR,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AFR_02907,AFR,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02908,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02909,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02910,AFR,2,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02911,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02912,AFR,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02913,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02914,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02915,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02916,AFR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
AFR_02917,AFR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02918,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02919,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02920,AFR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02921,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02922,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02923,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02924,AFR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02925,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02926,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02927,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02928,AFR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02929,AFR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AFR_02930,AFR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AFR_02931,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02932,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02933,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02934,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02935,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02936,AFR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AFR_02937,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02938,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02939,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02940,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02941,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02942,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02943,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02944,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02945,AFR,2,TARDBP,7.0,Moderate,Slow Progression,ALS2; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AFR_02946,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02947,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02948,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02949,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02950,AFR,3,SPG11,7.0,Moderate,Slow Progression,SOD1; SPG11; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | UBQLN2: Ubiquitin-proteasome clearance failure,Lysosome reformation failure; DNA repair defects
AFR_02951,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02952,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02953,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02954,AFR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02955,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02956,AFR,3,SOD1,7.0,Moderate,Slow Progression,SOD1; TBK1; VCP,1,3,SOD1; TBK1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02957,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02958,AFR,2,SOD1,7.0,Moderate,Fast Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02959,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02960,AFR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02961,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02962,AFR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AFR_02963,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02964,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02965,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02966,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02967,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02968,AFR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02969,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02970,AFR,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Unknown mechanism
AFR_02971,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02972,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02973,AFR,3,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AFR_02974,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02975,AFR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
AFR_02976,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02977,AFR,4,NEK1,9.2,Severe,Fast Progression,NEK1; SOD1; SPG11; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,DNA damage checkpoint failure
AFR_02978,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02979,AFR,3,LOC124629354,8.4,Severe,Fast Progression,DCTN1; FUS; LOC124629354,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,RNA_Metabolism,DCTN1: Retrograde transport failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
AFR_02980,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02981,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02982,AFR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AFR_02983,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02984,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02985,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02986,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02987,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02988,AFR,1,ERLIN1,6.6,Moderate,Slow Progression,ERLIN1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AFR_02989,AFR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_02990,AFR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AFR_02991,AFR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AFR_02992,AFR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AFR_02993,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02994,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02995,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AFR_02996,AFR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AFR_02997,AFR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AFR_02998,AFR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AFR_02999,AFR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00000,AMR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_00001,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SIGMAR1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation,Autophagy receptor dysfunction
AMR_00002,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00003,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00004,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00005,AMR,2,NEK1,8.4,Severe,Fast Progression,ALS2; NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_00006,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00007,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00008,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00009,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00010,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00011,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00012,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00013,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00014,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00015,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00016,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00017,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00018,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00019,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00020,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00021,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00022,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00023,AMR,3,TBK1,9.1,Severe,Fast Progression,HNRNPA2B1; SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,Proteostasis,HNRNPA2B1: Stress granule dysregulation | SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00024,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00025,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00026,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00027,AMR,1,KIF5A,7.8,Moderate,Fast Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_00028,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00029,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00030,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00031,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00032,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00033,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00034,AMR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00035,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00036,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00037,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00038,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00039,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00040,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00041,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00042,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00043,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00044,AMR,2,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00045,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00046,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00047,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00048,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_00049,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00050,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00051,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00052,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00053,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00054,AMR,3,VCP,7.0,Moderate,Slow Progression,ALS2; LOC130003372; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00055,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00056,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00057,AMR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00058,AMR,2,SETX,6.2,Moderate,Slow Progression,SETX; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Cytoskeletal_Axonal_Transport,SETX: R-loop accumulation; genomic instability | TUBA4A: Microtubule destabilization,R-loop accumulation; genomic instability
AMR_00059,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00060,AMR,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00061,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00062,AMR,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00063,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00064,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00065,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00066,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00067,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00068,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00069,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00070,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00071,AMR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00072,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AMR_00073,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00074,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00075,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00076,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00077,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00078,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00079,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00080,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00081,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00082,AMR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00083,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00084,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00085,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00086,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00087,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00088,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00089,AMR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00090,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00091,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00092,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00093,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00094,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00095,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00096,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00097,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_00098,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00099,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00100,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00101,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00102,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00103,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00104,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00105,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00106,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00107,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00108,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00109,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00110,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00111,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00112,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00113,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00114,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00115,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00116,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00117,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00118,AMR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_00119,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00120,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00121,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00122,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00123,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00124,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00125,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00126,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00127,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00128,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00129,AMR,2,FUS,10.0,Severe,Fast Progression,FUS; SIGMAR1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00130,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00131,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00132,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00133,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00134,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00135,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00136,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00137,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00138,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00139,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00140,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00141,AMR,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00142,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00143,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00144,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00145,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00146,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00147,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00148,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00149,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00150,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00151,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00152,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00153,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00154,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00155,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00156,AMR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00157,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00158,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00159,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00160,AMR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_00161,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00162,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00163,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00164,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00165,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00166,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00167,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00168,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00169,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00170,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00171,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00172,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00173,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00174,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00175,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00176,AMR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00177,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00178,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00179,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00180,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00181,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00182,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00183,AMR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
AMR_00184,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00185,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00186,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00187,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00188,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00189,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00190,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00191,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00192,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00193,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00194,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00195,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00196,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00197,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00198,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00199,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00200,AMR,2,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_00201,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00202,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00203,AMR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00204,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00205,AMR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_00206,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_00207,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00208,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00209,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00210,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00211,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00212,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00213,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00214,AMR,2,NEK1,8.4,Severe,Fast Progression,NEK1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,4,Proteostasis,NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DNA damage checkpoint failure
AMR_00215,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00216,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00217,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00218,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00219,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00220,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00221,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00222,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00223,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00224,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00225,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00226,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00227,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00228,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00229,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00230,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00231,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00232,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00233,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00234,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00235,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00236,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00237,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00238,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00239,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00240,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00241,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00242,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00243,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00244,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00245,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00246,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00247,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00248,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00249,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00250,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00251,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00252,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00253,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00254,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00255,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00256,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00257,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00258,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00259,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00260,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00261,AMR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00262,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00263,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00264,AMR,2,SOD1,7.0,Moderate,Fast Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00265,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00266,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00267,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00268,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00269,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00270,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00271,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00272,AMR,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00273,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00274,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00275,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00276,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00277,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00278,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00279,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00280,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00281,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00282,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00283,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_00284,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00285,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00286,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00287,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00288,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00289,AMR,3,OPTN,9.2,Severe,Fast Progression,OPTN; SIGMAR1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation,Autophagy receptor dysfunction
AMR_00290,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_00291,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00292,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00293,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00294,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00295,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00296,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00297,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00298,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00299,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00300,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00301,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00302,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00303,AMR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00304,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00305,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00306,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00307,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00308,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00309,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00310,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00311,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00312,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00313,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00314,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00315,AMR,3,SQSTM1,9.2,Severe,Fast Progression,SOD1; SPG11; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00316,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_00317,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00318,AMR,2,TARDBP,7.7,Moderate,Slow Progression,SETX; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00319,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00320,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00321,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00322,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00323,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00324,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00325,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00326,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00327,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00328,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00329,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00330,AMR,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00331,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00332,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00333,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00334,AMR,2,VCP,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00335,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00336,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00337,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00338,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00339,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00340,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00341,AMR,1,PRPH,7.8,Moderate,Fast Progression,PRPH,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00342,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00343,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00344,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00345,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00346,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00347,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00348,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00349,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00350,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00351,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00352,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00353,AMR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction
AMR_00354,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00355,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00356,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00357,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00358,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00359,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00360,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00361,AMR,2,SOD1,7.0,Moderate,Slow Progression,CHMP2B; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00362,AMR,3,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00363,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00364,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00365,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00366,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00367,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_00368,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00369,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00370,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00371,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00372,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00373,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00374,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00375,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00376,AMR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00377,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00378,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00379,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00380,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00381,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00382,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00383,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00384,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00385,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00386,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00387,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00388,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00389,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00390,AMR,2,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00391,AMR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00392,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00393,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00394,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00395,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00396,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00397,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00398,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00399,AMR,2,TARDBP,7.0,Moderate,Slow Progression,CHRNA3; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00400,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00401,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00402,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00403,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00404,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00405,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00406,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00407,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00408,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00409,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00410,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00411,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00412,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00413,AMR,3,FIG4,9.2,Severe,Fast Progression,FIG4; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,FIG4; SPG11,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosomal biogenesis failure
AMR_00414,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00415,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00416,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00417,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00418,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00419,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00420,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00421,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00422,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00423,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00424,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00425,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00426,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00427,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00428,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00429,AMR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
AMR_00430,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00431,AMR,3,FUS,10.0,Severe,Fast Progression,FUS; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00432,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00433,AMR,2,LOC130056973,8.4,Severe,Fast Progression,LOC130056973; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,Unknown mechanism
AMR_00434,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00435,AMR,3,LOC124629354,8.4,Severe,Fast Progression,ALS2; FIG4; LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; FIG4,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,Unknown mechanism
AMR_00436,AMR,1,SIGMAR1,7.2,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_00437,AMR,3,SPG11,7.0,Moderate,Slow Progression,HNRNPA1; SIGMAR1; SPG11,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,HNRNPA1: Stress granule dysregulation | SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00438,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00439,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00440,AMR,1,DCTN1,7.7,Moderate,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00441,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00442,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00443,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00444,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00445,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00446,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00447,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00448,AMR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00449,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00450,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00451,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00452,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00453,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00454,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00455,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00456,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00457,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00458,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00459,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00460,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00461,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00462,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_00463,AMR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00464,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00465,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00466,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00467,AMR,3,TBK1,9.1,Severe,Fast Progression,SOD1; SQSTM1; TBK1,1,3,SOD1; SQSTM1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00468,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00469,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00470,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00471,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00472,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00473,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00474,AMR,3,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00475,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00476,AMR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AMR_00477,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00478,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00479,AMR,2,TBK1,9.8,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00480,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00481,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00482,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00483,AMR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00484,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00485,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00486,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00487,AMR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
AMR_00488,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00489,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00490,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00491,AMR,3,TBK1,7.7,Moderate,Slow Progression,ALS2; SPTLC1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00492,AMR,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00493,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00494,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00495,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00496,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00497,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00498,AMR,2,SQSTM1,7.8,Moderate,Slow Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00499,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00500,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00501,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00502,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00503,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00504,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00505,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00506,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00507,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00508,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00509,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00510,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00511,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00512,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00513,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00514,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00515,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00516,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_00517,AMR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00518,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00519,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_00520,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00521,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00522,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00523,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00524,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00525,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00526,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00527,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00528,AMR,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00529,AMR,3,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
AMR_00530,AMR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
AMR_00531,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00532,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00533,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00534,AMR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00535,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00536,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00537,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00538,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00539,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00540,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00541,AMR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00542,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AMR_00543,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00544,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00545,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00546,AMR,2,TBK1,7.7,Moderate,Slow Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00547,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00548,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00549,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00550,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00551,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00552,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_00553,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00554,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00555,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00556,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00557,AMR,1,SETX,6.2,Moderate,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00558,AMR,2,TARDBP,7.0,Moderate,Slow Progression,SETX; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00559,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00560,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00561,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00562,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00563,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00564,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00565,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00566,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00567,AMR,2,SPG11,7.0,Moderate,Fast Progression,PLEKHG5; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00568,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00569,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00570,AMR,1,TARDBP,7.0,Moderate,Fast Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00571,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00572,AMR,3,TBK1,10.0,Severe,Fast Progression,PLEKHG5; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00573,AMR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00574,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00575,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00576,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00577,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00578,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00579,AMR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00580,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00581,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00582,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00583,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00584,AMR,3,VCP,7.0,Moderate,Slow Progression,ALS2; UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00585,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00586,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00587,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00588,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00589,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00590,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00591,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00592,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00593,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00594,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00595,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00596,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00597,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00598,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00599,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00600,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00601,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00602,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00603,AMR,2,TBK1,10.0,Severe,Fast Progression,C9orf72; TBK1,1,2,C9ORF72; TBK1,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | TBK1: Autophagy initiation kinase deficiency,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00604,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00605,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00606,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00607,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00608,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00609,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00610,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00611,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00612,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00613,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00614,AMR,2,SQSTM1,6.6,Moderate,Slow Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00615,AMR,2,FUS,9.0,Severe,Slow Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00616,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00617,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00618,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00619,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00620,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00621,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00622,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00623,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00624,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00625,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00626,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00627,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00628,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00629,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00630,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00631,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00632,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00633,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00634,AMR,2,LOC130001681,8.4,Severe,Fast Progression,ALS2; LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AMR_00635,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00636,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00637,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00638,AMR,2,SOD1,7.0,Moderate,Slow Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00639,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00640,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00641,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00642,AMR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00643,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00644,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00645,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00646,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00647,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00648,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00649,AMR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00650,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00651,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00652,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00653,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00654,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00655,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00656,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00657,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00658,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00659,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00660,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00661,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00662,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00663,AMR,1,LOC124629354,7.8,Moderate,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00664,AMR,2,SOD1,7.0,Moderate,Fast Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00665,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00666,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00667,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00668,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00669,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00670,AMR,2,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00671,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00672,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00673,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00674,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00675,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00676,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00677,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00678,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00679,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00680,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00681,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00682,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00683,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00684,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00685,AMR,2,LOC130003372,6.6,Moderate,Slow Progression,LOC130003372; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_00686,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00687,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00688,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00689,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00690,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00691,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00692,AMR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00693,AMR,3,TBK1,10.0,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00694,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00695,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00696,AMR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00697,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00698,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00699,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00700,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00701,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00702,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00703,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00704,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00705,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00706,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00707,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00708,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00709,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00710,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00711,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00712,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00713,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00714,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00715,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00716,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00717,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00718,AMR,1,PLEKHG5,6.2,Moderate,Slow Progression,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00719,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00720,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00721,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00722,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00723,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00724,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00725,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00726,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00727,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00728,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00729,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_00730,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00731,AMR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00732,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00733,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00734,AMR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_00735,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00736,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00737,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00738,AMR,2,SOD1,7.0,Moderate,Slow Progression,PARK7; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00739,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00740,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00741,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00742,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00743,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00744,AMR,3,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_00745,AMR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00746,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00747,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00748,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00749,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00750,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00751,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_00752,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00753,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00754,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00755,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00756,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00757,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00758,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00759,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00760,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00761,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00762,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00763,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00764,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00765,AMR,3,SOD1,7.0,Moderate,Fast Progression,ALS2; OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00766,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00767,AMR,2,SPG11,7.0,Moderate,Slow Progression,ANG; SPG11,0,0,,,1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,RNA_Metabolism,ANG: Ribosomal biogenesis impairment | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00768,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00769,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00770,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00771,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00772,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00773,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00774,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00775,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_00776,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00777,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00778,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00779,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00780,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00781,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00782,AMR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00783,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00784,AMR,2,VCP,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00785,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00786,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00787,AMR,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AMR_00788,AMR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00789,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00790,AMR,1,LOC130001681,9.2,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00791,AMR,3,SQSTM1,8.6,Severe,Fast Progression,SETX; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00792,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00793,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00794,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00795,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00796,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00797,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00798,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00799,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00800,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00801,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00802,AMR,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00803,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_00804,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00805,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00806,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00807,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00808,AMR,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00809,AMR,1,PRPH,7.8,Moderate,Fast Progression,PRPH,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00810,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00811,AMR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; UNC13A,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | UNC13A: Synaptic transmission defects,Autophagy receptor dysfunction
AMR_00812,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00813,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00814,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00815,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00816,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00817,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00818,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00819,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00820,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00821,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00822,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00823,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00824,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00825,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00826,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00827,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00828,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00829,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00830,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00831,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00832,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00833,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00834,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00835,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00836,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00837,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00838,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_00839,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00840,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00841,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AMR_00842,AMR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_00843,AMR,2,VCP,7.7,Moderate,Slow Progression,KIF5A; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,KIF5A: Anterograde transport failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00844,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00845,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00846,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00847,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00848,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00849,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00850,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00851,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00852,AMR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00853,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00854,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_00855,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00856,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00857,AMR,2,LOC108903148,9.2,Severe,Fast Progression,ALS2; LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AMR_00858,AMR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00859,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00860,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00861,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00862,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00863,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00864,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00865,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00866,AMR,3,SOD1,7.0,Moderate,Slow Progression,ERBB4; SOD1; UNC13A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,0,0,,,0,0,,,3,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00867,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00868,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00869,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00870,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00871,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00872,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00873,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00874,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00875,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00876,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00877,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00878,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00879,AMR,3,SOD1,7.7,Moderate,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00880,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00881,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00882,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00883,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00884,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00885,AMR,1,HNRNPA1,6.0,Moderate,Asymptomatic/Low Penetrance,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_00886,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00887,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00888,AMR,1,LOC124629354,8.4,Severe,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00889,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00890,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00891,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_00892,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00893,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00894,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00895,AMR,1,PLEKHG5,6.2,Moderate,Slow Progression,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00896,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00897,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00898,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00899,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00900,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00901,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00902,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00903,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00904,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00905,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00906,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00907,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00908,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00909,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00910,AMR,2,NEK1,8.4,Severe,Fast Progression,NEK1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,4,Proteostasis,NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DNA damage checkpoint failure
AMR_00911,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00912,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00913,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00914,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00915,AMR,2,LOC129995449,7.8,Moderate,Fast Progression,DCTN1; LOC129995449,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Unknown mechanism
AMR_00916,AMR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00917,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00918,AMR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_00919,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00920,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00921,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00922,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00923,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00924,AMR,2,FUS,9.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00925,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00926,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00927,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00928,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00929,AMR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_00930,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00931,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00932,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00933,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00934,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00935,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00936,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00937,AMR,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
AMR_00938,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00939,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00940,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00941,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00942,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00943,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_00944,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00945,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00946,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00947,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00948,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00949,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00950,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00951,AMR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00952,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00953,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00954,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00955,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; CHMP2B,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,Endosome-lysosome fusion failure
AMR_00956,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
AMR_00957,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00958,AMR,1,SQSTM1,8.6,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_00959,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00960,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00961,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00962,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00963,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00964,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00965,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00966,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_00967,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00968,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_00969,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00970,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AMR_00971,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00972,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00973,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00974,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_00975,AMR,2,OPTN,7.8,Moderate,Fast Progression,HNRNPA1; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA1: Stress granule dysregulation | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_00976,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00977,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00978,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00979,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00980,AMR,2,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1; TUBA4A,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation | TUBA4A: Microtubule destabilization,Stress granule dysregulation
AMR_00981,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00982,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_00983,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00984,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00985,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00986,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00987,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00988,AMR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_00989,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00990,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00991,AMR,2,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_00992,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00993,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_00994,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00995,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00996,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00997,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00998,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_00999,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01000,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01001,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01002,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01003,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01004,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01005,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01006,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01007,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01008,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01009,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01010,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01011,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01012,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01013,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01014,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01015,AMR,1,SQSTM1,8.6,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01016,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01017,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01018,AMR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01019,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01020,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01021,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01022,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01023,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01024,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01025,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01026,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01027,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01028,AMR,2,FIG4,7.8,Moderate,Fast Progression,FIG4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AMR_01029,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01030,AMR,1,KIF5A,7.8,Moderate,Fast Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_01031,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01032,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01033,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01034,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01035,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01036,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01037,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01038,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01039,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01040,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01041,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01042,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01043,AMR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01044,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01045,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01046,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01047,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01048,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01049,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01050,AMR,3,TBK1,10.0,Severe,Fast Progression,FIG4; TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AMR_01051,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01052,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01053,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01054,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01055,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01056,AMR,1,DCTN1,9.1,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01057,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01058,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01059,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01060,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01061,AMR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01062,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01063,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01064,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01065,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01066,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01067,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01068,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01069,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01070,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01071,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01072,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01073,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01074,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01075,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01076,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01077,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01078,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01079,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01080,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01081,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01082,AMR,1,ALS2,7.0,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01083,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01084,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01085,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01086,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01087,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01088,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01089,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01090,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01091,AMR,1,LOC124629354,7.8,Moderate,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01092,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01093,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01094,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01095,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01096,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01097,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01098,AMR,3,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
AMR_01099,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01100,AMR,1,ALS2,7.0,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01101,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01102,AMR,2,SOD1,7.0,Moderate,Fast Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01103,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01104,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01105,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01106,AMR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AMR_01107,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01108,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01109,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01110,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01111,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01112,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01113,AMR,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01114,AMR,2,TBK1,9.1,Severe,Fast Progression,TARDBP; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01115,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01116,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01117,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01118,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01119,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01120,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01121,AMR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SIGMAR1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation,Autophagy receptor dysfunction
AMR_01122,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01123,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01124,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01125,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01126,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01127,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01128,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01129,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01130,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01131,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01132,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01133,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01134,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01135,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01136,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01137,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01138,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01139,AMR,4,TBK1,9.8,Severe,Fast Progression,ALS2; SETX; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01140,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01141,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01142,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01143,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01144,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01145,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01146,AMR,2,FUS,9.9,Severe,Slow Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01147,AMR,3,FUS,10.0,Severe,Fast Progression,FUS; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01148,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01149,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01150,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01151,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01152,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01153,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01154,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01155,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01156,AMR,3,SOD1,7.7,Moderate,Fast Progression,KIF5A; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,6,Proteostasis,KIF5A: Anterograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01157,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01158,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01159,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01160,AMR,2,SPTLC1,6.9,Moderate,Slow Progression,ALS2; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AMR_01161,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01162,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01163,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01164,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01165,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01166,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01167,AMR,3,TBK1,10.0,Severe,Fast Progression,SIGMAR1; SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01168,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01169,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01170,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01171,AMR,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
AMR_01172,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01173,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01174,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01175,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01176,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01177,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01178,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01179,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01180,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01181,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01182,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01183,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01184,AMR,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01185,AMR,2,FUS,10.0,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01186,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01187,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01188,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01189,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01190,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01191,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01192,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_01193,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01194,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01195,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01196,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01197,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01198,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01199,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01200,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01201,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01202,AMR,3,TBK1,10.0,Severe,Fast Progression,ALS2; OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01203,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01204,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01205,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01206,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01207,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01208,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01209,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01210,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01211,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01212,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01213,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01214,AMR,2,KIF5A,6.6,Moderate,Slow Progression,ALS2; KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_01215,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01216,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01217,AMR,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01218,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01219,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01220,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01221,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01222,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01223,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01224,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01225,AMR,2,ALS2,7.0,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01226,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01227,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01228,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01229,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01230,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01231,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01232,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01233,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01234,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01235,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01236,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01237,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01238,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01239,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01240,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01241,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01242,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01243,AMR,2,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01244,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01245,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01246,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01247,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01248,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01249,AMR,2,TBK1,10.0,Severe,Fast Progression,LOC108903148; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01250,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01251,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01252,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01253,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01254,AMR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AMR_01255,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01256,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01257,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01258,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01259,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01260,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01261,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01262,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01263,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01264,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01265,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01266,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01267,AMR,2,SETX,6.2,Moderate,Slow Progression,SETX; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Mitochondrial,SETX: R-loop accumulation; genomic instability | SIGMAR1: MAM calcium dysregulation,R-loop accumulation; genomic instability
AMR_01268,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01269,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01270,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01271,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01272,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01273,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01274,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01275,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01276,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01277,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01278,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01279,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01280,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01281,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01282,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01283,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01284,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01285,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01286,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01287,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01288,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01289,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01290,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01291,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01292,AMR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AMR_01293,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01294,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01295,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01296,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01297,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01298,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01299,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01300,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01301,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01302,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01303,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01304,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01305,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01306,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01307,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01308,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01309,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01310,AMR,2,TARDBP,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01311,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01312,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01313,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01314,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01315,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01316,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01317,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01318,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01319,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01320,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01321,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01322,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01323,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01324,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01325,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01326,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01327,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01328,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01329,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01330,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01331,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01332,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01333,AMR,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01334,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01335,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01336,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01337,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01338,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01339,AMR,1,SLC52A3,6.6,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01340,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01341,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01342,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01343,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01344,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01345,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01346,AMR,1,SQSTM1,7.8,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01347,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01348,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01349,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01350,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01351,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01352,AMR,1,NEK1,7.8,Moderate,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_01353,AMR,2,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01354,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01355,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01356,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01357,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01358,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01359,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01360,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01361,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01362,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01363,AMR,2,UNC13A,6.0,Moderate,Slow Progression,ALS2; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_01364,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01365,AMR,3,SPG11,7.0,Moderate,Fast Progression,SETX; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,5,DNA_Damage,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01366,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01367,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01368,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01369,AMR,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01370,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01371,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01372,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01373,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01374,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01375,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01376,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01377,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01378,AMR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01379,AMR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01380,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01381,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01382,AMR,2,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01383,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01384,AMR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01385,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01386,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01387,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01388,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01389,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01390,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01391,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01392,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01393,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01394,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01395,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01396,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01397,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01398,AMR,2,SOD1,7.7,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01399,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01400,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01401,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01402,AMR,2,TBK1,7.7,Moderate,Slow Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AMR_01403,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01404,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01405,AMR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01406,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01407,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01408,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01409,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01410,AMR,1,SETX,4.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01411,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01412,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1; TUBA4A,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,TBK1: Autophagy initiation kinase deficiency | TUBA4A: Microtubule destabilization,Autophagy initiation kinase deficiency
AMR_01413,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01414,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01415,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01416,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01417,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01418,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01419,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01420,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01421,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01422,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01423,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01424,AMR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01425,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01426,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01427,AMR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01428,AMR,2,UBQLN2,7.7,Moderate,Fast Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01429,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01430,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01431,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01432,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01433,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01434,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01435,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01436,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01437,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01438,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01439,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01440,AMR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01441,AMR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction
AMR_01442,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01443,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01444,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01445,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01446,AMR,2,C9orf72,8.8,Severe,Fast Progression,C9orf72; SPG11,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,DPR toxicity; RNA foci; AMPA receptor dysregulation
AMR_01447,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01448,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01449,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01450,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01451,AMR,2,TBK1,10.0,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01452,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01453,AMR,2,SOD1,7.0,Moderate,Fast Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01454,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01455,AMR,1,ERLIN1,6.6,Moderate,Slow Progression,ERLIN1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01456,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01457,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01458,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01459,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01460,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01461,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01462,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01463,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01464,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01465,AMR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01466,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01467,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01468,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01469,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01470,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01471,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01472,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01473,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01474,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01475,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01476,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01477,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01478,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01479,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01480,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01481,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01482,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01483,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01484,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01485,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01486,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01487,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01488,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01489,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01490,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01491,AMR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01492,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01493,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01494,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01495,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01496,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01497,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01498,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01499,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01500,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01501,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01502,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01503,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01504,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01505,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01506,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01507,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01508,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01509,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01510,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01511,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01512,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01513,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01514,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01515,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01516,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01517,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01518,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01519,AMR,2,UBQLN2,7.7,Moderate,Slow Progression,PLEKHG5; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01520,AMR,2,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01521,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01522,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01523,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01524,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01525,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01526,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01527,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01528,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01529,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01530,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01531,AMR,2,SETX,6.2,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,R-loop accumulation; genomic instability
AMR_01532,AMR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AMR_01533,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01534,AMR,2,TBK1,10.0,Severe,Fast Progression,FIG4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01535,AMR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01536,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01537,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01538,AMR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AMR_01539,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01540,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01541,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01542,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01543,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01544,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01545,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01546,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01547,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01548,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01549,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01550,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01551,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01552,AMR,3,TBK1,10.0,Severe,Fast Progression,SOD1; SPG11; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01553,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01554,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01555,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01556,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01557,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01558,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01559,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01560,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01561,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01562,AMR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01563,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01564,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01565,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01566,AMR,1,SIGMAR1,7.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01567,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01568,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01569,AMR,4,OPTN,9.2,Severe,Fast Progression,OPTN; SLC52A3; SPG11; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AMR_01570,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01571,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01572,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01573,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01574,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01575,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01576,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01577,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01578,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01579,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01580,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01581,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01582,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01583,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01584,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01585,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01586,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01587,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01588,AMR,2,SOD1,7.7,Moderate,Slow Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01589,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01590,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01591,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01592,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01593,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01594,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01595,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01596,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01597,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01598,AMR,2,FIG4,7.8,Moderate,Fast Progression,FIG4; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,3,RNA_Metabolism,FIG4: Lysosomal biogenesis failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosomal biogenesis failure
AMR_01599,AMR,2,VCP,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01600,AMR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01601,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01602,AMR,3,UBQLN2,7.7,Moderate,Fast Progression,ALS2; SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01603,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01604,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01605,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01606,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01607,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01608,AMR,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01609,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01610,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01611,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01612,AMR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AMR_01613,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01614,AMR,3,FUS,9.9,Severe,Fast Progression,FUS; SIGMAR1; SLC52A3,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01615,AMR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01616,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01617,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01618,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_01619,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01620,AMR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_01621,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01622,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01623,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01624,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01625,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01626,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01627,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01628,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01629,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01630,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01631,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01632,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01633,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01634,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01635,AMR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_01636,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01637,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01638,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01639,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01640,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01641,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01642,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01643,AMR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_01644,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_01645,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01646,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01647,AMR,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01648,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01649,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01650,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01651,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01652,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01653,AMR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_01654,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01655,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01656,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01657,AMR,1,LOC124629354,8.4,Severe,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01658,AMR,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01659,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01660,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01661,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_01662,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01663,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01664,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01665,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01666,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01667,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01668,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01669,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01670,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01671,AMR,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01672,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01673,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01674,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01675,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01676,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01677,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01678,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01679,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01680,AMR,3,FIG4,7.8,Moderate,Fast Progression,FIG4; SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,2,FIG4; SPG11,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Lysosomal biogenesis failure
AMR_01681,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01682,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01683,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01684,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01685,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01686,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01687,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01688,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01689,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01690,AMR,3,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1; TARDBP,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AMR_01691,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01692,AMR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01693,AMR,2,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01694,AMR,4,LOC108903148,9.2,Severe,Fast Progression,FUS; LOC108903148; SOD1; TUBA4A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,5,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TUBA4A: Microtubule destabilization,Unknown mechanism
AMR_01695,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01696,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01697,AMR,1,VCP,7.7,Moderate,Asymptomatic/Low Penetrance,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01698,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01699,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01700,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01701,AMR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01702,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01703,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01704,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01705,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01706,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01707,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01708,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01709,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01710,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01711,AMR,2,SLC52A3,8.4,Severe,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_01712,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01713,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01714,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01715,AMR,2,SETX,5.2,Mild,Slow Progression,ERBB4; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01716,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01717,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01718,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01719,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01720,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01721,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01722,AMR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01723,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01724,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01725,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01726,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01727,AMR,1,PLEKHG5,6.2,Moderate,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01728,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01729,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01730,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01731,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01732,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01733,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01734,AMR,2,FUS,9.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01735,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01736,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01737,AMR,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01738,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01739,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01740,AMR,2,TARDBP,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01741,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01742,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01743,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01744,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01745,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01746,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01747,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01748,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01749,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01750,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01751,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01752,AMR,2,TARDBP,7.7,Moderate,Slow Progression,TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01753,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01754,AMR,2,SPG11,7.0,Moderate,Slow Progression,C9orf72; SPG11,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01755,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01756,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01757,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01758,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01759,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01760,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01761,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01762,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01763,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01764,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01765,AMR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AMR_01766,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01767,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_01768,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01769,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01770,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01771,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01772,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01773,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01774,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01775,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01776,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01777,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01778,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01779,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01780,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01781,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01782,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01783,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01784,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01785,AMR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01786,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01787,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01788,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01789,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01790,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01791,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01792,AMR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_01793,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01794,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01795,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01796,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01797,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01798,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01799,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01800,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01801,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01802,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01803,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01804,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01805,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01806,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01807,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01808,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01809,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01810,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01811,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01812,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01813,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01814,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01815,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01816,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01817,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01818,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01819,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01820,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01821,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01822,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01823,AMR,2,FUS,9.9,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01824,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01825,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01826,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01827,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01828,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01829,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01830,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01831,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01832,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01833,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01834,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01835,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01836,AMR,2,TBK1,10.0,Severe,Fast Progression,ANXA11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01837,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01838,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01839,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_01840,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01841,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_01842,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01843,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01844,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01845,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01846,AMR,1,SETX,5.7,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01847,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01848,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01849,AMR,2,SOD1,7.0,Moderate,Slow Progression,LOC130003372; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01850,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01851,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01852,AMR,1,LOC124629354,8.4,Severe,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01853,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01854,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01855,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01856,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01857,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01858,AMR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01859,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01860,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01861,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01862,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_01863,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01864,AMR,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
AMR_01865,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01866,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01867,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01868,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01869,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01870,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01871,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01872,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01873,AMR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
AMR_01874,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01875,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01876,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01877,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01878,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01879,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01880,AMR,2,SQSTM1,8.4,Severe,Fast Progression,SQSTM1; VCP,1,2,SQSTM1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction (p62)
AMR_01881,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01882,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01883,AMR,1,ANG,6.0,Moderate,Slow Progression,ANG,0,0,,,1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,ANG: Ribosomal biogenesis impairment,Ribosomal biogenesis impairment
AMR_01884,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01885,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01886,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01887,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01888,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01889,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01890,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01891,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01892,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01893,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01894,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01895,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01896,AMR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01897,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01898,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01899,AMR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01900,AMR,2,TBK1,9.8,Severe,Fast Progression,SLC52A3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01901,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01902,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01903,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01904,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01905,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01906,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01907,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01908,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01909,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01910,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01911,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01912,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01913,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01914,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01915,AMR,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Unknown mechanism
AMR_01916,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01917,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_01918,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01919,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01920,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01921,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01922,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01923,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01924,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01925,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01926,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01927,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01928,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01929,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01930,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01931,AMR,2,TBK1,9.8,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01932,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01933,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01934,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01935,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01936,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01937,AMR,2,VCP,7.0,Moderate,Fast Progression,SQSTM1; VCP,1,2,SQSTM1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01938,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_01939,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01940,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01941,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01942,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_01943,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01944,AMR,3,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01945,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01946,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01947,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01948,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01949,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01950,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01951,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01952,AMR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_01953,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01954,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01955,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_01956,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01957,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01958,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01959,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01960,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01961,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01962,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01963,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_01964,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01965,AMR,3,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_01966,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01967,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01968,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01969,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01970,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01971,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01972,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01973,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01974,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01975,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01976,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01977,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01978,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01979,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01980,AMR,2,VCP,7.0,Moderate,Slow Progression,TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_01981,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01982,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_01983,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01984,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01985,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01986,AMR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01987,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01988,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_01989,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01990,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_01991,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_01992,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01993,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01994,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01995,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01996,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01997,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_01998,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_01999,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02000,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02001,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02002,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02003,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02004,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02005,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02006,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02007,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02008,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02009,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02010,AMR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
AMR_02011,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02012,AMR,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02013,AMR,1,SQSTM1,6.6,Moderate,Asymptomatic/Low Penetrance,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02014,AMR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02015,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02016,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02017,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02018,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02019,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02020,AMR,2,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02021,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02022,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02023,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02024,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02025,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02026,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02027,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02028,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02029,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02030,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02031,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02032,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02033,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02034,AMR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02035,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02036,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02037,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02038,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02039,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02040,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02041,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02042,AMR,2,TBK1,10.0,Severe,Fast Progression,DCTN1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02043,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02044,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02045,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction
AMR_02046,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02047,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02048,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02049,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02050,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02051,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02052,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_02053,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02054,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02055,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02056,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02057,AMR,1,SETX,5.7,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02058,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02059,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02060,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02061,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02062,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02063,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02064,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02065,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02066,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02067,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02068,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02069,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02070,AMR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02071,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02072,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02073,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02074,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02075,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02076,AMR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02077,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02078,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02079,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02080,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02081,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02082,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02083,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02084,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02085,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02086,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02087,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02088,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02089,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02090,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02091,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02092,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02093,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02094,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02095,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02096,AMR,2,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_02097,AMR,2,DCTN1,9.1,Severe,Fast Progression,DCTN1; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,DCTN1: Retrograde transport failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Retrograde transport failure
AMR_02098,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02099,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02100,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02101,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02102,AMR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_02103,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02104,AMR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02105,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02106,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02107,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02108,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02109,AMR,2,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02110,AMR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02111,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02112,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02113,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02114,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02115,AMR,2,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
AMR_02116,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
AMR_02117,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02118,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02119,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02120,AMR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02121,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02122,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02123,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
AMR_02124,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02125,AMR,3,OPTN,9.2,Severe,Fast Progression,OPTN; SLC52A3; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction
AMR_02126,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02127,AMR,2,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02128,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02129,AMR,3,SPG11,7.0,Moderate,Slow Progression,SETX; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,5,DNA_Damage,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02130,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02131,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02132,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02133,AMR,3,FUS,10.0,Severe,Fast Progression,FIG4; FUS; SLC52A3,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,3,RNA_Metabolism,FIG4: Lysosomal biogenesis failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02134,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02135,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02136,AMR,3,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02137,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02138,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02139,AMR,2,FUS,9.9,Severe,Fast Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02140,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02141,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02142,AMR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02143,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02144,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02145,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02146,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02147,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02148,AMR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02149,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_02150,AMR,2,TBK1,10.0,Severe,Fast Progression,FIG4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02151,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02152,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02153,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02154,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02155,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02156,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02157,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02158,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02159,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02160,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02161,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02162,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02163,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02164,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02165,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02166,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02167,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02168,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02169,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02170,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02171,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02172,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02173,AMR,2,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02174,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02175,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02176,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02177,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02178,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02179,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02180,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_02181,AMR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02182,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02183,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02184,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02185,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02186,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02187,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02188,AMR,2,OPTN,9.2,Severe,Fast Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction
AMR_02189,AMR,1,FIG4,9.2,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_02190,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02191,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
AMR_02192,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02193,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02194,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02195,AMR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
AMR_02196,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02197,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02198,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02199,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02200,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02201,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02202,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02203,AMR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02204,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02205,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02206,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02207,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02208,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02209,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02210,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02211,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02212,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02213,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02214,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02215,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02216,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02217,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_02218,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02219,AMR,1,FIG4,9.2,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_02220,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02221,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02222,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02223,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02224,AMR,1,SETX,5.7,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02225,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02226,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02227,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02228,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02229,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02230,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02231,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02232,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02233,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02234,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02235,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02236,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02237,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02238,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02239,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02240,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02241,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02242,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02243,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02244,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02245,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02246,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02247,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02248,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02249,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02250,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02251,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02252,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02253,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02254,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02255,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02256,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02257,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02258,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02259,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02260,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02261,AMR,2,SPG11,6.5,Moderate,Slow Progression,SIGMAR1; SPG11,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02262,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02263,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02264,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02265,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02266,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02267,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02268,AMR,5,FUS,10.0,Severe,Fast Progression,ALS2; FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Mitochondrial,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02269,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02270,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02271,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02272,AMR,2,SQSTM1,6.6,Moderate,Slow Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02273,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02274,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02275,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02276,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02277,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02278,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02279,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02280,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02281,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02282,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02283,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02284,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02285,AMR,2,SOD1,7.7,Moderate,Slow Progression,PLEKHG5; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02286,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02287,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02288,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02289,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02290,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02291,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02292,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02293,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02294,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02295,AMR,2,LOC129995449,7.8,Moderate,Fast Progression,KIF5A; LOC129995449,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Unknown mechanism
AMR_02296,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02297,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02298,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02299,AMR,2,SQSTM1,6.6,Moderate,Slow Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02300,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02301,AMR,1,ERLIN1,6.6,Moderate,Slow Progression,ERLIN1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02302,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02303,AMR,2,SOD1,7.7,Moderate,Fast Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02304,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02305,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02306,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02307,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02308,AMR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02309,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02310,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_02311,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02312,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_02313,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02314,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02315,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02316,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02317,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02318,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02319,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02320,AMR,4,FIG4,7.8,Moderate,Fast Progression,FIG4; FUS; PLEKHG5; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,5,Mitochondrial,FIG4: Lysosomal biogenesis failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
AMR_02321,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02322,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02323,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02324,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02325,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02326,AMR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02327,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02328,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02329,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02330,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02331,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02332,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02333,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02334,AMR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_02335,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02336,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02337,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02338,AMR,3,OPTN,6.6,Moderate,Slow Progression,HNRNPA1; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA1: Stress granule dysregulation | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02339,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02340,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02341,AMR,1,KIF5A,7.8,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
AMR_02342,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02343,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02344,AMR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02345,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_02346,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02347,AMR,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02348,AMR,2,OPTN,8.4,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02349,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02350,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02351,AMR,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02352,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02353,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02354,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02355,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02356,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02357,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02358,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02359,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02360,AMR,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_02361,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02362,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02363,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02364,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02365,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02366,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02367,AMR,4,OPTN,8.4,Severe,Fast Progression,ALS2; OPTN; SETX; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_02368,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02369,AMR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02370,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02371,AMR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02372,AMR,1,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02373,AMR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02374,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02375,AMR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02376,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02377,AMR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02378,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02379,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02380,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02381,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02382,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02383,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02384,AMR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02385,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02386,AMR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02387,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02388,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02389,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02390,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02391,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02392,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02393,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02394,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02395,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02396,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02397,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02398,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02399,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02400,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02401,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02402,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02403,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02404,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02405,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02406,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02407,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02408,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02409,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02410,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02411,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02412,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02413,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02414,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02415,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02416,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02417,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02418,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02419,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02420,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02421,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02422,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02423,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02424,AMR,2,FUS,9.9,Severe,Fast Progression,FUS; TARDBP,0,0,,,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02425,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02426,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02427,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02428,AMR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02429,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02430,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02431,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02432,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02433,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02434,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02435,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02436,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02437,AMR,2,UNC13A,6.0,Moderate,Slow Progression,SOD1; UNC13A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,0,0,,,0,0,,,3,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_02438,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02439,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02440,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02441,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02442,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02443,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02444,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02445,AMR,1,LOC108903148,9.2,Severe,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02446,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02447,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02448,AMR,1,TBK1,7.0,Moderate,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02449,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02450,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02451,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02452,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02453,AMR,2,FUS,9.9,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02454,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02455,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02456,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02457,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02458,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02459,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02460,AMR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_02461,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02462,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02463,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02464,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02465,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02466,AMR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02467,AMR,2,ALS2,6.5,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
AMR_02468,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02469,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02470,AMR,2,LOC108903148,9.2,Severe,Fast Progression,HNRNPA2B1; LOC108903148,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Unknown mechanism
AMR_02471,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02472,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02473,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02474,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02475,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02476,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02477,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02478,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02479,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02480,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02481,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02482,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02483,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02484,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_02485,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02486,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02487,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02488,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02489,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02490,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02491,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02492,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02493,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02494,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02495,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02496,AMR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02497,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02498,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02499,AMR,1,SQSTM1,8.4,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02500,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02501,AMR,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02502,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02503,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02504,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02505,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02506,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02507,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02508,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02509,AMR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_02510,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02511,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02512,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02513,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02514,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02515,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02516,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02517,AMR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
AMR_02518,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02519,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02520,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02521,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02522,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02523,AMR,2,SPG11,7.7,Moderate,Fast Progression,SPG11; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | UBQLN2: Ubiquitin-proteasome clearance failure,Lysosome reformation failure; DNA repair defects
AMR_02524,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; CHMP2B,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,Endosome-lysosome fusion failure
AMR_02525,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02526,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02527,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02528,AMR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02529,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02530,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02531,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02532,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02533,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02534,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02535,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02536,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02537,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02538,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02539,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02540,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02541,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | TUBA4A: Microtubule destabilization,Endosome-lysosome fusion failure
AMR_02542,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02543,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02544,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02545,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02546,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02547,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02548,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02549,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02550,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02551,AMR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02552,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02553,AMR,2,TARDBP,7.0,Moderate,Slow Progression,TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02554,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02555,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02556,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02557,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02558,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02559,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02560,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02561,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02562,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02563,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02564,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02565,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02566,AMR,2,NEK1,8.4,Severe,Fast Progression,NEK1; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,3,RNA_Metabolism,NEK1: DNA damage checkpoint failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,DNA damage checkpoint failure
AMR_02567,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02568,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02569,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02570,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02571,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02572,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02573,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02574,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02575,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02576,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02577,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02578,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02579,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02580,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02581,AMR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_02582,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02583,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02584,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02585,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02586,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02587,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02588,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02589,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02590,AMR,2,TBK1,9.1,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02591,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02592,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02593,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02594,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02595,AMR,2,SOD1,9.8,Severe,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02596,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02597,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02598,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02599,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02600,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02601,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02602,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02603,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02604,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02605,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02606,AMR,2,OPTN,8.4,Severe,Fast Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
AMR_02607,AMR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02608,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02609,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02610,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02611,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02612,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02613,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02614,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02615,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02616,AMR,2,SLC52A3,8.4,Severe,Fast Progression,SLC52A3; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
AMR_02617,AMR,2,FUS,10.0,Severe,Fast Progression,FUS; TARDBP,0,0,,,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02618,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02619,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02620,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02621,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02622,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02623,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02624,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02625,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02626,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02627,AMR,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02628,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02629,AMR,1,ANG,6.0,Moderate,Asymptomatic/Low Penetrance,ANG,0,0,,,1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,ANG: Ribosomal biogenesis impairment,Ribosomal biogenesis impairment
AMR_02630,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02631,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02632,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02633,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02634,AMR,2,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02635,AMR,2,ALS2,7.0,Moderate,Fast Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
AMR_02636,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02637,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02638,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02639,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02640,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02641,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02642,AMR,3,DCTN1,7.0,Moderate,Slow Progression,ALS2; DCTN1; SPG11,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure | SPG11: Lysosome reformation failure; DNA repair defects,Retrograde transport failure
AMR_02643,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02644,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02645,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02646,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02647,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02648,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02649,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02650,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02651,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02652,AMR,2,DCTN1,7.0,Moderate,Slow Progression,DCTN1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Retrograde transport failure
AMR_02653,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02654,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02655,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02656,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02657,AMR,1,OPTN,9.2,Severe,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02658,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02659,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02660,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02661,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02662,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02663,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02664,AMR,2,TBK1,9.8,Severe,Fast Progression,ERBB4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02665,AMR,3,SOD1,7.0,Moderate,Slow Progression,PARK7; SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02666,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02667,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02668,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02669,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02670,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02671,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02672,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02673,AMR,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
AMR_02674,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02675,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02676,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02677,AMR,2,LOC130001681,9.2,Severe,Fast Progression,LOC130001681; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_02678,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02679,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02680,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02681,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02682,AMR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
AMR_02683,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02684,AMR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02685,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02686,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02687,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02688,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02689,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02690,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02691,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02692,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02693,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02694,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02695,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02696,AMR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02697,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02698,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02699,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02700,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02701,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02702,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02703,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02704,AMR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02705,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02706,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02707,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02708,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02709,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02710,AMR,1,CHRNA3,6.0,Moderate,Asymptomatic/Low Penetrance,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02711,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02712,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02713,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02714,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02715,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02716,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02717,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02718,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02719,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02720,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02721,AMR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02722,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02723,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02724,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02725,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02726,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02727,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02728,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02729,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02730,AMR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
AMR_02731,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02732,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02733,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02734,AMR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02735,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02736,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02737,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02738,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02739,AMR,2,SLC52A3,8.4,Severe,Fast Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_02740,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02741,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02742,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02743,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02744,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02745,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02746,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02747,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02748,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_02749,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02750,AMR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02751,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02752,AMR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02753,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02754,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02755,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02756,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02757,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02758,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02759,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02760,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02761,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02762,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02763,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02764,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02765,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02766,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02767,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02768,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02769,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02770,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02771,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02772,AMR,2,DCTN1,7.7,Moderate,Slow Progression,DCTN1; SPG11,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | SPG11: Lysosome reformation failure; DNA repair defects,Retrograde transport failure
AMR_02773,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02774,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02775,AMR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02776,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02777,AMR,2,TBK1,9.8,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02778,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02779,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02780,AMR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
AMR_02781,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02782,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02783,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02784,AMR,2,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02785,AMR,1,FIG4,9.2,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
AMR_02786,AMR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02787,AMR,2,OPTN,6.0,Moderate,Slow Progression,OPTN; SIGMAR1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation,Autophagy receptor dysfunction
AMR_02788,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02789,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02790,AMR,2,SQSTM1,7.8,Moderate,Fast Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02791,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02792,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02793,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02794,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02795,AMR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02796,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02797,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02798,AMR,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02799,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02800,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02801,AMR,2,LOC108903148,9.2,Severe,Fast Progression,FUS; LOC108903148,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
AMR_02802,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02803,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02804,AMR,1,ALS2,7.0,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02805,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02806,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02807,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02808,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02809,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02810,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02811,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02812,AMR,2,KIF5A,7.8,Moderate,Fast Progression,KIF5A; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,KIF5A: Anterograde transport failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Anterograde transport failure
AMR_02813,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02814,AMR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02815,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02816,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02817,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02818,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02819,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02820,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02821,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02822,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02823,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02824,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02825,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02826,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02827,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02828,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02829,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02830,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02831,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02832,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02833,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02834,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02835,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02836,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02837,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02838,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02839,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02840,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02841,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02842,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02843,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02844,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02845,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02846,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02847,AMR,2,TBK1,9.8,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02848,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02849,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02850,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02851,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02852,AMR,2,SQSTM1,9.2,Severe,Fast Progression,SETX; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02853,AMR,1,DCTN1,9.1,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
AMR_02854,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02855,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02856,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02857,AMR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02858,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02859,AMR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02860,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02861,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02862,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02863,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02864,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02865,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02866,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02867,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02868,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02869,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02870,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02871,AMR,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02872,AMR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02873,AMR,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
AMR_02874,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02875,AMR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02876,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02877,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02878,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02879,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02880,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02881,AMR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02882,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02883,AMR,1,ERBB4,5.0,Mild,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02884,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02885,AMR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02886,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02887,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02888,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02889,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02890,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02891,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02892,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02893,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02894,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02895,AMR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02896,AMR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02897,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02898,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02899,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02900,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02901,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02902,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02903,AMR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02904,AMR,2,SOD1,7.7,Moderate,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02905,AMR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02906,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02907,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02908,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02909,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02910,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02911,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02912,AMR,2,NEK1,8.4,Severe,Fast Progression,NEK1; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,NEK1; SPG11,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,NEK1: DNA damage checkpoint failure | SPG11: Lysosome reformation failure; DNA repair defects,DNA damage checkpoint failure
AMR_02913,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02914,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02915,AMR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02916,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02917,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02918,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02919,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02920,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02921,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02922,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02923,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02924,AMR,1,TUBA4A,6.0,Moderate,Asymptomatic/Low Penetrance,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
AMR_02925,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02926,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02927,AMR,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
AMR_02928,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02929,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02930,AMR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02931,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02932,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02933,AMR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
AMR_02934,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02935,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02936,AMR,1,SCAF4,6.6,Moderate,Slow Progression,SCAF4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
AMR_02937,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02938,AMR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
AMR_02939,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02940,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02941,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02942,AMR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
AMR_02943,AMR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02944,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02945,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02946,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02947,AMR,2,SPG11,7.0,Moderate,Fast Progression,FUS; SPG11,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02948,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02949,AMR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
AMR_02950,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02951,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02952,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02953,AMR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02954,AMR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
AMR_02955,AMR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02956,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02957,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02958,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02959,AMR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
AMR_02960,AMR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
AMR_02961,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02962,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02963,AMR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
AMR_02964,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02965,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02966,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02967,AMR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02968,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02969,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02970,AMR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02971,AMR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
AMR_02972,AMR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02973,AMR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02974,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02975,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02976,AMR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | HNRNPA2B1: Stress granule dysregulation,Endosome-lysosome fusion failure
AMR_02977,AMR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02978,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02979,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02980,AMR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
AMR_02981,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02982,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02983,AMR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
AMR_02984,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02985,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02986,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02987,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02988,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02989,AMR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
AMR_02990,AMR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
AMR_02991,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02992,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02993,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02994,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02995,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
AMR_02996,AMR,2,SOD1,7.0,Moderate,Slow Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02997,AMR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
AMR_02998,AMR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
AMR_02999,AMR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00000,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00001,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00002,EAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00003,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00004,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00005,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00006,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00007,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00008,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00009,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00010,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00011,EAS,1,KIF5A,7.8,Moderate,Fast Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
EAS_00012,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00013,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00014,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00015,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00016,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00017,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00018,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00019,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00020,EAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00021,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00022,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00023,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00024,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00025,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00026,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00027,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00028,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00029,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00030,EAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00031,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00032,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_00033,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00034,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00035,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00036,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00037,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00038,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00039,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00040,EAS,2,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00041,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00042,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00043,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00044,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00045,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00046,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00047,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00048,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00049,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00050,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00051,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00052,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00053,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00054,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00055,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00056,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00057,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00058,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00059,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00060,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00061,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00062,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00063,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00064,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00065,EAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00066,EAS,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00067,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00068,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00069,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00070,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00071,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00072,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00073,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00074,EAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00075,EAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_00076,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00077,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00078,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00079,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00080,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00081,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00082,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00083,EAS,2,SYNE1,9.2,Severe,Slow Progression,OPTN; SYNE1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Unknown mechanism
EAS_00084,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00085,EAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Endosome-lysosome fusion failure
EAS_00086,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00087,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00088,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00089,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00090,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00091,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00092,EAS,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00093,EAS,2,ALS2,6.3,Moderate,Slow Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Endosome-lysosome fusion failure
EAS_00094,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00095,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00096,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00097,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00098,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00099,EAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00100,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00101,EAS,2,SPG11,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
EAS_00102,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00103,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00104,EAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_00105,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00106,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00107,EAS,1,ALS2,6.5,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00108,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00109,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00110,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00111,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00112,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00113,EAS,3,ALS2,7.7,Moderate,Slow Progression,ALS2; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00114,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00115,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00116,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00117,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00118,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00119,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00120,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_00121,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00122,EAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
EAS_00123,EAS,2,SOD1,7.0,Moderate,Slow Progression,HNRNPA1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,HNRNPA1: Stress granule dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00124,EAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00125,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00126,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00127,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00128,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00129,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00130,EAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00131,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00132,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00133,EAS,1,KIF5A,9.2,Severe,Fast Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
EAS_00134,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00135,EAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00136,EAS,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00137,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00138,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00139,EAS,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00140,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00141,EAS,1,SOD1,10.0,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00142,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00143,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00144,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00145,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00146,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00147,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00148,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00149,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00150,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00151,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00152,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00153,EAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00154,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00155,EAS,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00156,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00157,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00158,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00159,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00160,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00161,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00162,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00163,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00164,EAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_00165,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00166,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00167,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00168,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00169,EAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00170,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00171,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00172,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00173,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00174,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00175,EAS,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EAS_00176,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00177,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00178,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00179,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00180,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00181,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00182,EAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00183,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00184,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00185,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00186,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00187,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00188,EAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_00189,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00190,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00191,EAS,2,SOD1,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00192,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00193,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00194,EAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00195,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00196,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00197,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00198,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00199,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00200,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00201,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00202,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00203,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00204,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00205,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00206,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00207,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00208,EAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00209,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00210,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00211,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00212,EAS,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00213,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00214,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00215,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00216,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00217,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00218,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00219,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00220,EAS,2,SQSTM1,9.2,Severe,Fast Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00221,EAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EAS_00222,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00223,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00224,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00225,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00226,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00227,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00228,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00229,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00230,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00231,EAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_00232,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00233,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00234,EAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00235,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00236,EAS,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00237,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00238,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00239,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00240,EAS,4,TBK1,10.0,Severe,Fast Progression,SOD1; SQSTM1; TARDBP; TBK1,1,3,SOD1; SQSTM1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62) | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00241,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00242,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00243,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00244,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00245,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00246,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00247,EAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EAS_00248,EAS,3,SOD1,7.0,Moderate,Slow Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00249,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00250,EAS,2,VCP,7.0,Moderate,Slow Progression,TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00251,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00252,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00253,EAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
EAS_00254,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00255,EAS,2,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1; SPG11,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,MAM calcium dysregulation
EAS_00256,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00257,EAS,2,SOD1,7.0,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00258,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00259,EAS,2,SPG11,6.5,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00260,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00261,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00262,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00263,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00264,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00265,EAS,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EAS_00266,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00267,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00268,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00269,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00270,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00271,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00272,EAS,2,OPTN,9.2,Severe,Fast Progression,CHMP2B; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00273,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00274,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00275,EAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00276,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00277,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00278,EAS,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_00279,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00280,EAS,2,SOD1,7.0,Moderate,Slow Progression,CHMP2B; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00281,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00282,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00283,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00284,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00285,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00286,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00287,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00288,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00289,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00290,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00291,EAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_00292,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00293,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00294,EAS,1,SQSTM1,6.6,Moderate,Asymptomatic/Low Penetrance,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00295,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00296,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00297,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00298,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00299,EAS,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00300,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00301,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00302,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00303,EAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00304,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00305,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00306,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00307,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00308,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00309,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00310,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00311,EAS,2,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Ubiquitin-proteasome clearance failure
EAS_00312,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00313,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00314,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00315,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00316,EAS,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_00317,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00318,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00319,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00320,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00321,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00322,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00323,EAS,2,FUS,9.9,Severe,Fast Progression,FUS; SYNE1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00324,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00325,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00326,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00327,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00328,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00329,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00330,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00331,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00332,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00333,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00334,EAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_00335,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00336,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00337,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00338,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00339,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00340,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00341,EAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EAS_00342,EAS,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00343,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00344,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00345,EAS,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00346,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00347,EAS,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00348,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00349,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00350,EAS,2,ALS2,7.2,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
EAS_00351,EAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00352,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00353,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00354,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00355,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00356,EAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00357,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00358,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00359,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00360,EAS,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
EAS_00361,EAS,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00362,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00363,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00364,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_00365,EAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_00366,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00367,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00368,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00369,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00370,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00371,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00372,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00373,EAS,3,ALS2,6.5,Moderate,Slow Progression,ALS2; SCAF4; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
EAS_00374,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00375,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00376,EAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | UNC13A: Synaptic transmission defects,Endosome-lysosome fusion failure
EAS_00377,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00378,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00379,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00380,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00381,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00382,EAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00383,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00384,EAS,2,SQSTM1,9.2,Severe,Fast Progression,ERLIN1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00385,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00386,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00387,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00388,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00389,EAS,2,SOD1,7.7,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00390,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00391,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00392,EAS,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00393,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00394,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00395,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00396,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00397,EAS,1,SPG11,7.7,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00398,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00399,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00400,EAS,3,FUS,9.9,Severe,Slow Progression,ALS2; FUS; SETX,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00401,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00402,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00403,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00404,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00405,EAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_00406,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00407,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00408,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00409,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00410,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00411,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00412,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00413,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00414,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00415,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00416,EAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EAS_00417,EAS,2,SLC52A3,8.4,Severe,Fast Progression,SLC52A3; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
EAS_00418,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00419,EAS,2,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00420,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00421,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00422,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00423,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00424,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00425,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00426,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00427,EAS,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
EAS_00428,EAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_00429,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00430,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00431,EAS,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
EAS_00432,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00433,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00434,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00435,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00436,EAS,1,SETX,6.2,Moderate,Fast Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_00437,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00438,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00439,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00440,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00441,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_00442,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00443,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00444,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00445,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00446,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00447,EAS,2,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00448,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00449,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00450,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00451,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00452,EAS,1,SLC52A3,8.4,Severe,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00453,EAS,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
EAS_00454,EAS,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00455,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00456,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00457,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00458,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00459,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00460,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00461,EAS,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_00462,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00463,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00464,EAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00465,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00466,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00467,EAS,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00468,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00469,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00470,EAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00471,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00472,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00473,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00474,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_00475,EAS,2,OPTN,7.8,Moderate,Fast Progression,FIG4; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00476,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00477,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00478,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00479,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00480,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00481,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00482,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00483,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00484,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00485,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00486,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00487,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00488,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00489,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00490,EAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_00491,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00492,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00493,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00494,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00495,EAS,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00496,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00497,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00498,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00499,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00500,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00501,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00502,EAS,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00503,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00504,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00505,EAS,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EAS_00506,EAS,2,VCP,7.7,Moderate,Slow Progression,CHCHD10; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,CHCHD10,CHCHD10: Cristae disruption; mtDNA instability,0,0,,,0,0,,,0,0,,,2,Proteostasis,CHCHD10: Cristae disruption; mtDNA instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00507,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00508,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00509,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00510,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00511,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00512,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00513,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00514,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00515,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00516,EAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_00517,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00518,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00519,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00520,EAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00521,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00522,EAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00523,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00524,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00525,EAS,2,OPTN,9.2,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00526,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00527,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00528,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00529,EAS,2,TBK1,9.8,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00530,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00531,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00532,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00533,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00534,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00535,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00536,EAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00537,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00538,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00539,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00540,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00541,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00542,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00543,EAS,1,ERBB4,5.0,Mild,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00544,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00545,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00546,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00547,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00548,EAS,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00549,EAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EAS_00550,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00551,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00552,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00553,EAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_00554,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00555,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00556,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00557,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00558,EAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00559,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00560,EAS,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00561,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00562,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00563,EAS,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00564,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00565,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00566,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00567,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00568,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00569,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00570,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00571,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00572,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00573,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00574,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00575,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00576,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00577,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00578,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00579,EAS,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
EAS_00580,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00581,EAS,1,FIG4,7.8,Moderate,Slow Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_00582,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00583,EAS,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_00584,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00585,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00586,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00587,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00588,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00589,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00590,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00591,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00592,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00593,EAS,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00594,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00595,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00596,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00597,EAS,4,FUS,9.0,Severe,Fast Progression,ALS2; FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Mitochondrial,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00598,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00599,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00600,EAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00601,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00602,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00603,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00604,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00605,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00606,EAS,1,PARK7,7.7,Moderate,Slow Progression,PARK7,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00607,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00608,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00609,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00610,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00611,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00612,EAS,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00613,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00614,EAS,1,LOC130003372,6.6,Moderate,Slow Progression,LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00615,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00616,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00617,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00618,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00619,EAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00620,EAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_00621,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00622,EAS,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_00623,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00624,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00625,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00626,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00627,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00628,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00629,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00630,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00631,EAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00632,EAS,3,DCTN1,7.0,Moderate,Slow Progression,DCTN1; SOD1; SYNE1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Retrograde transport failure
EAS_00633,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00634,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00635,EAS,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_00636,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00637,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00638,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00639,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00640,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00641,EAS,3,UBQLN2,7.7,Moderate,Fast Progression,FUS; SQSTM1; UBQLN2,1,2,SQSTM1; UBQLN2,SQSTM1: Autophagy receptor dysfunction (p62) | UBQLN2: Ubiquitin-proteasome clearance failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62) | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_00642,EAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00643,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00644,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00645,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00646,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00647,EAS,2,SOD1,7.7,Moderate,Slow Progression,SOD1; TUBA4A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TUBA4A: Microtubule destabilization,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00648,EAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EAS_00649,EAS,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00650,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00651,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00652,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00653,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00654,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00655,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00656,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00657,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00658,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00659,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00660,EAS,2,SPG11,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00661,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00662,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00663,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00664,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00665,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00666,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00667,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00668,EAS,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00669,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00670,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_00671,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00672,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00673,EAS,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00674,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00675,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00676,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00677,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00678,EAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction
EAS_00679,EAS,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
EAS_00680,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00681,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00682,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00683,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00684,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00685,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00686,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00687,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00688,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00689,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00690,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00691,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00692,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00693,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00694,EAS,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EAS_00695,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00696,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00697,EAS,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00698,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00699,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00700,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00701,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00702,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00703,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00704,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00705,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00706,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00707,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00708,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00709,EAS,2,SOD1,7.7,Moderate,Slow Progression,CHMP2B; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00710,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00711,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00712,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00713,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00714,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00715,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00716,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00717,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00718,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00719,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00720,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00721,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00722,EAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00723,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00724,EAS,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00725,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00726,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00727,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00728,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00729,EAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Endosome-lysosome fusion failure
EAS_00730,EAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00731,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00732,EAS,2,SOD1,9.8,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00733,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00734,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00735,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00736,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00737,EAS,2,PARK7,7.7,Moderate,Fast Progression,PARK7; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EAS_00738,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00739,EAS,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_00740,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00741,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00742,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00743,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00744,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00745,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00746,EAS,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00747,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00748,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00749,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00750,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00751,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00752,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00753,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00754,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00755,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00756,EAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00757,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00758,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00759,EAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_00760,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00761,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00762,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00763,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00764,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00765,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00766,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00767,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_00768,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00769,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00770,EAS,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00771,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00772,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00773,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00774,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00775,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00776,EAS,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_00777,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00778,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00779,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00780,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00781,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00782,EAS,2,SPTLC1,6.9,Moderate,Slow Progression,SLC52A3; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00783,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00784,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00785,EAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_00786,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00787,EAS,2,ALS2,7.0,Moderate,Slow Progression,ALS2; LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00788,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00789,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00790,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00791,EAS,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00792,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00793,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00794,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00795,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00796,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00797,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00798,EAS,3,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00799,EAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00800,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00801,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00802,EAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00803,EAS,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_00804,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00805,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00806,EAS,3,SLC52A3,9.2,Severe,Fast Progression,ANXA11; CHMP2B; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,Unknown mechanism
EAS_00807,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00808,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00809,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00810,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00811,EAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00812,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00813,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00814,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00815,EAS,2,SOD1,7.0,Moderate,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00816,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00817,EAS,3,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00818,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00819,EAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00820,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00821,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00822,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00823,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00824,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00825,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00826,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00827,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00828,EAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00829,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00830,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00831,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00832,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00833,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00834,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00835,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00836,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00837,EAS,1,SYNE1,9.2,Severe,Slow Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00838,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00839,EAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EAS_00840,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00841,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00842,EAS,2,OPTN,9.2,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00843,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00844,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00845,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00846,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00847,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00848,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00849,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00850,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00851,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00852,EAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00853,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00854,EAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00855,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00856,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00857,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00858,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00859,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00860,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00861,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00862,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00863,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00864,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00865,EAS,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00866,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00867,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00868,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00869,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00870,EAS,2,SIGMAR1,7.7,Moderate,Slow Progression,SETX; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Mitochondrial,SETX: R-loop accumulation; genomic instability | SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_00871,EAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00872,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00873,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00874,EAS,2,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_00875,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00876,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00877,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00878,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00879,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00880,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00881,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00882,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00883,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00884,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00885,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00886,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00887,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00888,EAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00889,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00890,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00891,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00892,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00893,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00894,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00895,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00896,EAS,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00897,EAS,2,TBK1,9.1,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00898,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00899,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00900,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00901,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00902,EAS,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00903,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00904,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00905,EAS,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Unknown mechanism
EAS_00906,EAS,2,TARDBP,7.0,Moderate,Slow Progression,TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_00907,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00908,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00909,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00910,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00911,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00912,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00913,EAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_00914,EAS,2,TBK1,10.0,Severe,Fast Progression,LOC108903148; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00915,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00916,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00917,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00918,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00919,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00920,EAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00921,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00922,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00923,EAS,1,PARK7,7.7,Moderate,Slow Progression,PARK7,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00924,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00925,EAS,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00926,EAS,1,TBK1,7.0,Moderate,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00927,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00928,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00929,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00930,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00931,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00932,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00933,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00934,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_00935,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00936,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00937,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00938,EAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00939,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00940,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00941,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00942,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00943,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00944,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00945,EAS,2,SOD1,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00946,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00947,EAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00948,EAS,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EAS_00949,EAS,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_00950,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00951,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00952,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00953,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00954,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00955,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00956,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_00957,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00958,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00959,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00960,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00961,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00962,EAS,2,TBK1,9.1,Severe,Fast Progression,NEK1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Proteostasis,NEK1: DNA damage checkpoint failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00963,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00964,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00965,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00966,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00967,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00968,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00969,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00970,EAS,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_00971,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00972,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00973,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00974,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00975,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00976,EAS,1,NEK1,9.2,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EAS_00977,EAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00978,EAS,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_00979,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00980,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00981,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00982,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00983,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_00984,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00985,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00986,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00987,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00988,EAS,1,LOC130001681,9.2,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_00989,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_00990,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00991,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00992,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00993,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00994,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00995,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00996,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_00997,EAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_00998,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_00999,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01000,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01001,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01002,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01003,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01004,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01005,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01006,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01007,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01008,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01009,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01010,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01011,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01012,EAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01013,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01014,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01015,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01016,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01017,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01018,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01019,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01020,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01021,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01022,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01023,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01024,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01025,EAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_01026,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01027,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01028,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01029,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01030,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01031,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01032,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01033,EAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01034,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01035,EAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01036,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01037,EAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_01038,EAS,1,SLC52A3,6.0,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01039,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01040,EAS,2,VCP,7.0,Moderate,Slow Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01041,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01042,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01043,EAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_01044,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01045,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01046,EAS,3,SQSTM1,7.8,Moderate,Fast Progression,ALS2; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01047,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01048,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01049,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01050,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01051,EAS,3,OPTN,6.6,Moderate,Slow Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01052,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01053,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01054,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01055,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01056,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01057,EAS,1,UBQLN2,7.7,Moderate,Fast Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_01058,EAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01059,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01060,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01061,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01062,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01063,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01064,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01065,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01066,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01067,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01068,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01069,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01070,EAS,1,LOC130003372,6.6,Moderate,Slow Progression,LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01071,EAS,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01072,EAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01073,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01074,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01075,EAS,2,SQSTM1,8.4,Severe,Fast Progression,OPTN; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01076,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01077,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01078,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01079,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01080,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01081,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01082,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01083,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01084,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01085,EAS,1,PARK7,7.7,Moderate,Fast Progression,PARK7,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01086,EAS,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
EAS_01087,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01088,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01089,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01090,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01091,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01092,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01093,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01094,EAS,2,TBK1,10.0,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
EAS_01095,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01096,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01097,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01098,EAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01099,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01100,EAS,1,PRPH,7.8,Moderate,Fast Progression,PRPH,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01101,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01102,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01103,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01104,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01105,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01106,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01107,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01108,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | UBQLN2: Ubiquitin-proteasome clearance failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01109,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01110,EAS,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
EAS_01111,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01112,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01113,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01114,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01115,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01116,EAS,3,SOD1,7.0,Moderate,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01117,EAS,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01118,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01119,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01120,EAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01121,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01122,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01123,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01124,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01125,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01126,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01127,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01128,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01129,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01130,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01131,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01132,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01133,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01134,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01135,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01136,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01137,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01138,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01139,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01140,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01141,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01142,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01143,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01144,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01145,EAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_01146,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01147,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01148,EAS,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_01149,EAS,2,SQSTM1,9.2,Severe,Fast Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01150,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01151,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01152,EAS,1,DCTN1,9.1,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_01153,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01154,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01155,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01156,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01157,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01158,EAS,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; LOC108903148,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01159,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01160,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01161,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01162,EAS,2,KIF5A,6.6,Moderate,Slow Progression,ALS2; KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | KIF5A: Anterograde transport failure,Anterograde transport failure
EAS_01163,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01164,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01165,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01166,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01167,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01168,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01169,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01170,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01171,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01172,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01173,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01174,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01175,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01176,EAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01177,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01178,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01179,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01180,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01181,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01182,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01183,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01184,EAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01185,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01186,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01187,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01188,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01189,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01190,EAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01191,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01192,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01193,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01194,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01195,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01196,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01197,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01198,EAS,3,TARDBP,7.7,Moderate,Slow Progression,ALS2; SPTLC1; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01199,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01200,EAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01201,EAS,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01202,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01203,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01204,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01205,EAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01206,EAS,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
EAS_01207,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01208,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01209,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01210,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01211,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01212,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01213,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01214,EAS,1,LOC130001681,9.2,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01215,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01216,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01217,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01218,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01219,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01220,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01221,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01222,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01223,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01224,EAS,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01225,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01226,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01227,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_01228,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01229,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01230,EAS,2,OPTN,8.4,Severe,Fast Progression,ERBB4; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01231,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01232,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01233,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01234,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01235,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01236,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01237,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01238,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01239,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01240,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01241,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01242,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01243,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01244,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01245,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01246,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01247,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01248,EAS,1,DCTN1,7.7,Moderate,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_01249,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01250,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01251,EAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_01252,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01253,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01254,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01255,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01256,EAS,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01257,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01258,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01259,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01260,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01261,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01262,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01263,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01264,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01265,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01266,EAS,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01267,EAS,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01268,EAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01269,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01270,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01271,EAS,2,SPG11,7.7,Moderate,Slow Progression,HNRNPA1; SPG11,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,RNA_Metabolism,HNRNPA1: Stress granule dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01272,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01273,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01274,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01275,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01276,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01277,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01278,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01279,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01280,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01281,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01282,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01283,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01284,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01285,EAS,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01286,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01287,EAS,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01288,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01289,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01290,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01291,EAS,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01292,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01293,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01294,EAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01295,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01296,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01297,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01298,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01299,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01300,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01301,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01302,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01303,EAS,1,ALS2,6.3,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01304,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01305,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01306,EAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01307,EAS,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01308,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01309,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01310,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01311,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01312,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01313,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01314,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01315,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01316,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01317,EAS,1,ALS2,7.0,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01318,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01319,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01320,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01321,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01322,EAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure,Endosome-lysosome fusion failure
EAS_01323,EAS,2,FUS,9.9,Severe,Fast Progression,FUS; SPG11,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01324,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01325,EAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
EAS_01326,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01327,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01328,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01329,EAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01330,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01331,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01332,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01333,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01334,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01335,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01336,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01337,EAS,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01338,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01339,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01340,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01341,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01342,EAS,1,OPTN,6.0,Moderate,Asymptomatic/Low Penetrance,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01343,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01344,EAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01345,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01346,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01347,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01348,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01349,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01350,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01351,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01352,EAS,1,PARK7,7.7,Moderate,Slow Progression,PARK7,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01353,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01354,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01355,EAS,2,SPG11,6.5,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
EAS_01356,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01357,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01358,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01359,EAS,2,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01360,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01361,EAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01362,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01363,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01364,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01365,EAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01366,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01367,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01368,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01369,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01370,EAS,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01371,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01372,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01373,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01374,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01375,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01376,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01377,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01378,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01379,EAS,2,SOD1,7.0,Moderate,Slow Progression,PLEKHG5; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01380,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01381,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01382,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01383,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01384,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01385,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01386,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01387,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01388,EAS,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01389,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01390,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01391,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01392,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01393,EAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01394,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01395,EAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01396,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01397,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01398,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01399,EAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01400,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01401,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01402,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01403,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01404,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01405,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01406,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01407,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01408,EAS,2,TARDBP,7.0,Moderate,Slow Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01409,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01410,EAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01411,EAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_01412,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01413,EAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01414,EAS,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01415,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01416,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01417,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01418,EAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01419,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01420,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01421,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01422,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01423,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01424,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01425,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01426,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01427,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01428,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01429,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01430,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01431,EAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01432,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01433,EAS,2,FIG4,9.2,Severe,Fast Progression,FIG4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
EAS_01434,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01435,EAS,2,TARDBP,7.7,Moderate,Slow Progression,SETX; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,RNA_Metabolism,SETX: R-loop accumulation; genomic instability | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01436,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01437,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01438,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01439,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01440,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01441,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01442,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01443,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01444,EAS,2,SPTLC1,6.9,Moderate,Fast Progression,ALS2; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
EAS_01445,EAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01446,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01447,EAS,2,SOD1,9.1,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01448,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01449,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01450,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01451,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01452,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01453,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01454,EAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; TUBA4A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TUBA4A: Microtubule destabilization,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01455,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01456,EAS,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01457,EAS,2,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01458,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01459,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01460,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01461,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01462,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01463,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01464,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01465,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01466,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01467,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01468,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01469,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01470,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01471,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01472,EAS,2,SOD1,7.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01473,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01474,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01475,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01476,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01477,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01478,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01479,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01480,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01481,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01482,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01483,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01484,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01485,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01486,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01487,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01488,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01489,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01490,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01491,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01492,EAS,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01493,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01494,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01495,EAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_01496,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01497,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01498,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01499,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01500,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01501,EAS,2,SQSTM1,9.2,Severe,Fast Progression,SETX; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01502,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01503,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01504,EAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01505,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01506,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01507,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01508,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01509,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01510,EAS,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_01511,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01512,EAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EAS_01513,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01514,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01515,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01516,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01517,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01518,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01519,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01520,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01521,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01522,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01523,EAS,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01524,EAS,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01525,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01526,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01527,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01528,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01529,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01530,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01531,EAS,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01532,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01533,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01534,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01535,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01536,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01537,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01538,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01539,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01540,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01541,EAS,2,SQSTM1,8.6,Severe,Fast Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01542,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01543,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01544,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01545,EAS,2,VCP,7.7,Moderate,Slow Progression,TUBA4A; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,TUBA4A: Microtubule destabilization | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01546,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01547,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01548,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01549,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01550,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01551,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01552,EAS,4,TBK1,9.8,Severe,Fast Progression,ALS2; SOD1; TBK1; UNC13A,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | UNC13A: Synaptic transmission defects,Autophagy initiation kinase deficiency
EAS_01553,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01554,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01555,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01556,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01557,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01558,EAS,1,DCTN1,7.0,Moderate,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_01559,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01560,EAS,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01561,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01562,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01563,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01564,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01565,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01566,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01567,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01568,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01569,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01570,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01571,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01572,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01573,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01574,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01575,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01576,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01577,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01578,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01579,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01580,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01581,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01582,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01583,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01584,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01585,EAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_01586,EAS,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_01587,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01588,EAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01589,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01590,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01591,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01592,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01593,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01594,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01595,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01596,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01597,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01598,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01599,EAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01600,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01601,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01602,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01603,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01604,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01605,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01606,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01607,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01608,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01609,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01610,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01611,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01612,EAS,1,C9orf72,8.8,Severe,Fast Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
EAS_01613,EAS,2,FIG4,7.8,Moderate,Fast Progression,FIG4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
EAS_01614,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01615,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01616,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01617,EAS,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_01618,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01619,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01620,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01621,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01622,EAS,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01623,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01624,EAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_01625,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01626,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01627,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01628,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01629,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01630,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01631,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01632,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01633,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01634,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01635,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01636,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01637,EAS,1,DCTN1,9.1,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_01638,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01639,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01640,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01641,EAS,2,SOD1,10.0,Severe,Fast Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01642,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01643,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01644,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01645,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01646,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01647,EAS,2,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01648,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01649,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01650,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01651,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01652,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01653,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01654,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01655,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01656,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01657,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01658,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01659,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01660,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01661,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01662,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01663,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01664,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01665,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01666,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01667,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01668,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01669,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01670,EAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
EAS_01671,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01672,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01673,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01674,EAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; TUBA4A,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | TUBA4A: Microtubule destabilization,Autophagy receptor dysfunction
EAS_01675,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01676,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01677,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01678,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01679,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01680,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01681,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01682,EAS,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_01683,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01684,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01685,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01686,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01687,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01688,EAS,2,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Unknown mechanism
EAS_01689,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01690,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01691,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01692,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01693,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01694,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01695,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01696,EAS,2,SLC52A3,8.4,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
EAS_01697,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01698,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01699,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01700,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01701,EAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_01702,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01703,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01704,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01705,EAS,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
EAS_01706,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01707,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01708,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01709,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01710,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01711,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01712,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01713,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01714,EAS,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01715,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01716,EAS,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EAS_01717,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01718,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01719,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01720,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01721,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01722,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01723,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01724,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01725,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01726,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01727,EAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_01728,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01729,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01730,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01731,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01732,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01733,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01734,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01735,EAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01736,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01737,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01738,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01739,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01740,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01741,EAS,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_01742,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01743,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01744,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01745,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01746,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01747,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01748,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01749,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01750,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01751,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01752,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01753,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01754,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01755,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01756,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01757,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01758,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01759,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01760,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01761,EAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01762,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01763,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01764,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01765,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01766,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01767,EAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01768,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01769,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01770,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01771,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01772,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01773,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01774,EAS,1,SIGMAR1,7.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01775,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01776,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01777,EAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01778,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01779,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01780,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01781,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01782,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01783,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01784,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01785,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01786,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01787,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01788,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01789,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01790,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01791,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01792,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01793,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01794,EAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_01795,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01796,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01797,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01798,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01799,EAS,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01800,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01801,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01802,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01803,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01804,EAS,1,SLC52A3,9.2,Severe,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01805,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01806,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01807,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01808,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01809,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01810,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01811,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01812,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01813,EAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01814,EAS,3,TBK1,9.8,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01815,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01816,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01817,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01818,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01819,EAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01820,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01821,EAS,3,ALS2,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
EAS_01822,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01823,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01824,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01825,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01826,EAS,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_01827,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01828,EAS,2,FUS,9.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01829,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01830,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01831,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01832,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01833,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01834,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01835,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01836,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01837,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01838,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01839,EAS,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01840,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01841,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_01842,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01843,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01844,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01845,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01846,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01847,EAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
EAS_01848,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01849,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01850,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01851,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01852,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01853,EAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_01854,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01855,EAS,1,SYNE1,9.2,Severe,Slow Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01856,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01857,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01858,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01859,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01860,EAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01861,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01862,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01863,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01864,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01865,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01866,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01867,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01868,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01869,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01870,EAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01871,EAS,2,SOD1,7.0,Moderate,Slow Progression,HNRNPA2B1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,HNRNPA2B1: Stress granule dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01872,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01873,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01874,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01875,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01876,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01877,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01878,EAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EAS_01879,EAS,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01880,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01881,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01882,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01883,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01884,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01885,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01886,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01887,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01888,EAS,2,ALS2,7.7,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
EAS_01889,EAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01890,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01891,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01892,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01893,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01894,EAS,2,FUS,9.9,Severe,Fast Progression,FIG4; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,3,RNA_Metabolism,FIG4: Lysosomal biogenesis failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01895,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01896,EAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_01897,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01898,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01899,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01900,EAS,3,SQSTM1,7.8,Moderate,Fast Progression,SOD1; SQSTM1; VCP,1,3,SOD1; SQSTM1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction (p62)
EAS_01901,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01902,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01903,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01904,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01905,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01906,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01907,EAS,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EAS_01908,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01909,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01910,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01911,EAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_01912,EAS,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01913,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01914,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01915,EAS,3,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
EAS_01916,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01917,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01918,EAS,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
EAS_01919,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01920,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01921,EAS,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01922,EAS,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01923,EAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01924,EAS,1,LOC124629354,8.4,Severe,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01925,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01926,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01927,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01928,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01929,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01930,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01931,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01932,EAS,2,TBK1,9.8,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01933,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01934,EAS,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EAS_01935,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01936,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01937,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01938,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01939,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01940,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01941,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01942,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01943,EAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01944,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01945,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01946,EAS,2,LOC130001681,9.2,Severe,Fast Progression,DCTN1; LOC130001681,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Unknown mechanism
EAS_01947,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01948,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01949,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01950,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01951,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01952,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01953,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01954,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01955,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01956,EAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_01957,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01958,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_01959,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01960,EAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_01961,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01962,EAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EAS_01963,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01964,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01965,EAS,2,VCP,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_01966,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01967,EAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01968,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01969,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01970,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01971,EAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01972,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01973,EAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_01974,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01975,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01976,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01977,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01978,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01979,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01980,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_01981,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01982,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01983,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01984,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01985,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01986,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_01987,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01988,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01989,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_01990,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01991,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01992,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01993,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01994,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01995,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01996,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_01997,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_01998,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_01999,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02000,EAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02001,EAS,5,TBK1,10.0,Severe,Fast Progression,CHMP2B; SCAF4; SOD1; TBK1; VCP,1,3,SOD1; TBK1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
EAS_02002,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02003,EAS,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02004,EAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02005,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_02006,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02007,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02008,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02009,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02010,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02011,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02012,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02013,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02014,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02015,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02016,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02017,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02018,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02019,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02020,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02021,EAS,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02022,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02023,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02024,EAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02025,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_02026,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02027,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02028,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02029,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02030,EAS,2,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Unknown mechanism
EAS_02031,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02032,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02033,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02034,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02035,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02036,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02037,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02038,EAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_02039,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02040,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02041,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02042,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02043,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02044,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02045,EAS,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02046,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02047,EAS,1,SYNE1,9.2,Severe,Slow Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02048,EAS,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02049,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02050,EAS,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02051,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02052,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02053,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02054,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02055,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02056,EAS,2,SQSTM1,8.4,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02057,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02058,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02059,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02060,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02061,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02062,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02063,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02064,EAS,3,FUS,10.0,Severe,Fast Progression,FUS; SPTLC1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02065,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02066,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02067,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02068,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02069,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02070,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02071,EAS,2,VCP,7.0,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02072,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02073,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02074,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02075,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02076,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02077,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02078,EAS,2,SPG11,7.0,Moderate,Slow Progression,SPG11; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Cytoskeletal_Axonal_Transport,SPG11: Lysosome reformation failure; DNA repair defects | TUBA4A: Microtubule destabilization,Lysosome reformation failure; DNA repair defects
EAS_02079,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02080,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02081,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02082,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02083,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02084,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02085,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02086,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02087,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02088,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02089,EAS,2,FIG4,8.4,Severe,Fast Progression,FIG4; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosomal biogenesis failure
EAS_02090,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02091,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02092,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02093,EAS,3,SOD1,7.0,Moderate,Slow Progression,ALS2; SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02094,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02095,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02096,EAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02097,EAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02098,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02099,EAS,1,SLC52A3,6.0,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02100,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02101,EAS,2,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02102,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02103,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02104,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02105,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02106,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02107,EAS,2,SPG11,7.0,Moderate,Slow Progression,SPG11; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Excitotoxicity,SPG11: Lysosome reformation failure; DNA repair defects | UNC13A: Synaptic transmission defects,Lysosome reformation failure; DNA repair defects
EAS_02108,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02109,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02110,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_02111,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02112,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02113,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02114,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02115,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02116,EAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02117,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02118,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02119,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02120,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02121,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02122,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02123,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02124,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02125,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02126,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02127,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02128,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_02129,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02130,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02131,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02132,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02133,EAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
EAS_02134,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02135,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02136,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02137,EAS,2,VCP,7.0,Moderate,Slow Progression,SIGMAR1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02138,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02139,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02140,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02141,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02142,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02143,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02144,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02145,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02146,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02147,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02148,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02149,EAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02150,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02151,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02152,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02153,EAS,3,SQSTM1,8.4,Severe,Fast Progression,SPG11; SQSTM1; UBQLN2,1,2,SQSTM1; UBQLN2,SQSTM1: Autophagy receptor dysfunction (p62) | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62) | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction (p62)
EAS_02154,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02155,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02156,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02157,EAS,4,SLC52A3,8.4,Severe,Fast Progression,ERBB4; OPTN; SLC52A3; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
EAS_02158,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02159,EAS,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02160,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02161,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02162,EAS,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02163,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02164,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02165,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02166,EAS,3,SQSTM1,7.8,Moderate,Fast Progression,CHMP2B; SQSTM1; UNC13A,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,3,Proteostasis,CHMP2B: ESCRT-III dysfunction | SQSTM1: Autophagy receptor dysfunction (p62) | UNC13A: Synaptic transmission defects,Autophagy receptor dysfunction (p62)
EAS_02167,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02168,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02169,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02170,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02171,EAS,2,HNRNPA2B1,6.0,Moderate,Slow Progression,ALS2; HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
EAS_02172,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02173,EAS,2,LOC129995449,7.8,Moderate,Fast Progression,FUS; LOC129995449,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Unknown mechanism
EAS_02174,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02175,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02176,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02177,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02178,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02179,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02180,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02181,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02182,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02183,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02184,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02185,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02186,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02187,EAS,3,KIF5A,7.8,Moderate,Fast Progression,ALS2; CHRNA3; KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | KIF5A: Anterograde transport failure,Anterograde transport failure
EAS_02188,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02189,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02190,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02191,EAS,2,FIG4,9.2,Severe,Fast Progression,FIG4; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosomal biogenesis failure
EAS_02192,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02193,EAS,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02194,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02195,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02196,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02197,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02198,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02199,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02200,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02201,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02202,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02203,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02204,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02205,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02206,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02207,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02208,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02209,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02210,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02211,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02212,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02213,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02214,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02215,EAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EAS_02216,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02217,EAS,2,TARDBP,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_02218,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02219,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02220,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02221,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02222,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02223,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02224,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02225,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02226,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02227,EAS,1,ALS2,5.0,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02228,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02229,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02230,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02231,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_02232,EAS,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02233,EAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02234,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02235,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02236,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02237,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02238,EAS,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02239,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02240,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02241,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02242,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02243,EAS,2,VCP,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02244,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02245,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02246,EAS,2,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EAS_02247,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02248,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02249,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02250,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02251,EAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02252,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02253,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02254,EAS,1,SYNE1,9.2,Severe,Slow Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02255,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02256,EAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02257,EAS,2,SOD1,7.0,Moderate,Slow Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02258,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02259,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02260,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02261,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02262,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02263,EAS,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02264,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02265,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02266,EAS,3,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02267,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02268,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02269,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02270,EAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02271,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02272,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02273,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02274,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02275,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02276,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02277,EAS,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
EAS_02278,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02279,EAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02280,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02281,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02282,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02283,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; SPG11,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02284,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02285,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02286,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02287,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02288,EAS,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02289,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02290,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02291,EAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_02292,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02293,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02294,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02295,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02296,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02297,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02298,EAS,2,VCP,7.7,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02299,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02300,EAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_02301,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02302,EAS,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02303,EAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02304,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02305,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02306,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02307,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02308,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02309,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02310,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02311,EAS,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02312,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02313,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02314,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02315,EAS,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02316,EAS,2,TBK1,7.7,Moderate,Slow Progression,TARDBP; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02317,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02318,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02319,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_02320,EAS,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02321,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02322,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02323,EAS,2,VCP,7.0,Moderate,Slow Progression,TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02324,EAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02325,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02326,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02327,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02328,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02329,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02330,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02331,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02332,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02333,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02334,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02335,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02336,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02337,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02338,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02339,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02340,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02341,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02342,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02343,EAS,1,PLEKHG5,6.2,Moderate,Slow Progression,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02344,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02345,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02346,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02347,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02348,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02349,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02350,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02351,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02352,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02353,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02354,EAS,2,SOD1,7.0,Moderate,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02355,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02356,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02357,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02358,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02359,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02360,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02361,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02362,EAS,1,ALS2,5.0,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02363,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02364,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02365,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02366,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02367,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02368,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02369,EAS,1,VCP,9.1,Severe,Fast Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02370,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02371,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02372,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02373,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02374,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02375,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02376,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02377,EAS,2,SOD1,7.0,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02378,EAS,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02379,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02380,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02381,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02382,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02383,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02384,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02385,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02386,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02387,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02388,EAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02389,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02390,EAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EAS_02391,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02392,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02393,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02394,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02395,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02396,EAS,2,TBK1,9.8,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02397,EAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02398,EAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02399,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02400,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02401,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02402,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02403,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02404,EAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02405,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_02406,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02407,EAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02408,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02409,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02410,EAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EAS_02411,EAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02412,EAS,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,Unknown mechanism
EAS_02413,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02414,EAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02415,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02416,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; SPG11,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02417,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02418,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02419,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02420,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02421,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02422,EAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02423,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02424,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02425,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02426,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02427,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02428,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02429,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02430,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_02431,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02432,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02433,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02434,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02435,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02436,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02437,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02438,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02439,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02440,EAS,2,VCP,7.0,Moderate,Slow Progression,ERBB4; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02441,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02442,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02443,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02444,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02445,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02446,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02447,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02448,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02449,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02450,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02451,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02452,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02453,EAS,1,OPTN,6.0,Moderate,Asymptomatic/Low Penetrance,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02454,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02455,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02456,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02457,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02458,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02459,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02460,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02461,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02462,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02463,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02464,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02465,EAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02466,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02467,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02468,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02469,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02470,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02471,EAS,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EAS_02472,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02473,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02474,EAS,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02475,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02476,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02477,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02478,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02479,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02480,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02481,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02482,EAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EAS_02483,EAS,2,OPTN,8.4,Severe,Fast Progression,LOC108903148; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02484,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02485,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02486,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02487,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02488,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02489,EAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02490,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02491,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02492,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02493,EAS,2,TBK1,9.1,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02494,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02495,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02496,EAS,1,OPTN,6.6,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02497,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02498,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02499,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02500,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02501,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02502,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02503,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02504,EAS,2,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_02505,EAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02506,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02507,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02508,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02509,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02510,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02511,EAS,3,SQSTM1,7.8,Moderate,Slow Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction (p62)
EAS_02512,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02513,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02514,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02515,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02516,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02517,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02518,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02519,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02520,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02521,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02522,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02523,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02524,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02525,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02526,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02527,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02528,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02529,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02530,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02531,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02532,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02533,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02534,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02535,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02536,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02537,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02538,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02539,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02540,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02541,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02542,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02543,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02544,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02545,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02546,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02547,EAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02548,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02549,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02550,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02551,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02552,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02553,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02554,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02555,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02556,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02557,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02558,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02559,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02560,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02561,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02562,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02563,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02564,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02565,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02566,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_02567,EAS,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02568,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02569,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02570,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02571,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02572,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02573,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02574,EAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02575,EAS,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_02576,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02577,EAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_02578,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02579,EAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02580,EAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02581,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02582,EAS,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02583,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02584,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02585,EAS,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02586,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02587,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02588,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02589,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02590,EAS,2,SOD1,7.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02591,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02592,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02593,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02594,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02595,EAS,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02596,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02597,EAS,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02598,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02599,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02600,EAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_02601,EAS,2,HNRNPA1,6.0,Moderate,Asymptomatic/Low Penetrance,HNRNPA1; SIGMAR1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,HNRNPA1: Stress granule dysregulation | SIGMAR1: MAM calcium dysregulation,Stress granule dysregulation
EAS_02602,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02603,EAS,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EAS_02604,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02605,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02606,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02607,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02608,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02609,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02610,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02611,EAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
EAS_02612,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02613,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02614,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02615,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02616,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02617,EAS,2,FUS,9.9,Severe,Slow Progression,FUS; SPG11,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02618,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02619,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02620,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02621,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02622,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02623,EAS,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02624,EAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02625,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02626,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02627,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02628,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02629,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02630,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_02631,EAS,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02632,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02633,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02634,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02635,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02636,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02637,EAS,1,SPG11,7.7,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02638,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02639,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02640,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02641,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02642,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02643,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02644,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02645,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02646,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02647,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02648,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02649,EAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02650,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02651,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02652,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02653,EAS,2,SOD1,7.7,Moderate,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02654,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02655,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02656,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02657,EAS,3,OPTN,9.2,Severe,Fast Progression,DCTN1; OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,Proteostasis,DCTN1: Retrograde transport failure | OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
EAS_02658,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02659,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02660,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02661,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02662,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02663,EAS,2,FUS,9.9,Severe,Slow Progression,FUS; HNRNPA2B1,0,0,,,1,2,FUS; HNRNPA2B1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA2B1: Stress granule dysregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA2B1: Stress granule dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02664,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02665,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02666,EAS,2,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
EAS_02667,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02668,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02669,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02670,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02671,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02672,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02673,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02674,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02675,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02676,EAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02677,EAS,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EAS_02678,EAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02679,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02680,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02681,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02682,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02683,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02684,EAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02685,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02686,EAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02687,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02688,EAS,2,FUS,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02689,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02690,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02691,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02692,EAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02693,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02694,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02695,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02696,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02697,EAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02698,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02699,EAS,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_02700,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02701,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02702,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02703,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02704,EAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02705,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02706,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02707,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02708,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02709,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02710,EAS,1,FIG4,7.8,Moderate,Slow Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_02711,EAS,3,ALS2,7.0,Moderate,Fast Progression,ALS2; SETX; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | SQSTM1: Autophagy receptor dysfunction (p62),Endosome-lysosome fusion failure
EAS_02712,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02713,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02714,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02715,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02716,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02717,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02718,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02719,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02720,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02721,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02722,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02723,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02724,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02725,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02726,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02727,EAS,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02728,EAS,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02729,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02730,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02731,EAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02732,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02733,EAS,2,PRPH,7.8,Moderate,Fast Progression,PRPH; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
EAS_02734,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02735,EAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02736,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02737,EAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02738,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02739,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02740,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02741,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02742,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02743,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02744,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02745,EAS,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EAS_02746,EAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02747,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02748,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02749,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02750,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_02751,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02752,EAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02753,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02754,EAS,1,SETX,4.0,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02755,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02756,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02757,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02758,EAS,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EAS_02759,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02760,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02761,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02762,EAS,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02763,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02764,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02765,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02766,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02767,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02768,EAS,2,ALS2,7.7,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
EAS_02769,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02770,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02771,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02772,EAS,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02773,EAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02774,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02775,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02776,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02777,EAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02778,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02779,EAS,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02780,EAS,2,VCP,7.0,Moderate,Slow Progression,CHMP2B; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02781,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02782,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02783,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02784,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02785,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02786,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02787,EAS,2,VCP,7.0,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02788,EAS,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction
EAS_02789,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02790,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02791,EAS,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
EAS_02792,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02793,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02794,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02795,EAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EAS_02796,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02797,EAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02798,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02799,EAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02800,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02801,EAS,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02802,EAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02803,EAS,2,SQSTM1,9.2,Severe,Fast Progression,SQSTM1; VCP,1,2,SQSTM1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction (p62)
EAS_02804,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02805,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02806,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02807,EAS,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02808,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02809,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02810,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02811,EAS,2,TBK1,10.0,Severe,Fast Progression,TBK1; TUBA4A,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,TBK1: Autophagy initiation kinase deficiency | TUBA4A: Microtubule destabilization,Autophagy initiation kinase deficiency
EAS_02812,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02813,EAS,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02814,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02815,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02816,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02817,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02818,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02819,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02820,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02821,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02822,EAS,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02823,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02824,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02825,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02826,EAS,2,SPG11,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
EAS_02827,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02828,EAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02829,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02830,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02831,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02832,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_02833,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02834,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02835,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02836,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_02837,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02838,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02839,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02840,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02841,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02842,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02843,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02844,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02845,EAS,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02846,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02847,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02848,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02849,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02850,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02851,EAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02852,EAS,2,DCTN1,7.0,Moderate,Slow Progression,DCTN1; HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,DCTN1: Retrograde transport failure | HNRNPA1: Stress granule dysregulation,Retrograde transport failure
EAS_02853,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02854,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02855,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02856,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02857,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02858,EAS,2,VCP,7.0,Moderate,Slow Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02859,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02860,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02861,EAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02862,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02863,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02864,EAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02865,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02866,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02867,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02868,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02869,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02870,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02871,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02872,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02873,EAS,4,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02874,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02875,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02876,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02877,EAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02878,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02879,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02880,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02881,EAS,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02882,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02883,EAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02884,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02885,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02886,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02887,EAS,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EAS_02888,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02889,EAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02890,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02891,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02892,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02893,EAS,2,CHMP2B,7.0,Moderate,Slow Progression,ALS2; CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; CHMP2B,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_02894,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02895,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02896,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02897,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02898,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02899,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02900,EAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02901,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02902,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02903,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02904,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02905,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02906,EAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02907,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02908,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02909,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02910,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02911,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02912,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02913,EAS,1,ERBB4,5.0,Mild,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02914,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02915,EAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02916,EAS,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02917,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02918,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02919,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02920,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02921,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02922,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02923,EAS,1,DCTN1,7.0,Moderate,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EAS_02924,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02925,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02926,EAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02927,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02928,EAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02929,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02930,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02931,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02932,EAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EAS_02933,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02934,EAS,1,SETX,4.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02935,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02936,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02937,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02938,EAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02939,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02940,EAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EAS_02941,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02942,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02943,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02944,EAS,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EAS_02945,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02946,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02947,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02948,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02949,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02950,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02951,EAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EAS_02952,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02953,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02954,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02955,EAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02956,EAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EAS_02957,EAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EAS_02958,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02959,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02960,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02961,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02962,EAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02963,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02964,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02965,EAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EAS_02966,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02967,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02968,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02969,EAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EAS_02970,EAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_02971,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02972,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02973,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02974,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02975,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02976,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02977,EAS,3,SOD1,7.0,Moderate,Fast Progression,SOD1; SQSTM1; VCP,1,3,SOD1; SQSTM1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EAS_02978,EAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EAS_02979,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02980,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02981,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02982,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02983,EAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EAS_02984,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02985,EAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EAS_02986,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02987,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02988,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02989,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02990,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02991,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02992,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02993,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02994,EAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EAS_02995,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02996,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02997,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EAS_02998,EAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EAS_02999,EAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00000,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00001,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00002,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00003,EUR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00004,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00005,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00006,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00007,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00008,EUR,1,SLC52A3,9.2,Severe,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00009,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00010,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00011,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00012,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00013,EUR,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00014,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00015,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00016,EUR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EUR_00017,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00018,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00019,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00020,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00021,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00022,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00023,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00024,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00025,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00026,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
EUR_00027,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00028,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00029,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00030,EUR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EUR_00031,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00032,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00033,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00034,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00035,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00036,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00037,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00038,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00039,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00040,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00041,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00042,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00043,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00044,EUR,1,CHCHD10,6.6,Moderate,Slow Progression,CHCHD10,0,0,,,0,0,,,0,0,,,1,1,CHCHD10,CHCHD10: Cristae disruption; mtDNA instability,0,0,,,0,0,,,0,0,,,1,Mitochondrial,CHCHD10: Cristae disruption; mtDNA instability,Cristae disruption; mtDNA instability
EUR_00045,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00046,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00047,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00048,EUR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00049,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00050,EUR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00051,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00052,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00053,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00054,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00055,EUR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00056,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00057,EUR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EUR_00058,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00059,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00060,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00061,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00062,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00063,EUR,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00064,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00065,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00066,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00067,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00068,EUR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00069,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00070,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00071,EUR,1,SPG11,7.7,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00072,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00073,EUR,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00074,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00075,EUR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00076,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00077,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00078,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00079,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_00080,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00081,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00082,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00083,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00084,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00085,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00086,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00087,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00088,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00089,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00090,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00091,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00092,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00093,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00094,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00095,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00096,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00097,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00098,EUR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00099,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00100,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00101,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00102,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00103,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00104,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00105,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00106,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00107,EUR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00108,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00109,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00110,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00111,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00112,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00113,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00114,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00115,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00116,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00117,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00118,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00119,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00120,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00121,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00122,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00123,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00124,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00125,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00126,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00127,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00128,EUR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_00129,EUR,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00130,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00131,EUR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00132,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00133,EUR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00134,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00135,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00136,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00137,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00138,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00139,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00140,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00141,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00142,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00143,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00144,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00145,EUR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00146,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00147,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00148,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00149,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00150,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00151,EUR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00152,EUR,2,TBK1,9.8,Severe,Fast Progression,SLC52A3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00153,EUR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00154,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00155,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00156,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00157,EUR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00158,EUR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00159,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00160,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00161,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00162,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00163,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00164,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00165,EUR,2,FUS,10.0,Severe,Fast Progression,FUS; NEK1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | NEK1: DNA damage checkpoint failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00166,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00167,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00168,EUR,1,ANG,6.0,Moderate,Slow Progression,ANG,0,0,,,1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,ANG: Ribosomal biogenesis impairment,Ribosomal biogenesis impairment
EUR_00169,EUR,1,SLC52A3,6.0,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00170,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00171,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00172,EUR,3,OPTN,7.8,Moderate,Fast Progression,ALS2; OPTN; UBQLN2,1,2,OPTN; UBQLN2,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
EUR_00173,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00174,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00175,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00176,EUR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00177,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00178,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00179,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00180,EUR,2,LOC124629354,7.8,Moderate,Fast Progression,LOC124629354; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Unknown mechanism
EUR_00181,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00182,EUR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00183,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00184,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00185,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00186,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00187,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00188,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00189,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00190,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00191,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00192,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00193,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00194,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00195,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00196,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00197,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00198,EUR,2,SPG11,7.0,Moderate,Fast Progression,PLEKHG5; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00199,EUR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00200,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00201,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00202,EUR,2,VCP,9.1,Severe,Fast Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00203,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00204,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00205,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00206,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00207,EUR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00208,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00209,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00210,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00211,EUR,2,VCP,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00212,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00213,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00214,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00215,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00216,EUR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_00217,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00218,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00219,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00220,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00221,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00222,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00223,EUR,3,FIG4,7.8,Moderate,Fast Progression,FIG4; SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,2,FIG4; SPG11,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosomal biogenesis failure
EUR_00224,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00225,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00226,EUR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00227,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00228,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00229,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00230,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00231,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00232,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00233,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
EUR_00234,EUR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_00235,EUR,2,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00236,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00237,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00238,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00239,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00240,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00241,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00242,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00243,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00244,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00245,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00246,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00247,EUR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EUR_00248,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00249,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00250,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00251,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00252,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00253,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00254,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00255,EUR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_00256,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00257,EUR,1,PARK7,7.7,Moderate,Slow Progression,PARK7,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00258,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00259,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00260,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00261,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00262,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00263,EUR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EUR_00264,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00265,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00266,EUR,2,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00267,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00268,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00269,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00270,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00271,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00272,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00273,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00274,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00275,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00276,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00277,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00278,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00279,EUR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00280,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00281,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00282,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction
EUR_00283,EUR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00284,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00285,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00286,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00287,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00288,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00289,EUR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00290,EUR,2,CHRNA3,8.4,Severe,Slow Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EUR_00291,EUR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00292,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00293,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00294,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00295,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00296,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00297,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00298,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00299,EUR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EUR_00300,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00301,EUR,2,TBK1,7.0,Moderate,Slow Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00302,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_00303,EUR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00304,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00305,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00306,EUR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_00307,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00308,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00309,EUR,3,FIG4,7.8,Moderate,Fast Progression,FIG4; OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,2,FIG4; SPG11,FIG4: Lysosomal biogenesis failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure | OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Lysosomal biogenesis failure
EUR_00310,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00311,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00312,EUR,2,DCTN1,7.0,Moderate,Slow Progression,ALS2; DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_00313,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00314,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00315,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00316,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00317,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00318,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00319,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00320,EUR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00321,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00322,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00323,EUR,2,SQSTM1,7.8,Moderate,Fast Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00324,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00325,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00326,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00327,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00328,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_00329,EUR,1,SOD1,7.7,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00330,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00331,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00332,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00333,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00334,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00335,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00336,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00337,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00338,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00339,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00340,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00341,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00342,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00343,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00344,EUR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_00345,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00346,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00347,EUR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00348,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00349,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00350,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00351,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00352,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00353,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00354,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00355,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00356,EUR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_00357,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00358,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00359,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00360,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00361,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00362,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00363,EUR,2,SIGMAR1,7.7,Moderate,Slow Progression,DCTN1; SIGMAR1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_00364,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00365,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00366,EUR,2,C9orf72,8.8,Severe,Slow Progression,C9orf72; VCP,1,2,C9ORF72; VCP,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
EUR_00367,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00368,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00369,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00370,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00371,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00372,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00373,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00374,EUR,1,ALS2,7.0,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00375,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00376,EUR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EUR_00377,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00378,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00379,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00380,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00381,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00382,EUR,2,VCP,7.7,Moderate,Slow Progression,SIGMAR1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00383,EUR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00384,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00385,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00386,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00387,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00388,EUR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EUR_00389,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00390,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00391,EUR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00392,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00393,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00394,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00395,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00396,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00397,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00398,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00399,EUR,3,ALS2,7.7,Moderate,Slow Progression,ALS2; KIF5A; SIGMAR1,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | KIF5A: Anterograde transport failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
EUR_00400,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00401,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00402,EUR,2,SPG11,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
EUR_00403,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00404,EUR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
EUR_00405,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00406,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00407,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00408,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00409,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00410,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00411,EUR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00412,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00413,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00414,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00415,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00416,EUR,1,CHCHD10,6.6,Moderate,Slow Progression,CHCHD10,0,0,,,0,0,,,0,0,,,1,1,CHCHD10,CHCHD10: Cristae disruption; mtDNA instability,0,0,,,0,0,,,0,0,,,1,Mitochondrial,CHCHD10: Cristae disruption; mtDNA instability,Cristae disruption; mtDNA instability
EUR_00417,EUR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00418,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00419,EUR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00420,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00421,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00422,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00423,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00424,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00425,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00426,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00427,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00428,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00429,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00430,EUR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00431,EUR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00432,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00433,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00434,EUR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
EUR_00435,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00436,EUR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00437,EUR,2,SOD1,7.7,Moderate,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00438,EUR,3,ERBB4,6.5,Moderate,Slow Progression,ALS2; ERBB4; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Unknown mechanism
EUR_00439,EUR,3,SOD1,7.0,Moderate,Fast Progression,SOD1; TARDBP; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00440,EUR,3,VCP,7.0,Moderate,Slow Progression,ALS2; SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00441,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00442,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00443,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00444,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00445,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00446,EUR,2,UNC13A,6.0,Moderate,Slow Progression,ALS2; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | UNC13A: Synaptic transmission defects,Synaptic transmission defects
EUR_00447,EUR,1,SLC52A3,6.0,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00448,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00449,EUR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00450,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00451,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00452,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00453,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00454,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00455,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00456,EUR,2,ERBB4,6.5,Moderate,Slow Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EUR_00457,EUR,2,FUS,10.0,Severe,Fast Progression,CHRNA3; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00458,EUR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00459,EUR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00460,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00461,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00462,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00463,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00464,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00465,EUR,2,SPG11,7.7,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
EUR_00466,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00467,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00468,EUR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00469,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00470,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00471,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00472,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00473,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00474,EUR,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00475,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00476,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00477,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00478,EUR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EUR_00479,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00480,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_00481,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00482,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00483,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00484,EUR,1,C9orf72,8.8,Severe,Fast Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
EUR_00485,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00486,EUR,2,OPTN,8.4,Severe,Fast Progression,OPTN; UBQLN2,1,2,OPTN; UBQLN2,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
EUR_00487,EUR,2,FIG4,9.2,Severe,Fast Progression,FIG4; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | SQSTM1: Autophagy receptor dysfunction (p62),Lysosomal biogenesis failure
EUR_00488,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00489,EUR,1,OPTN,7.8,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00490,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00491,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00492,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00493,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00494,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00495,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00496,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00497,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00498,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00499,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00500,EUR,2,SOD1,7.7,Moderate,Fast Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00501,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00502,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00503,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00504,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00505,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00506,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00507,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00508,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00509,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00510,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00511,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00512,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00513,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00514,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00515,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00516,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00517,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00518,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00519,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00520,EUR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00521,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; CHMP2B,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,Endosome-lysosome fusion failure
EUR_00522,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00523,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00524,EUR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00525,EUR,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
EUR_00526,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00527,EUR,2,OPTN,9.2,Severe,Fast Progression,LOC108903148; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00528,EUR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00529,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00530,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00531,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00532,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00533,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00534,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00535,EUR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00536,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00537,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00538,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00539,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00540,EUR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00541,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00542,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00543,EUR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00544,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00545,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00546,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00547,EUR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_00548,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00549,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00550,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00551,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00552,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00553,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00554,EUR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00555,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00556,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00557,EUR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00558,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00559,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00560,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00561,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00562,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00563,EUR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00564,EUR,2,VCP,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00565,EUR,2,DCTN1,7.0,Moderate,Slow Progression,ALS2; DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_00566,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00567,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00568,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00569,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00570,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00571,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00572,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00573,EUR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_00574,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00575,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00576,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00577,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00578,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00579,EUR,3,SPG11,7.0,Moderate,Fast Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00580,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00581,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00582,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00583,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00584,EUR,2,SPG11,7.7,Moderate,Slow Progression,SIGMAR1; SPG11,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00585,EUR,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00586,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00587,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00588,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00589,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00590,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00591,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00592,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00593,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00594,EUR,2,FUS,10.0,Severe,Fast Progression,FUS; SLC52A3,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00595,EUR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00596,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00597,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00598,EUR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00599,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00600,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00601,EUR,1,SETX,5.2,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00602,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00603,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00604,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_00605,EUR,2,FUS,10.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00606,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00607,EUR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00608,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00609,EUR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00610,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00611,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00612,EUR,4,FUS,10.0,Severe,Fast Progression,FUS; OPTN; SLC52A3; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00613,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00614,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00615,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00616,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00617,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00618,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00619,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_00620,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00621,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00622,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00623,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00624,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00625,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00626,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00627,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00628,EUR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00629,EUR,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00630,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00631,EUR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00632,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00633,EUR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_00634,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00635,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00636,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00637,EUR,2,SQSTM1,8.4,Severe,Fast Progression,NEK1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Proteostasis,NEK1: DNA damage checkpoint failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00638,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00639,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00640,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00641,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00642,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00643,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00644,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00645,EUR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00646,EUR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00647,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00648,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00649,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00650,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00651,EUR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00652,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00653,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00654,EUR,2,TBK1,7.0,Moderate,Slow Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00655,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00656,EUR,2,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,ESCRT-III dysfunction
EUR_00657,EUR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EUR_00658,EUR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00659,EUR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
EUR_00660,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00661,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00662,EUR,2,ANXA11,8.6,Severe,Fast Progression,ANXA11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Unknown mechanism
EUR_00663,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00664,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00665,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00666,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00667,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00668,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00669,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00670,EUR,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00671,EUR,2,SOD1,7.0,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00672,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00673,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00674,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00675,EUR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00676,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00677,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00678,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00679,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00680,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00681,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00682,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00683,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00684,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00685,EUR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00686,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00687,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00688,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00689,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00690,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00691,EUR,1,SOD1,7.7,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00692,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00693,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00694,EUR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00695,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00696,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00697,EUR,1,LOC129995449,7.8,Moderate,Slow Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00698,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00699,EUR,2,OPTN,9.2,Severe,Fast Progression,FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00700,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00701,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00702,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00703,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00704,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00705,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00706,EUR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_00707,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00708,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00709,EUR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00710,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00711,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00712,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00713,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00714,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00715,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00716,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00717,EUR,3,TBK1,9.1,Severe,Fast Progression,PLEKHG5; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00718,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00719,EUR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_00720,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00721,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00722,EUR,2,LOC124629354,7.8,Moderate,Fast Progression,LOC124629354; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Unknown mechanism
EUR_00723,EUR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00724,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00725,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00726,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00727,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00728,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00729,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00730,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00731,EUR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00732,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00733,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00734,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00735,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00736,EUR,2,TBK1,10.0,Severe,Fast Progression,DCTN1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00737,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00738,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00739,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00740,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00741,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00742,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00743,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00744,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00745,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00746,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00747,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00748,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
EUR_00749,EUR,1,ALS2,7.0,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00750,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00751,EUR,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
EUR_00752,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00753,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00754,EUR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00755,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00756,EUR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00757,EUR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00758,EUR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00759,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00760,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00761,EUR,4,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; NEK1; SQSTM1; UNC13A,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,3,Proteostasis,NEK1: DNA damage checkpoint failure | SQSTM1: Autophagy receptor dysfunction (p62) | UNC13A: Synaptic transmission defects,Unknown mechanism
EUR_00762,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00763,EUR,2,SQSTM1,8.4,Severe,Fast Progression,OPTN; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00764,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00765,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00766,EUR,2,TBK1,10.0,Severe,Fast Progression,CHRNA3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00767,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00768,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00769,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00770,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00771,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00772,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00773,EUR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00774,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00775,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00776,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00777,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00778,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00779,EUR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00780,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00781,EUR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00782,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00783,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00784,EUR,2,SOD1,7.0,Moderate,Fast Progression,CHMP2B; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00785,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00786,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00787,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00788,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00789,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00790,EUR,2,SPTLC1,6.9,Moderate,Slow Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EUR_00791,EUR,2,SOD1,7.0,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00792,EUR,1,SLC52A3,9.2,Severe,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00793,EUR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00794,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00795,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00796,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00797,EUR,2,FUS,9.9,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00798,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00799,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00800,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00801,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00802,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00803,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00804,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00805,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00806,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00807,EUR,1,LOC130003372,6.6,Moderate,Slow Progression,LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00808,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00809,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00810,EUR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EUR_00811,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00812,EUR,3,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
EUR_00813,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00814,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00815,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00816,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00817,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00818,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00819,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00820,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00821,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00822,EUR,3,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00823,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00824,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00825,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EUR_00826,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00827,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00828,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00829,EUR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00830,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00831,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00832,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00833,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00834,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_00835,EUR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_00836,EUR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00837,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00838,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00839,EUR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00840,EUR,2,SOD1,7.0,Moderate,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00841,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00842,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00843,EUR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_00844,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00845,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00846,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00847,EUR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_00848,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00849,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00850,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00851,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00852,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00853,EUR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00854,EUR,2,SOD1,7.0,Moderate,Slow Progression,PLEKHG5; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00855,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00856,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00857,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00858,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00859,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00860,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00861,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00862,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00863,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00864,EUR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_00865,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Endosome-lysosome fusion failure
EUR_00866,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00867,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00868,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00869,EUR,2,LOC124629354,8.4,Severe,Fast Progression,ALS2; LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
EUR_00870,EUR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00871,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00872,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00873,EUR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_00874,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00875,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00876,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00877,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00878,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00879,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00880,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00881,EUR,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_00882,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00883,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00884,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00885,EUR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_00886,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00887,EUR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00888,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00889,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00890,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00891,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00892,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00893,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00894,EUR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00895,EUR,2,VCP,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_00896,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00897,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00898,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00899,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00900,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00901,EUR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_00902,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00903,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00904,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00905,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00906,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00907,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00908,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00909,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00910,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_00911,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00912,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00913,EUR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EUR_00914,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00915,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00916,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00917,EUR,1,LOC129995449,7.8,Moderate,Slow Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00918,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00919,EUR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_00920,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00921,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00922,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00923,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00924,EUR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00925,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00926,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00927,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00928,EUR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00929,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00930,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00931,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00932,EUR,1,SOD1,7.7,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00933,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00934,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00935,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00936,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00937,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00938,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00939,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00940,EUR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00941,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00942,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00943,EUR,2,SOD1,9.8,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00944,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00945,EUR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00946,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00947,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_00948,EUR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00949,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00950,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00951,EUR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00952,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00953,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00954,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00955,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00956,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00957,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00958,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00959,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_00960,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00961,EUR,2,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
EUR_00962,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00963,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00964,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00965,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00966,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00967,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00968,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00969,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00970,EUR,1,LOC108903148,7.8,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_00971,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00972,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00973,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00974,EUR,2,NEK1,8.4,Severe,Fast Progression,ALS2; NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EUR_00975,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00976,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00977,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00978,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00979,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00980,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00981,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00982,EUR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
EUR_00983,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00984,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00985,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00986,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00987,EUR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_00988,EUR,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_00989,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00990,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00991,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00992,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00993,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_00994,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00995,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00996,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00997,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00998,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_00999,EUR,3,SQSTM1,9.2,Severe,Fast Progression,ALS2; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01000,EUR,2,SPG11,7.7,Moderate,Slow Progression,SPG11; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Excitotoxicity,SPG11: Lysosome reformation failure; DNA repair defects | UNC13A: Synaptic transmission defects,Lysosome reformation failure; DNA repair defects
EUR_01001,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01002,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01003,EUR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EUR_01004,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01005,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01006,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01007,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01008,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01009,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01010,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01011,EUR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01012,EUR,3,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
EUR_01013,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01014,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01015,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01016,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01017,EUR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01018,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01019,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01020,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01021,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01022,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01023,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01024,EUR,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01025,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01026,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01027,EUR,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01028,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01029,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01030,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01031,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01032,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01033,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01034,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01035,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01036,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01037,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01038,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01039,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01040,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01041,EUR,2,SPG11,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01042,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01043,EUR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01044,EUR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01045,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01046,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01047,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01048,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01049,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01050,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01051,EUR,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01052,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01053,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01054,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01055,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
EUR_01056,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01057,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01058,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01059,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01060,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01061,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01062,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01063,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01064,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01065,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01066,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01067,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01068,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01069,EUR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01070,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01071,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01072,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01073,EUR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01074,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01075,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01076,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01077,EUR,1,LOC129995449,7.8,Moderate,Slow Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01078,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01079,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01080,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01081,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01082,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01083,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01084,EUR,2,DCTN1,7.7,Moderate,Slow Progression,ALS2; DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_01085,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01086,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01087,EUR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01088,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01089,EUR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01090,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01091,EUR,1,SQSTM1,8.6,Severe,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01092,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01093,EUR,3,OPTN,7.8,Moderate,Fast Progression,ALS2; OPTN; UBQLN2,1,2,OPTN; UBQLN2,OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy receptor dysfunction
EUR_01094,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01095,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01096,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01097,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01098,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01099,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01100,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01101,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01102,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01103,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01104,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01105,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01106,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01107,EUR,2,SQSTM1,9.2,Severe,Fast Progression,SETX; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01108,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01109,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01110,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01111,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01112,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01113,EUR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01114,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01115,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01116,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01117,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01118,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01119,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01120,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01121,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01122,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01123,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01124,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01125,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01126,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01127,EUR,2,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01128,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01129,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01130,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01131,EUR,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EUR_01132,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01133,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01134,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01135,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01136,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01137,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01138,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01139,EUR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01140,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01141,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01142,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01143,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01144,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01145,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01146,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01147,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01148,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01149,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01150,EUR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01151,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01152,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01153,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01154,EUR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01155,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01156,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01157,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01158,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01159,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01160,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01161,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01162,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01163,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01164,EUR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EUR_01165,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01166,EUR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_01167,EUR,3,TBK1,9.8,Severe,Fast Progression,DCTN1; SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,3,Proteostasis,DCTN1: Retrograde transport failure | SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01168,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01169,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01170,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01171,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_01172,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01173,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01174,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01175,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01176,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01177,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01178,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01179,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01180,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01181,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01182,EUR,2,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01183,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01184,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01185,EUR,2,SQSTM1,9.2,Severe,Fast Progression,SQSTM1; VCP,1,2,SQSTM1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction (p62)
EUR_01186,EUR,2,SOD1,7.0,Moderate,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01187,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01188,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01189,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01190,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01191,EUR,2,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_01192,EUR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01193,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01194,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01195,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01196,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01197,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01198,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01199,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01200,EUR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_01201,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01202,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01203,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01204,EUR,3,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1; VCP,1,3,SOD1; TBK1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
EUR_01205,EUR,1,LOC130001681,9.2,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01206,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01207,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01208,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01209,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01210,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01211,EUR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01212,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01213,EUR,2,OPTN,7.8,Moderate,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01214,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01215,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01216,EUR,3,SPG11,7.0,Moderate,Slow Progression,CHMP2B; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,CHMP2B; SPG11,CHMP2B: ESCRT-III dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01217,EUR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01218,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01219,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01220,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01221,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01222,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01223,EUR,2,NEK1,8.4,Severe,Fast Progression,NEK1; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Cytoskeletal_Axonal_Transport,NEK1: DNA damage checkpoint failure | TUBA4A: Microtubule destabilization,DNA damage checkpoint failure
EUR_01224,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01225,EUR,1,ERBB4,5.0,Mild,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01226,EUR,3,SPG11,7.0,Moderate,Fast Progression,OPTN; SLC52A3; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01227,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01228,EUR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01229,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01230,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01231,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01232,EUR,1,LOC129995449,7.8,Moderate,Slow Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01233,EUR,2,TBK1,10.0,Severe,Fast Progression,CHRNA3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01234,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01235,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01236,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01237,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01238,EUR,2,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,Unknown mechanism
EUR_01239,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01240,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01241,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01242,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01243,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01244,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01245,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01246,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01247,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01248,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01249,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01250,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01251,EUR,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01252,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01253,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01254,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01255,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01256,EUR,3,SPTLC1,6.9,Moderate,Fast Progression,SOD1; SPG11; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
EUR_01257,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01258,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01259,EUR,2,LOC130001681,9.2,Severe,Fast Progression,LOC130001681; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EUR_01260,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01261,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01262,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01263,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01264,EUR,2,SETX,6.2,Moderate,Slow Progression,SETX; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Cytoskeletal_Axonal_Transport,SETX: R-loop accumulation; genomic instability | TUBA4A: Microtubule destabilization,R-loop accumulation; genomic instability
EUR_01265,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01266,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01267,EUR,1,PRPH,7.8,Moderate,Fast Progression,PRPH,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01268,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01269,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01270,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01271,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01272,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01273,EUR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
EUR_01274,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01275,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01276,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01277,EUR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EUR_01278,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01279,EUR,1,LOC108903148,7.8,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01280,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01281,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01282,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01283,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01284,EUR,1,SQSTM1,8.6,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01285,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01286,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01287,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01288,EUR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01289,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01290,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01291,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01292,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01293,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01294,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01295,EUR,2,SOD1,7.0,Moderate,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01296,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01297,EUR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01298,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01299,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01300,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01301,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01302,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01303,EUR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01304,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01305,EUR,1,ALS2,7.0,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01306,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01307,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01308,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01309,EUR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01310,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01311,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01312,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01313,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01314,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01315,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01316,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01317,EUR,2,SOD1,7.0,Moderate,Fast Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01318,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01319,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01320,EUR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01321,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01322,EUR,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01323,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01324,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01325,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01326,EUR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01327,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01328,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01329,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01330,EUR,2,SETX,6.2,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01331,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_01332,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01333,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01334,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01335,EUR,3,TARDBP,7.7,Moderate,Slow Progression,ALS2; SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_01336,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01337,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01338,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_01339,EUR,2,CHRNA3,8.4,Severe,Slow Progression,ALS2; CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
EUR_01340,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01341,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01342,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01343,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01344,EUR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01345,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01346,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01347,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01348,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01349,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01350,EUR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01351,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01352,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01353,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01354,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01355,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01356,EUR,4,SPG11,7.0,Moderate,Fast Progression,ALS2; SOD1; SPG11; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
EUR_01357,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01358,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01359,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01360,EUR,2,SOD1,7.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01361,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01362,EUR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01363,EUR,2,NEK1,8.4,Severe,Fast Progression,NEK1; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,3,RNA_Metabolism,NEK1: DNA damage checkpoint failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,DNA damage checkpoint failure
EUR_01364,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01365,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01366,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01367,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01368,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_01369,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01370,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01371,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01372,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01373,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01374,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01375,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01376,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01377,EUR,1,SETX,4.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01378,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01379,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01380,EUR,2,VCP,7.0,Moderate,Slow Progression,SLC52A3; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01381,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01382,EUR,2,SPG11,7.0,Moderate,Slow Progression,SETX; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01383,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_01384,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01385,EUR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01386,EUR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01387,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01388,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01389,EUR,1,SLC52A3,9.2,Severe,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01390,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01391,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01392,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01393,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01394,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01395,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01396,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01397,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01398,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01399,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01400,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01401,EUR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01402,EUR,2,SLC52A3,8.4,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
EUR_01403,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01404,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01405,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01406,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01407,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01408,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01409,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01410,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01411,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01412,EUR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01413,EUR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01414,EUR,1,LOC108903148,7.8,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01415,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01416,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01417,EUR,2,DCTN1,10.0,Severe,Fast Progression,ALS2; DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_01418,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01419,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01420,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01421,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01422,EUR,3,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01423,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01424,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01425,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01426,EUR,2,SLC52A3,9.2,Severe,Fast Progression,OPTN; SLC52A3,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Unknown mechanism
EUR_01427,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01428,EUR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
EUR_01429,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01430,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01431,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01432,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01433,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01434,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01435,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_01436,EUR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01437,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01438,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01439,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01440,EUR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EUR_01441,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01442,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01443,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01444,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01445,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01446,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01447,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01448,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01449,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01450,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01451,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01452,EUR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01453,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01454,EUR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01455,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01456,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01457,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_01458,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01459,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01460,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01461,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01462,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01463,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01464,EUR,3,ALS2,7.0,Moderate,Slow Progression,ALS2; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation,Endosome-lysosome fusion failure
EUR_01465,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01466,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01467,EUR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01468,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01469,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01470,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01471,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01472,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01473,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01474,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01475,EUR,2,VCP,7.0,Moderate,Slow Progression,TARDBP; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01476,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01477,EUR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EUR_01478,EUR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01479,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01480,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01481,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01482,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01483,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01484,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01485,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01486,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01487,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01488,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01489,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01490,EUR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01491,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01492,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01493,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01494,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01495,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01496,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01497,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01498,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01499,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01500,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01501,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01502,EUR,2,TBK1,9.1,Severe,Fast Progression,SPTLC1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01503,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01504,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01505,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
EUR_01506,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01507,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01508,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01509,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01510,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01511,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01512,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01513,EUR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01514,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01515,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01516,EUR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01517,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01518,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
EUR_01519,EUR,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01520,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01521,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01522,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01523,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01524,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01525,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01526,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01527,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01528,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01529,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01530,EUR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01531,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01532,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01533,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01534,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01535,EUR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_01536,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01537,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01538,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01539,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01540,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01541,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01542,EUR,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01543,EUR,1,SIGMAR1,5.0,Mild,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_01544,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01545,EUR,1,TARDBP,7.7,Moderate,Fast Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_01546,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01547,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01548,EUR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_01549,EUR,2,FUS,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01550,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01551,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01552,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01553,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01554,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01555,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01556,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01557,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01558,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01559,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01560,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01561,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01562,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01563,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01564,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01565,EUR,3,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01566,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01567,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01568,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01569,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01570,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01571,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01572,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01573,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01574,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01575,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01576,EUR,2,OPTN,9.2,Severe,Fast Progression,CHRNA3; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01577,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01578,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01579,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01580,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01581,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01582,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01583,EUR,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01584,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01585,EUR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EUR_01586,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01587,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01588,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01589,EUR,2,SOD1,7.0,Moderate,Slow Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01590,EUR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_01591,EUR,3,SOD1,7.7,Moderate,Fast Progression,SETX; SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01592,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01593,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01594,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01595,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01596,EUR,1,PRPH,7.8,Moderate,Slow Progression,PRPH,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01597,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01598,EUR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01599,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01600,EUR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EUR_01601,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01602,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01603,EUR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_01604,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01605,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01606,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01607,EUR,2,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01608,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01609,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01610,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01611,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01612,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01613,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01614,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_01615,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01616,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01617,EUR,2,SOD1,7.0,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01618,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01619,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01620,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01621,EUR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_01622,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01623,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01624,EUR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_01625,EUR,4,TBK1,10.0,Severe,Fast Progression,DCTN1; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01626,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01627,EUR,3,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01628,EUR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_01629,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01630,EUR,3,SOD1,7.0,Moderate,Fast Progression,SOD1; TARDBP; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01631,EUR,2,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EUR_01632,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01633,EUR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EUR_01634,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01635,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01636,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01637,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01638,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01639,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01640,EUR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EUR_01641,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01642,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01643,EUR,2,SPG11,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01644,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01645,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01646,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01647,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01648,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01649,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01650,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01651,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01652,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01653,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01654,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01655,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01656,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01657,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01658,EUR,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_01659,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01660,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01661,EUR,2,NEK1,8.4,Severe,Fast Progression,NEK1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Proteostasis,NEK1: DNA damage checkpoint failure | TBK1: Autophagy initiation kinase deficiency,DNA damage checkpoint failure
EUR_01662,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01663,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01664,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_01665,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01666,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01667,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01668,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction
EUR_01669,EUR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01670,EUR,2,SQSTM1,8.4,Severe,Fast Progression,DCTN1; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01671,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01672,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01673,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01674,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01675,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01676,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01677,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01678,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01679,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01680,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01681,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01682,EUR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01683,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01684,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01685,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01686,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_01687,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01688,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01689,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01690,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01691,EUR,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01692,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01693,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01694,EUR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01695,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01696,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01697,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01698,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01699,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01700,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01701,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01702,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01703,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01704,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01705,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01706,EUR,2,TBK1,10.0,Severe,Fast Progression,ERBB4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01707,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01708,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01709,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01710,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01711,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01712,EUR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01713,EUR,1,LOC130056973,8.4,Severe,Fast Progression,LOC130056973,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01714,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01715,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01716,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01717,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01718,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01719,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01720,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01721,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01722,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01723,EUR,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01724,EUR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EUR_01725,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01726,EUR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01727,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01728,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01729,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01730,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01731,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01732,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01733,EUR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01734,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01735,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01736,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01737,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01738,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01739,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01740,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01741,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01742,EUR,2,SPG11,7.0,Moderate,Fast Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Lysosome reformation failure; DNA repair defects
EUR_01743,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01744,EUR,2,FUS,9.9,Severe,Fast Progression,FUS; NEK1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | NEK1: DNA damage checkpoint failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01745,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01746,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01747,EUR,2,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
EUR_01748,EUR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01749,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01750,EUR,2,LOC108903148,7.8,Moderate,Slow Progression,LOC108903148; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
EUR_01751,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01752,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01753,EUR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_01754,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01755,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01756,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01757,EUR,2,FUS,10.0,Severe,Fast Progression,FUS; NEK1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | NEK1: DNA damage checkpoint failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01758,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01759,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01760,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01761,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01762,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01763,EUR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_01764,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01765,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01766,EUR,3,SOD1,9.8,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01767,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01768,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01769,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01770,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01771,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01772,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01773,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01774,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01775,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01776,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01777,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01778,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01779,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01780,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01781,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01782,EUR,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01783,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01784,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01785,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01786,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01787,EUR,2,VCP,7.7,Moderate,Slow Progression,PLEKHG5; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01788,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01789,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01790,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01791,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01792,EUR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01793,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01794,EUR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EUR_01795,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01796,EUR,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; KIF5A,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,KIF5A,KIF5A: Anterograde transport failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | KIF5A: Anterograde transport failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01797,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01798,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01799,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01800,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01801,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01802,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01803,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01804,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01805,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01806,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01807,EUR,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
EUR_01808,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01809,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01810,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01811,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01812,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01813,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01814,EUR,2,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01815,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01816,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01817,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01818,EUR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01819,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01820,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01821,EUR,3,OPTN,8.4,Severe,Fast Progression,HNRNPA1; LOC108903148; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA1: Stress granule dysregulation | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01822,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01823,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01824,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01825,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01826,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01827,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01828,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01829,EUR,1,SOD1,10.0,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01830,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01831,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01832,EUR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01833,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01834,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01835,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01836,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01837,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01838,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01839,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01840,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01841,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01842,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01843,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01844,EUR,2,TBK1,7.0,Moderate,Slow Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01845,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01846,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01847,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01848,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01849,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01850,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01851,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01852,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01853,EUR,2,SOD1,7.7,Moderate,Slow Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01854,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01855,EUR,1,SETX,4.6,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01856,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01857,EUR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01858,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01859,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01860,EUR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01861,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01862,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01863,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01864,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01865,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01866,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01867,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01868,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01869,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01870,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01871,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01872,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01873,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01874,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01875,EUR,1,SQSTM1,6.6,Moderate,Asymptomatic/Low Penetrance,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01876,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01877,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01878,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01879,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01880,EUR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01881,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01882,EUR,2,FUS,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01883,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01884,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01885,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01886,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01887,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01888,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01889,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01890,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01891,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01892,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01893,EUR,2,VCP,7.0,Moderate,Slow Progression,HNRNPA1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA1: Stress granule dysregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01894,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01895,EUR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_01896,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01897,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01898,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01899,EUR,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01900,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01901,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01902,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01903,EUR,1,SETX,4.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01904,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01905,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01906,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01907,EUR,2,NEK1,8.4,Severe,Fast Progression,NEK1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,4,Proteostasis,NEK1: DNA damage checkpoint failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DNA damage checkpoint failure
EUR_01908,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01909,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01910,EUR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_01911,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01912,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01913,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01914,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01915,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_01916,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01917,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01918,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01919,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01920,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01921,EUR,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01922,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01923,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01924,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01925,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01926,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01927,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01928,EUR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_01929,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01930,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01931,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01932,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01933,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01934,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01935,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01936,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01937,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01938,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01939,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01940,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01941,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01942,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01943,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01944,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01945,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01946,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01947,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01948,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01949,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01950,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01951,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01952,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01953,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01954,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01955,EUR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_01956,EUR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01957,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01958,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01959,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01960,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01961,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_01962,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01963,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01964,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01965,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01966,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01967,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01968,EUR,2,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction (p62)
EUR_01969,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01970,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01971,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01972,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01973,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_01974,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01975,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01976,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01977,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01978,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01979,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01980,EUR,2,FUS,9.9,Severe,Fast Progression,FUS; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | UBQLN2: Ubiquitin-proteasome clearance failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_01981,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01982,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01983,EUR,1,FIG4,9.2,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EUR_01984,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01985,EUR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_01986,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01987,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01988,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01989,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01990,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01991,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_01992,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01993,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01994,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; PLEKHG5,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_01995,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_01996,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01997,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_01998,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_01999,EUR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02000,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02001,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02002,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02003,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02004,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02005,EUR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_02006,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02007,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02008,EUR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02009,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02010,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction
EUR_02011,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02012,EUR,2,LOC130056973,8.4,Severe,Fast Progression,LOC130056973; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EUR_02013,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02014,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02015,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02016,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02017,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02018,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02019,EUR,1,LOC124629354,7.8,Moderate,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02020,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02021,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02022,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02023,EUR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02024,EUR,2,OPTN,8.4,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02025,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02026,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02027,EUR,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02028,EUR,2,FIG4,8.4,Severe,Fast Progression,FIG4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,4,Proteostasis,FIG4: Lysosomal biogenesis failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Lysosomal biogenesis failure
EUR_02029,EUR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EUR_02030,EUR,2,NEK1,8.4,Severe,Fast Progression,ALS2; NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EUR_02031,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02032,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02033,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02034,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02035,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02036,EUR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02037,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02038,EUR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EUR_02039,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02040,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02041,EUR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_02042,EUR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02043,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02044,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02045,EUR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02046,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02047,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02048,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02049,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02050,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02051,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02052,EUR,2,SPG11,7.0,Moderate,Slow Progression,SETX; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02053,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02054,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02055,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02056,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02057,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02058,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02059,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02060,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02061,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02062,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02063,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02064,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02065,EUR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02066,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02067,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02068,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02069,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02070,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02071,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02072,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02073,EUR,3,ALS2,7.0,Moderate,Slow Progression,ALS2; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | UNC13A: Synaptic transmission defects,Endosome-lysosome fusion failure
EUR_02074,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02075,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02076,EUR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02077,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02078,EUR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02079,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02080,EUR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02081,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02082,EUR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_02083,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02084,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02085,EUR,2,SOD1,7.7,Moderate,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02086,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02087,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02088,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_02089,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02090,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02091,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02092,EUR,2,TBK1,10.0,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02093,EUR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02094,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02095,EUR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_02096,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02097,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02098,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02099,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02100,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02101,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02102,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02103,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02104,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02105,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02106,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02107,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02108,EUR,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02109,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02110,EUR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_02111,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02112,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02113,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02114,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02115,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02116,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02117,EUR,2,VCP,9.1,Severe,Fast Progression,SLC52A3; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02118,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02119,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02120,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02121,EUR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02122,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02123,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02124,EUR,2,SQSTM1,9.2,Severe,Fast Progression,ANXA11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02125,EUR,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
EUR_02126,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02127,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02128,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02129,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02130,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02131,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02132,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02133,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02134,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02135,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02136,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02137,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02138,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02139,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02140,EUR,1,SPG11,7.0,Moderate,Asymptomatic/Low Penetrance,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02141,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02142,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02143,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02144,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02145,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02146,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02147,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02148,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02149,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02150,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02151,EUR,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
EUR_02152,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02153,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02154,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02155,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02156,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02157,EUR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_02158,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02159,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02160,EUR,2,FUS,9.9,Severe,Fast Progression,FUS; SPG11,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02161,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02162,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02163,EUR,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_02164,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02165,EUR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02166,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02167,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02168,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02169,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02170,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02171,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02172,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02173,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02174,EUR,2,TBK1,10.0,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02175,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02176,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02177,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02178,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02179,EUR,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_02180,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02181,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02182,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02183,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02184,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02185,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02186,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02187,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02188,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02189,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02190,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02191,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02192,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02193,EUR,2,TBK1,10.0,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02194,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02195,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02196,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02197,EUR,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
EUR_02198,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02199,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02200,EUR,1,SETX,5.2,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02201,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02202,EUR,2,SOD1,7.0,Moderate,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02203,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02204,EUR,2,FUS,9.9,Severe,Fast Progression,DCTN1; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,RNA_Metabolism,DCTN1: Retrograde transport failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02205,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02206,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02207,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02208,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02209,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02210,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02211,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02212,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02213,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02214,EUR,2,VCP,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02215,EUR,2,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EUR_02216,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02217,EUR,4,CHRNA3,8.4,Severe,Fast Progression,ALS2; CHRNA3; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Unknown mechanism
EUR_02218,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02219,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02220,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02221,EUR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02222,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02223,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02224,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02225,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02226,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02227,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02228,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02229,EUR,1,SETX,5.2,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02230,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02231,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02232,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02233,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02234,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02235,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02236,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02237,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_02238,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02239,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02240,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02241,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02242,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02243,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02244,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02245,EUR,2,SOD1,7.0,Moderate,Slow Progression,CHMP2B; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02246,EUR,2,SPG11,7.0,Moderate,Slow Progression,ERBB4; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02247,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02248,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02249,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02250,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02251,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02252,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02253,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02254,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02255,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02256,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02257,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02258,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02259,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02260,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02261,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02262,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02263,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02264,EUR,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02265,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02266,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02267,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02268,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02269,EUR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02270,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02271,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02272,EUR,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02273,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02274,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02275,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02276,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02277,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02278,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02279,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02280,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02281,EUR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; TUBA4A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TUBA4A: Microtubule destabilization,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02282,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02283,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02284,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02285,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02286,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02287,EUR,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02288,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02289,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02290,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02291,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02292,EUR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_02293,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02294,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02295,EUR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_02296,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02297,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02298,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02299,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02300,EUR,2,TBK1,10.0,Severe,Fast Progression,CHRNA3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02301,EUR,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02302,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02303,EUR,2,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
EUR_02304,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02305,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02306,EUR,2,TBK1,10.0,Severe,Slow Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02307,EUR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02308,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02309,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02310,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02311,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02312,EUR,1,LOC129995449,7.8,Moderate,Slow Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02313,EUR,1,PRPH,7.8,Moderate,Fast Progression,PRPH,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02314,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02315,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02316,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; UNC13A,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | UNC13A: Synaptic transmission defects,Autophagy receptor dysfunction
EUR_02317,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02318,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02319,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02320,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02321,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02322,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02323,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02324,EUR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02325,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02326,EUR,2,DCTN1,7.0,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Retrograde transport failure
EUR_02327,EUR,1,LOC129995449,7.8,Moderate,Slow Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02328,EUR,2,SPG11,7.0,Moderate,Slow Progression,LOC129995449; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02329,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02330,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02331,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02332,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02333,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02334,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02335,EUR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02336,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02337,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02338,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02339,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02340,EUR,2,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
EUR_02341,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02342,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02343,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02344,EUR,2,VCP,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02345,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02346,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02347,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02348,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02349,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02350,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02351,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02352,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
EUR_02353,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02354,EUR,2,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02355,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02356,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02357,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02358,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02359,EUR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02360,EUR,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_02361,EUR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_02362,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02363,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02364,EUR,2,SPG11,7.0,Moderate,Fast Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02365,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02366,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02367,EUR,3,SYNE1,9.2,Severe,Fast Progression,FIG4; SYNE1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency,Unknown mechanism
EUR_02368,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02369,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02370,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02371,EUR,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_02372,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02373,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02374,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Endosome-lysosome fusion failure
EUR_02375,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02376,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02377,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02378,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02379,EUR,2,SOD1,7.0,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02380,EUR,2,TBK1,10.0,Severe,Fast Progression,NEK1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Proteostasis,NEK1: DNA damage checkpoint failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02381,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02382,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02383,EUR,2,LOC108903148,7.8,Moderate,Fast Progression,ALS2; LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
EUR_02384,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02385,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02386,EUR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_02387,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02388,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02389,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02390,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02391,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02392,EUR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_02393,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02394,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02395,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02396,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02397,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02398,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02399,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02400,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02401,EUR,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02402,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02403,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02404,EUR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02405,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02406,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02407,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02408,EUR,2,SLC52A3,6.6,Moderate,Slow Progression,SIGMAR1; SLC52A3,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,Unknown mechanism
EUR_02409,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02410,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02411,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02412,EUR,4,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02413,EUR,2,TBK1,9.1,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02414,EUR,2,UNC13A,6.0,Moderate,Slow Progression,ALS2; UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | UNC13A: Synaptic transmission defects,Synaptic transmission defects
EUR_02415,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02416,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02417,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02418,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02419,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02420,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02421,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_02422,EUR,1,LOC129995449,7.8,Moderate,Slow Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02423,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02424,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02425,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02426,EUR,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02427,EUR,4,LOC108903148,7.8,Moderate,Fast Progression,ALS2; LOC108903148; SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EUR_02428,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02429,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02430,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02431,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02432,EUR,1,SETX,5.7,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02433,EUR,1,SQSTM1,8.6,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02434,EUR,2,TARDBP,7.0,Moderate,Slow Progression,SLC52A3; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_02435,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02436,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02437,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02438,EUR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02439,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02440,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02441,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02442,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02443,EUR,2,SPG11,7.0,Moderate,Slow Progression,SIGMAR1; SPG11,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02444,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02445,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02446,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02447,EUR,2,TARDBP,7.0,Moderate,Slow Progression,SCAF4; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_02448,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02449,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02450,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02451,EUR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02452,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02453,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02454,EUR,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02455,EUR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02456,EUR,1,SOD1,10.0,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02457,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02458,EUR,2,SPG11,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02459,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02460,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02461,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02462,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02463,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02464,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02465,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02466,EUR,1,CHRNA3,8.4,Severe,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02467,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02468,EUR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02469,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02470,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02471,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02472,EUR,1,NEK1,7.8,Moderate,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EUR_02473,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02474,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02475,EUR,3,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1; TBK1,1,3,OPTN; SOD1; TBK1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy receptor dysfunction
EUR_02476,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02477,EUR,2,NEK1,8.4,Severe,Slow Progression,NEK1; PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EUR_02478,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02479,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02480,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02481,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02482,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02483,EUR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02484,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02485,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02486,EUR,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02487,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02488,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02489,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02490,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02491,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02492,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02493,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
EUR_02494,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02495,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02496,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02497,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02498,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02499,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02500,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02501,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02502,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02503,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02504,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02505,EUR,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02506,EUR,4,SQSTM1,7.8,Moderate,Fast Progression,ALS2; HNRNPA1; SQSTM1; TARDBP,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,2,HNRNPA1; TARDBP,HNRNPA1: Stress granule dysregulation | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | HNRNPA1: Stress granule dysregulation | SQSTM1: Autophagy receptor dysfunction (p62) | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction (p62)
EUR_02507,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02508,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02509,EUR,2,SPG11,7.0,Moderate,Slow Progression,SIGMAR1; SPG11,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02510,EUR,2,LOC108903148,7.8,Moderate,Slow Progression,LOC108903148; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02511,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02512,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02513,EUR,1,NEK1,9.2,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EUR_02514,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02515,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02516,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02517,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02518,EUR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02519,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02520,EUR,2,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EUR_02521,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02522,EUR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02523,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02524,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02525,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02526,EUR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02527,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02528,EUR,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02529,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02530,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02531,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02532,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02533,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02534,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02535,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02536,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02537,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02538,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02539,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02540,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02541,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02542,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02543,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02544,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02545,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02546,EUR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02547,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02548,EUR,1,LOC130056973,8.4,Severe,Fast Progression,LOC130056973,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02549,EUR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02550,EUR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02551,EUR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02552,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02553,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02554,EUR,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02555,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02556,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02557,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02558,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02559,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02560,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02561,EUR,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
EUR_02562,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02563,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02564,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02565,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02566,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02567,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02568,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02569,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02570,EUR,2,LOC108903148,9.2,Severe,Fast Progression,ALS2; LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
EUR_02571,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02572,EUR,2,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02573,EUR,1,LOC129995449,7.8,Moderate,Slow Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02574,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02575,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02576,EUR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02577,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02578,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SIGMAR1,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SIGMAR1: MAM calcium dysregulation,Autophagy receptor dysfunction
EUR_02579,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02580,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02581,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02582,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02583,EUR,2,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02584,EUR,1,DCTN1,7.0,Moderate,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_02585,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02586,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02587,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02588,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02589,EUR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02590,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02591,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02592,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02593,EUR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02594,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02595,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02596,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02597,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02598,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02599,EUR,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02600,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02601,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02602,EUR,4,TBK1,9.1,Severe,Fast Progression,LOC108903148; SQSTM1; TBK1; TUBA4A,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | TUBA4A: Microtubule destabilization,Autophagy initiation kinase deficiency
EUR_02603,EUR,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02604,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02605,EUR,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02606,EUR,2,SQSTM1,9.2,Severe,Fast Progression,SQSTM1; TARDBP,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction (p62)
EUR_02607,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02608,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02609,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02610,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02611,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02612,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02613,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02614,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02615,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02616,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02617,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02618,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02619,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02620,EUR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02621,EUR,3,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02622,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02623,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02624,EUR,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
EUR_02625,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02626,EUR,2,LOC130001681,9.2,Severe,Fast Progression,LOC130001681; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
EUR_02627,EUR,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02628,EUR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_02629,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02630,EUR,2,TBK1,10.0,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02631,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02632,EUR,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02633,EUR,1,LOC129995449,7.8,Moderate,Slow Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02634,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02635,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02636,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02637,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02638,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02639,EUR,3,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02640,EUR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_02641,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02642,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02643,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02644,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02645,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02646,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02647,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02648,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02649,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02650,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02651,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02652,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02653,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02654,EUR,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02655,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02656,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02657,EUR,3,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02658,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02659,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02660,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_02661,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02662,EUR,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02663,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02664,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02665,EUR,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
EUR_02666,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02667,EUR,1,SLC52A3,6.0,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02668,EUR,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02669,EUR,2,SPTLC1,6.9,Moderate,Fast Progression,SPTLC1; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
EUR_02670,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02671,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02672,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02673,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02674,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02675,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02676,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02677,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02678,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02679,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02680,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02681,EUR,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02682,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02683,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02684,EUR,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_02685,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02686,EUR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02687,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02688,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02689,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02690,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02691,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02692,EUR,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02693,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02694,EUR,1,SLC52A3,9.2,Severe,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02695,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02696,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02697,EUR,3,SQSTM1,8.4,Severe,Fast Progression,SETX; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02698,EUR,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02699,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02700,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02701,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02702,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02703,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02704,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02705,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02706,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02707,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02708,EUR,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_02709,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02710,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02711,EUR,2,SOD1,7.7,Moderate,Fast Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02712,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02713,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02714,EUR,2,ALS2,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
EUR_02715,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02716,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02717,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02718,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02719,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02720,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02721,EUR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02722,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02723,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02724,EUR,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02725,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02726,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02727,EUR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02728,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02729,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02730,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02731,EUR,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02732,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02733,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02734,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02735,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02736,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02737,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02738,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02739,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02740,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02741,EUR,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
EUR_02742,EUR,2,TBK1,9.1,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
EUR_02743,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02744,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02745,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02746,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02747,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02748,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02749,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02750,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02751,EUR,1,LOC130001681,9.2,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02752,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
EUR_02753,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02754,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_02755,EUR,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02756,EUR,2,SPG11,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02757,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02758,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02759,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02760,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02761,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02762,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02763,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02764,EUR,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02765,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02766,EUR,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02767,EUR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_02768,EUR,1,CHRNA3,8.4,Severe,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02769,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02770,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02771,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02772,EUR,2,SPG11,7.0,Moderate,Fast Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02773,EUR,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_02774,EUR,1,VCP,7.0,Moderate,Fast Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02775,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02776,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02777,EUR,1,LOC129995449,7.8,Moderate,Slow Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02778,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02779,EUR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02780,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02781,EUR,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02782,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02783,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02784,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02785,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02786,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02787,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02788,EUR,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02789,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02790,EUR,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_02791,EUR,2,SOD1,7.0,Moderate,Slow Progression,CHMP2B; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02792,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02793,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02794,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02795,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02796,EUR,3,SPG11,7.7,Moderate,Slow Progression,SIGMAR1; SPG11,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02797,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02798,EUR,1,LOC124629354,7.8,Moderate,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02799,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02800,EUR,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
EUR_02801,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02802,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02803,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02804,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02805,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02806,EUR,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02807,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02808,EUR,2,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
EUR_02809,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02810,EUR,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02811,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02812,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02813,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02814,EUR,2,FUS,10.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02815,EUR,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02816,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02817,EUR,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02818,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02819,EUR,1,CHRNA3,8.4,Severe,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02820,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02821,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02822,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02823,EUR,1,LOC130003372,6.6,Moderate,Slow Progression,LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02824,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02825,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02826,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02827,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02828,EUR,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02829,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02830,EUR,1,TBK1,10.0,Severe,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02831,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02832,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02833,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02834,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02835,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02836,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02837,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02838,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02839,EUR,1,SETX,5.7,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02840,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02841,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02842,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02843,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02844,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02845,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02846,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02847,EUR,2,ALS2,7.0,Moderate,Slow Progression,ALS2; DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure,Endosome-lysosome fusion failure
EUR_02848,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02849,EUR,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02850,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02851,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02852,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02853,EUR,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02854,EUR,1,PRPH,7.8,Moderate,Fast Progression,PRPH,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02855,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02856,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02857,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02858,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02859,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02860,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02861,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02862,EUR,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
EUR_02863,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02864,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02865,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02866,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02867,EUR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02868,EUR,1,SLC52A3,6.6,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02869,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02870,EUR,2,SQSTM1,7.8,Moderate,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
EUR_02871,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02872,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02873,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02874,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02875,EUR,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02876,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02877,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02878,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02879,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02880,EUR,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02881,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02882,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02883,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02884,EUR,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EUR_02885,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02886,EUR,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02887,EUR,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
EUR_02888,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02889,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02890,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02891,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02892,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02893,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02894,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02895,EUR,1,PLEKHG5,6.2,Moderate,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02896,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02897,EUR,2,VCP,7.7,Moderate,Slow Progression,UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
EUR_02898,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02899,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02900,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02901,EUR,2,TBK1,10.0,Severe,Fast Progression,LOC124629354; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02902,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02903,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02904,EUR,2,TBK1,10.0,Severe,Fast Progression,TARDBP; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02905,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02906,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02907,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02908,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02909,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02910,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02911,EUR,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
EUR_02912,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02913,EUR,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
EUR_02914,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02915,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02916,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02917,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02918,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02919,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02920,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02921,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02922,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02923,EUR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02924,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02925,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02926,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02927,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02928,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02929,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02930,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02931,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02932,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02933,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02934,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02935,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02936,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02937,EUR,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02938,EUR,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02939,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02940,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02941,EUR,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
EUR_02942,EUR,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02943,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02944,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02945,EUR,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02946,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02947,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02948,EUR,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
EUR_02949,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02950,EUR,1,SLC52A3,6.0,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02951,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02952,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02953,EUR,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
EUR_02954,EUR,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
EUR_02955,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02956,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02957,EUR,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02958,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02959,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02960,EUR,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02961,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02962,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02963,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02964,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02965,EUR,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02966,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02967,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02968,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02969,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02970,EUR,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
EUR_02971,EUR,2,TBK1,10.0,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02972,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02973,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02974,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02975,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02976,EUR,2,UBQLN2,7.0,Moderate,Slow Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
EUR_02977,EUR,2,SOD1,7.0,Moderate,Slow Progression,PLEKHG5; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02978,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02979,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02980,EUR,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
EUR_02981,EUR,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02982,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02983,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02984,EUR,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
EUR_02985,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02986,EUR,1,SCAF4,6.6,Moderate,Slow Progression,SCAF4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02987,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02988,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02989,EUR,1,LOC130056973,8.4,Severe,Fast Progression,LOC130056973,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
EUR_02990,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02991,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02992,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02993,EUR,2,SOD1,7.7,Moderate,Slow Progression,SOD1; UNC13A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,0,0,,,0,0,,,3,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02994,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02995,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02996,EUR,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
EUR_02997,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02998,EUR,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
EUR_02999,EUR,2,TBK1,9.1,Severe,Fast Progression,FIG4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00000,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00001,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00002,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00003,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00004,SAS,1,FIG4,9.2,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_00005,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00006,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00007,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00008,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00009,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00010,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00011,SAS,3,ALS2,7.7,Moderate,Slow Progression,ALS2; SIGMAR1; UNC13A,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,1,1,UNC13A,UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,Mitochondrial,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation | UNC13A: Synaptic transmission defects,Endosome-lysosome fusion failure
SAS_00012,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00013,SAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00014,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00015,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00016,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00017,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00018,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00019,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00020,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00021,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00022,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00023,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00024,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00025,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00026,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00027,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00028,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00029,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00030,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00031,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00032,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00033,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00034,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00035,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00036,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00037,SAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00038,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00039,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00040,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00041,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00042,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00043,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00044,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00045,SAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_00046,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00047,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00048,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00049,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00050,SAS,2,VCP,7.0,Moderate,Slow Progression,SQSTM1; VCP,1,2,SQSTM1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00051,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00052,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00053,SAS,2,SPG11,7.7,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
SAS_00054,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00055,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00056,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00057,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00058,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00059,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00060,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00061,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00062,SAS,3,KIF5A,7.8,Moderate,Fast Progression,ALS2; KIF5A; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,Proteostasis,ALS2: Endosome-lysosome fusion failure | KIF5A: Anterograde transport failure | TBK1: Autophagy initiation kinase deficiency,Anterograde transport failure
SAS_00063,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00064,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00065,SAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00066,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00067,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00068,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00069,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00070,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00071,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00072,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00073,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00074,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00075,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00076,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00077,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00078,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00079,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00080,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00081,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00082,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00083,SAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction
SAS_00084,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; TARDBP,0,0,,,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00085,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00086,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00087,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00088,SAS,2,TBK1,9.1,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00089,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_00090,SAS,2,VCP,7.0,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00091,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00092,SAS,2,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00093,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00094,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00095,SAS,2,ALS2,7.0,Moderate,Slow Progression,ALS2; LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00096,SAS,1,LOC108903148,7.8,Moderate,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00097,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00098,SAS,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00099,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00100,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00101,SAS,2,SETX,6.2,Moderate,Slow Progression,SETX; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00102,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00103,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00104,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00105,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00106,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00107,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00108,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00109,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00110,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00111,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00112,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00113,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00114,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00115,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00116,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00117,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00118,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00119,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00120,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00121,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00122,SAS,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00123,SAS,2,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA1: Stress granule dysregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Stress granule dysregulation
SAS_00124,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00125,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00126,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00127,SAS,2,ALS2,7.7,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
SAS_00128,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00129,SAS,2,SPTLC1,6.9,Moderate,Fast Progression,SPTLC1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
SAS_00130,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00131,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00132,SAS,2,SIGMAR1,7.7,Moderate,Slow Progression,HNRNPA1; SIGMAR1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,HNRNPA1: Stress granule dysregulation | SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_00133,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_00134,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00135,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00136,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00137,SAS,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00138,SAS,3,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00139,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00140,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00141,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00142,SAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
SAS_00143,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00144,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00145,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00146,SAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00147,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00148,SAS,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00149,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00150,SAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_00151,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00152,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00153,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00154,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00155,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00156,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00157,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00158,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00159,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00160,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00161,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00162,SAS,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_00163,SAS,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00164,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00165,SAS,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
SAS_00166,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00167,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00168,SAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00169,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00170,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00171,SAS,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_00172,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00173,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00174,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00175,SAS,2,SOD1,7.7,Moderate,Slow Progression,CHRNA3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00176,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00177,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00178,SAS,1,LOC108903148,6.6,Moderate,Slow Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00179,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00180,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00181,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00182,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00183,SAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00184,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00185,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00186,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00187,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00188,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00189,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00190,SAS,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_00191,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00192,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00193,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00194,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00195,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00196,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00197,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00198,SAS,2,SOD1,7.7,Moderate,Fast Progression,CHMP2B; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,4,Proteostasis,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00199,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00200,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00201,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00202,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00203,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_00204,SAS,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
SAS_00205,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00206,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00207,SAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00208,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00209,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00210,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00211,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00212,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00213,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00214,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00215,SAS,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
SAS_00216,SAS,2,SOD1,7.0,Moderate,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00217,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00218,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00219,SAS,4,FUS,10.0,Severe,Fast Progression,ALS2; CHCHD10; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,CHCHD10; FUS,CHCHD10: Cristae disruption; mtDNA instability | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,Mitochondrial,ALS2: Endosome-lysosome fusion failure | CHCHD10: Cristae disruption; mtDNA instability | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00220,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00221,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00222,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00223,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00224,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00225,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00226,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00227,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00228,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00229,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00230,SAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_00231,SAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_00232,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00233,SAS,3,FUS,10.0,Severe,Fast Progression,FUS; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | UBQLN2: Ubiquitin-proteasome clearance failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00234,SAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy receptor dysfunction
SAS_00235,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00236,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00237,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00238,SAS,2,FUS,9.9,Severe,Fast Progression,FUS; SPG11,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00239,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00240,SAS,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_00241,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00242,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00243,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00244,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00245,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00246,SAS,1,C9orf72,8.8,Severe,Slow Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
SAS_00247,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00248,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00249,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00250,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00251,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_00252,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00253,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00254,SAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
SAS_00255,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00256,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00257,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00258,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00259,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00260,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00261,SAS,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00262,SAS,2,SIGMAR1,7.7,Moderate,Slow Progression,CHRNA3; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_00263,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00264,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00265,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00266,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00267,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00268,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00269,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00270,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00271,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00272,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00273,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00274,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00275,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00276,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00277,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00278,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00279,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00280,SAS,2,SOD1,7.0,Moderate,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00281,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00282,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00283,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00284,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00285,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00286,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00287,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00288,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00289,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00290,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00291,SAS,3,OPTN,7.8,Moderate,Fast Progression,ALS2; OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
SAS_00292,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00293,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00294,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00295,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_00296,SAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00297,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00298,SAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00299,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00300,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00301,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00302,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00303,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00304,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00305,SAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00306,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00307,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00308,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00309,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00310,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00311,SAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00312,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00313,SAS,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
SAS_00314,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00315,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00316,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_00317,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00318,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00319,SAS,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_00320,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00321,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00322,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00323,SAS,3,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00324,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00325,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00326,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00327,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00328,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00329,SAS,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00330,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00331,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00332,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00333,SAS,3,OPTN,8.4,Severe,Fast Progression,OPTN; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction
SAS_00334,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00335,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00336,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00337,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00338,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00339,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00340,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00341,SAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00342,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00343,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00344,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00345,SAS,2,OPTN,8.4,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
SAS_00346,SAS,3,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,5,DNA_Damage,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00347,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00348,SAS,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
SAS_00349,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00350,SAS,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00351,SAS,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00352,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00353,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00354,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00355,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00356,SAS,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00357,SAS,1,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00358,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00359,SAS,2,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00360,SAS,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00361,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00362,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00363,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00364,SAS,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00365,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_00366,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00367,SAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00368,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00369,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00370,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00371,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00372,SAS,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00373,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00374,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00375,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00376,SAS,3,SOD1,7.7,Moderate,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00377,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00378,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00379,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00380,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00381,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00382,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00383,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00384,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00385,SAS,1,SLC52A3,9.2,Severe,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00386,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00387,SAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00388,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00389,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00390,SAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_00391,SAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00392,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00393,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00394,SAS,2,VCP,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00395,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00396,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00397,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00398,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00399,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00400,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00401,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00402,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00403,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_00404,SAS,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_00405,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00406,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00407,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00408,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00409,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00410,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00411,SAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00412,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00413,SAS,3,FUS,10.0,Severe,Fast Progression,FUS; LOC124629354; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00414,SAS,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
SAS_00415,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00416,SAS,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00417,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00418,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00419,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00420,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00421,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00422,SAS,1,SETX,4.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00423,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00424,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00425,SAS,2,TARDBP,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00426,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00427,SAS,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
SAS_00428,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00429,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; TUBA4A,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TUBA4A,TUBA4A: Microtubule destabilization,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TUBA4A: Microtubule destabilization,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00430,SAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00431,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00432,SAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00433,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00434,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00435,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00436,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00437,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00438,SAS,1,LOC130003372,6.6,Moderate,Slow Progression,LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00439,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_00440,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00441,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00442,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00443,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00444,SAS,3,TBK1,10.0,Severe,Fast Progression,CHRNA3; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00445,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00446,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00447,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00448,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00449,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00450,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00451,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00452,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00453,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00454,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00455,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00456,SAS,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00457,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00458,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00459,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00460,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00461,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00462,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00463,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00464,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00465,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00466,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00467,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00468,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00469,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00470,SAS,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00471,SAS,2,SLC52A3,9.2,Severe,Slow Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
SAS_00472,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00473,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00474,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00475,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00476,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00477,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00478,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00479,SAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00480,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00481,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00482,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00483,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00484,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00485,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00486,SAS,1,TARDBP,7.7,Moderate,Fast Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00487,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00488,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00489,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00490,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00491,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00492,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00493,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00494,SAS,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00495,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00496,SAS,2,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
SAS_00497,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00498,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_00499,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00500,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00501,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00502,SAS,1,ERLIN1,6.6,Moderate,Slow Progression,ERLIN1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00503,SAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00504,SAS,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_00505,SAS,1,SOD1,9.8,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00506,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00507,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00508,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00509,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00510,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00511,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00512,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00513,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00514,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00515,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00516,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00517,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00518,SAS,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00519,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00520,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00521,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00522,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00523,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00524,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00525,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00526,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00527,SAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00528,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00529,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00530,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00531,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00532,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00533,SAS,2,FUS,9.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00534,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00535,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00536,SAS,2,SPG11,7.0,Moderate,Slow Progression,SETX; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,2,DNA_Damage,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00537,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00538,SAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00539,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00540,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00541,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00542,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00543,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00544,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00545,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00546,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00547,SAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
SAS_00548,SAS,2,FUS,9.0,Severe,Fast Progression,DCTN1; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,RNA_Metabolism,DCTN1: Retrograde transport failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00549,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00550,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00551,SAS,2,SOD1,7.0,Moderate,Fast Progression,LOC108903148; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00552,SAS,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00553,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00554,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00555,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00556,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00557,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00558,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00559,SAS,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00560,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00561,SAS,2,SPG11,7.0,Moderate,Slow Progression,SIGMAR1; SPG11,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00562,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00563,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00564,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00565,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00566,SAS,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_00567,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00568,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00569,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00570,SAS,3,SOD1,7.0,Moderate,Fast Progression,ALS2; SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00571,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00572,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00573,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00574,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00575,SAS,2,SQSTM1,9.2,Severe,Fast Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00576,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00577,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00578,SAS,2,OPTN,8.4,Severe,Fast Progression,OPTN; SLC52A3,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00579,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00580,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00581,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00582,SAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00583,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00584,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00585,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00586,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00587,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00588,SAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_00589,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00590,SAS,2,SPG11,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00591,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00592,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00593,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00594,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00595,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00596,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00597,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00598,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00599,SAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00600,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00601,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00602,SAS,2,VCP,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00603,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00604,SAS,1,SQSTM1,7.8,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00605,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00606,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00607,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00608,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00609,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00610,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00611,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00612,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00613,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00614,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00615,SAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00616,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_00617,SAS,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
SAS_00618,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00619,SAS,2,ALS2,6.5,Moderate,Fast Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Endosome-lysosome fusion failure
SAS_00620,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_00621,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00622,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00623,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00624,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00625,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00626,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00627,SAS,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00628,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00629,SAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00630,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00631,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00632,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00633,SAS,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00634,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00635,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00636,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00637,SAS,1,SETX,5.2,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00638,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00639,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00640,SAS,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00641,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00642,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00643,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00644,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00645,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00646,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00647,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00648,SAS,1,FIG4,7.8,Moderate,Slow Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_00649,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00650,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00651,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00652,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00653,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_00654,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00655,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00656,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00657,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00658,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00659,SAS,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00660,SAS,2,CHMP2B,7.0,Moderate,Slow Progression,ALS2; CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; CHMP2B,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_00661,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00662,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00663,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00664,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00665,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00666,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00667,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00668,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00669,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00670,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00671,SAS,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_00672,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00673,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00674,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00675,SAS,2,LOC124629354,8.4,Severe,Fast Progression,LOC124629354; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
SAS_00676,SAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00677,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00678,SAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00679,SAS,4,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00680,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00681,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00682,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00683,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00684,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00685,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00686,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00687,SAS,2,SPG11,7.0,Moderate,Slow Progression,DCTN1; SPG11,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00688,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00689,SAS,2,SQSTM1,8.6,Severe,Fast Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00690,SAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00691,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00692,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00693,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00694,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00695,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00696,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00697,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00698,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00699,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00700,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00701,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00702,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00703,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00704,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00705,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00706,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00707,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00708,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00709,SAS,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00710,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00711,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00712,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00713,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00714,SAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00715,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00716,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00717,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00718,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00719,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00720,SAS,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00721,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00722,SAS,2,VCP,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00723,SAS,2,LOC130001681,8.4,Severe,Fast Progression,LOC130001681; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00724,SAS,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00725,SAS,3,TBK1,10.0,Severe,Fast Progression,OPTN; SOD1; TBK1,1,3,OPTN; SOD1; TBK1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00726,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00727,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00728,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00729,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00730,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00731,SAS,2,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00732,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00733,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00734,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00735,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00736,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00737,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00738,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00739,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00740,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00741,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00742,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00743,SAS,2,TARDBP,7.0,Moderate,Slow Progression,ALS2; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00744,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; UNC13A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,0,0,,,0,0,,,3,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00745,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00746,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00747,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00748,SAS,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00749,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00750,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00751,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00752,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00753,SAS,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00754,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00755,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00756,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00757,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00758,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00759,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00760,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00761,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00762,SAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
SAS_00763,SAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00764,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00765,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00766,SAS,2,LOC130001681,8.4,Severe,Fast Progression,LOC130001681; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
SAS_00767,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00768,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00769,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00770,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00771,SAS,2,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA1: Stress granule dysregulation | UBQLN2: Ubiquitin-proteasome clearance failure,Stress granule dysregulation
SAS_00772,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00773,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00774,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00775,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00776,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00777,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00778,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00779,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00780,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00781,SAS,2,TBK1,9.1,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
SAS_00782,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00783,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00784,SAS,2,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
SAS_00785,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00786,SAS,1,SLC52A3,9.2,Severe,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00787,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00788,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00789,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00790,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00791,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00792,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00793,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00794,SAS,3,CHMP2B,7.0,Moderate,Slow Progression,ALS2; CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; CHMP2B,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_00795,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00796,SAS,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00797,SAS,1,SETX,4.4,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00798,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; UNC13A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,0,0,,,0,0,,,3,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00799,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00800,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00801,SAS,2,VCP,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00802,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00803,SAS,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00804,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00805,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00806,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00807,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00808,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00809,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00810,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00811,SAS,1,SPG11,6.5,Moderate,Asymptomatic/Low Penetrance,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00812,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00813,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00814,SAS,1,ALS2,5.0,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00815,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00816,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00817,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00818,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00819,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00820,SAS,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00821,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00822,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00823,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00824,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00825,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00826,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00827,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_00828,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00829,SAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00830,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00831,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00832,SAS,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00833,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00834,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00835,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00836,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00837,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00838,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00839,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00840,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00841,SAS,1,SLC52A3,8.4,Severe,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00842,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00843,SAS,1,SETX,4.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00844,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00845,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00846,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00847,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00848,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00849,SAS,1,ALS2,6.3,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00850,SAS,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00851,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00852,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00853,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00854,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_00855,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00856,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00857,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00858,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00859,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00860,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00861,SAS,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00862,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00863,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00864,SAS,2,DCTN1,10.0,Severe,Fast Progression,ALS2; DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_00865,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00866,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00867,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00868,SAS,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00869,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00870,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_00871,SAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_00872,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00873,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00874,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00875,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00876,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00877,SAS,2,LOC130001681,9.2,Severe,Fast Progression,LOC130001681; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
SAS_00878,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00879,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00880,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00881,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00882,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00883,SAS,2,SPG11,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
SAS_00884,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00885,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00886,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_00887,SAS,2,FUS,9.9,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00888,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00889,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00890,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00891,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00892,SAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00893,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00894,SAS,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
SAS_00895,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00896,SAS,1,ALS2,5.5,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00897,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00898,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00899,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00900,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00901,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00902,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00903,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00904,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00905,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00906,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00907,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00908,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00909,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00910,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_00911,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_00912,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00913,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00914,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00915,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00916,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00917,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00918,SAS,2,TBK1,9.8,Severe,Fast Progression,SLC52A3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00919,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00920,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00921,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00922,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_00923,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00924,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_00925,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00926,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00927,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00928,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00929,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00930,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00931,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00932,SAS,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00933,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00934,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00935,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00936,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00937,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00938,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00939,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00940,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00941,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00942,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00943,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00944,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00945,SAS,1,FIG4,9.2,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_00946,SAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00947,SAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00948,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00949,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00950,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00951,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00952,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00953,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00954,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00955,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00956,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00957,SAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00958,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00959,SAS,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_00960,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00961,SAS,1,SLC52A3,6.6,Moderate,Asymptomatic/Low Penetrance,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_00962,SAS,2,UBQLN2,7.7,Moderate,Slow Progression,DCTN1; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_00963,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_00964,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_00965,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00966,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00967,SAS,1,FUS,9.0,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_00968,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00969,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00970,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00971,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00972,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00973,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00974,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00975,SAS,2,TARDBP,7.0,Moderate,Slow Progression,SIGMAR1; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,SIGMAR1: MAM calcium dysregulation | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_00976,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00977,SAS,2,SQSTM1,9.2,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_00978,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00979,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00980,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_00981,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_00982,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00983,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00984,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00985,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00986,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00987,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_00988,SAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Endosome-lysosome fusion failure
SAS_00989,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00990,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00991,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00992,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00993,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00994,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00995,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_00996,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_00997,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_00998,SAS,2,SPG11,7.0,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_00999,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01000,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01001,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01002,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01003,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01004,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01005,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01006,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01007,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01008,SAS,3,TBK1,10.0,Severe,Fast Progression,SQSTM1; TBK1; UBQLN2,1,3,SQSTM1; TBK1; UBQLN2,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
SAS_01009,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01010,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01011,SAS,2,TBK1,9.1,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01012,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01013,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01014,SAS,4,LOC108903148,9.2,Severe,Fast Progression,ALS2; LOC108903148; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Unknown mechanism
SAS_01015,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_01016,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01017,SAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01018,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01019,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01020,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01021,SAS,3,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
SAS_01022,SAS,2,VCP,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01023,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01024,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01025,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01026,SAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01027,SAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
SAS_01028,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01029,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01030,SAS,3,TBK1,7.0,Moderate,Slow Progression,ALS2; SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,3,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01031,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01032,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01033,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01034,SAS,2,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01035,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01036,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01037,SAS,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_01038,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01039,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01040,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01041,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01042,SAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01043,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01044,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01045,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; SIGMAR1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01046,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01047,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01048,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01049,SAS,2,TBK1,9.1,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01050,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01051,SAS,3,NEK1,9.2,Severe,Fast Progression,NEK1; SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,2,NEK1; SETX,NEK1: DNA damage checkpoint failure | SETX: R-loop accumulation; genomic instability,4,DNA_Damage,NEK1: DNA damage checkpoint failure | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,DNA damage checkpoint failure
SAS_01052,SAS,3,TBK1,7.0,Moderate,Fast Progression,ALS2; SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,Proteostasis,ALS2: Endosome-lysosome fusion failure | SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01053,SAS,2,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01054,SAS,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01055,SAS,2,ALS2,7.2,Moderate,Asymptomatic/Low Penetrance,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
SAS_01056,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01057,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01058,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01059,SAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01060,SAS,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01061,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01062,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01063,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01064,SAS,2,LOC108903148,9.2,Severe,Fast Progression,LOC108903148; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
SAS_01065,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01066,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01067,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01068,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01069,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01070,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01071,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01072,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01073,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01074,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01075,SAS,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
SAS_01076,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01077,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01078,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01079,SAS,2,UBQLN2,7.7,Moderate,Slow Progression,HNRNPA2B1; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,HNRNPA2B1: Stress granule dysregulation | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_01080,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01081,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01082,SAS,2,FUS,9.9,Severe,Fast Progression,FUS; KIF5A,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,KIF5A,KIF5A: Anterograde transport failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | KIF5A: Anterograde transport failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01083,SAS,2,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01084,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01085,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01086,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01087,SAS,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01088,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01089,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01090,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01091,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01092,SAS,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01093,SAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01094,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01095,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01096,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01097,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_01098,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01099,SAS,2,FUS,9.9,Severe,Slow Progression,FUS; UNC13A,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | UNC13A: Synaptic transmission defects,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01100,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01101,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01102,SAS,1,HNRNPA1,6.0,Moderate,Asymptomatic/Low Penetrance,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_01103,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01104,SAS,1,ERBB4,5.0,Mild,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01105,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01106,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01107,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01108,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01109,SAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01110,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01111,SAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01112,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01113,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01114,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01115,SAS,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01116,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01117,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01118,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01119,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01120,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01121,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01122,SAS,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01123,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01124,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01125,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01126,SAS,2,SOD1,7.0,Moderate,Slow Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01127,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01128,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01129,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01130,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01131,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01132,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01133,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01134,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01135,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01136,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01137,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01138,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01139,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01140,SAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01141,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01142,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01143,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01144,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01145,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01146,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01147,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01148,SAS,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01149,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01150,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01151,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_01152,SAS,3,SOD1,7.0,Moderate,Slow Progression,DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01153,SAS,1,ALS2,5.0,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01154,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01155,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01156,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01157,SAS,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01158,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01159,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01160,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01161,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01162,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01163,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01164,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01165,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01166,SAS,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01167,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01168,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01169,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01170,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01171,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01172,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01173,SAS,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01174,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_01175,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01176,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01177,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01178,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01179,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01180,SAS,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_01181,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01182,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01183,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01184,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01185,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_01186,SAS,1,PLEKHG5,6.2,Moderate,Slow Progression,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01187,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01188,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01189,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01190,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01191,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_01192,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01193,SAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01194,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01195,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01196,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01197,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01198,SAS,1,PARK7,7.7,Moderate,Slow Progression,PARK7,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01199,SAS,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
SAS_01200,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01201,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01202,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01203,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01204,SAS,2,VCP,7.0,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01205,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01206,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01207,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01208,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01209,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01210,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01211,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01212,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01213,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01214,SAS,2,SPG11,7.0,Moderate,Slow Progression,SPG11; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,4,RNA_Metabolism,SPG11: Lysosome reformation failure; DNA repair defects | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Lysosome reformation failure; DNA repair defects
SAS_01215,SAS,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01216,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01217,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01218,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01219,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01220,SAS,1,FUS,9.0,Severe,Asymptomatic/Low Penetrance,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01221,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01222,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01223,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01224,SAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_01225,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01226,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01227,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01228,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01229,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01230,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01231,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01232,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01233,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01234,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01235,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01236,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01237,SAS,2,TARDBP,7.0,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_01238,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01239,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; SIGMAR1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01240,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01241,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01242,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01243,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01244,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01245,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01246,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01247,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01248,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01249,SAS,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
SAS_01250,SAS,1,SETX,5.7,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_01251,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01252,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01253,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01254,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01255,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01256,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01257,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01258,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01259,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01260,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01261,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01262,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01263,SAS,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
SAS_01264,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01265,SAS,1,PARK7,7.7,Moderate,Slow Progression,PARK7,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01266,SAS,2,VCP,7.0,Moderate,Slow Progression,OPTN; VCP,1,2,OPTN; VCP,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01267,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01268,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01269,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01270,SAS,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01271,SAS,2,SYNE1,9.2,Severe,Fast Progression,SYNE1; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Unknown mechanism
SAS_01272,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01273,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01274,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01275,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01276,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01277,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01278,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01279,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01280,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01281,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01282,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01283,SAS,1,DCTN1,9.1,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_01284,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01285,SAS,2,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | VCP: Autophagosome maturation failure; TDP-43 accumulation,ESCRT-III dysfunction
SAS_01286,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01287,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01288,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01289,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01290,SAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01291,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01292,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01293,SAS,1,FIG4,9.2,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_01294,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01295,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01296,SAS,2,TBK1,10.0,Severe,Fast Progression,KIF5A; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,KIF5A: Anterograde transport failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01297,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01298,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01299,SAS,1,FIG4,7.8,Moderate,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_01300,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01301,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01302,SAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01303,SAS,2,TBK1,9.1,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01304,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01305,SAS,2,SOD1,7.7,Moderate,Slow Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01306,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01307,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01308,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01309,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01310,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_01311,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01312,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01313,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01314,SAS,2,TBK1,10.0,Severe,Fast Progression,CHRNA3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01315,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01316,SAS,3,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01317,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01318,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01319,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01320,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01321,SAS,1,ALS2,7.0,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01322,SAS,2,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01323,SAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1; VCP,1,2,SOD1; VCP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | VCP: Autophagosome maturation failure; TDP-43 accumulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01324,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01325,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01326,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01327,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01328,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01329,SAS,1,LOC130003372,6.6,Moderate,Slow Progression,LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01330,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01331,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01332,SAS,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01333,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01334,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01335,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01336,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01337,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01338,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01339,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01340,SAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01341,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01342,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01343,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01344,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01345,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01346,SAS,2,SQSTM1,8.4,Severe,Fast Progression,ERBB4; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01347,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01348,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01349,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01350,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01351,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01352,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01353,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01354,SAS,2,SOD1,7.0,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01355,SAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01356,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01357,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01358,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01359,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01360,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01361,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01362,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01363,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01364,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01365,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01366,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01367,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01368,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01369,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01370,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01371,SAS,2,UBQLN2,7.0,Moderate,Slow Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_01372,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01373,SAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01374,SAS,1,ERLIN1,6.6,Moderate,Slow Progression,ERLIN1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01375,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01376,SAS,3,TBK1,9.8,Severe,Fast Progression,ALS2; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01377,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01378,SAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01379,SAS,1,SETX,4.6,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_01380,SAS,2,TBK1,10.0,Severe,Fast Progression,DCTN1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,DCTN1: Retrograde transport failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01381,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01382,SAS,3,FUS,10.0,Severe,Fast Progression,FUS; SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,3,FUS; SIGMAR1; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01383,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01384,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01385,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01386,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01387,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01388,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01389,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01390,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01391,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01392,SAS,1,TBK1,7.0,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01393,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01394,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01395,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01396,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01397,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01398,SAS,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
SAS_01399,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01400,SAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01401,SAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01402,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01403,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01404,SAS,1,VCP,7.0,Moderate,Fast Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01405,SAS,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01406,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01407,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01408,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01409,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01410,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01411,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01412,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01413,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01414,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01415,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01416,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01417,SAS,1,SLC52A3,9.2,Severe,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01418,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01419,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01420,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01421,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01422,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01423,SAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01424,SAS,2,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01425,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01426,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01427,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_01428,SAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_01429,SAS,1,ALS2,7.7,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01430,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01431,SAS,2,TBK1,9.8,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01432,SAS,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_01433,SAS,3,ALS2,7.7,Moderate,Slow Progression,ALS2; DCTN1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | DCTN1: Retrograde transport failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
SAS_01434,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01435,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01436,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01437,SAS,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
SAS_01438,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01439,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_01440,SAS,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01441,SAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01442,SAS,2,OPTN,6.0,Moderate,Slow Progression,OPTN; TARDBP,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction
SAS_01443,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01444,SAS,2,SPG11,7.0,Moderate,Slow Progression,ERBB4; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01445,SAS,2,SQSTM1,9.2,Severe,Fast Progression,SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01446,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01447,SAS,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01448,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01449,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01450,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01451,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01452,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01453,SAS,2,SLC52A3,8.4,Severe,Fast Progression,SLC52A3; TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Unknown mechanism
SAS_01454,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01455,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01456,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01457,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01458,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01459,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01460,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01461,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01462,SAS,2,KIF5A,7.8,Moderate,Slow Progression,HNRNPA2B1; KIF5A,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation | KIF5A: Anterograde transport failure,Anterograde transport failure
SAS_01463,SAS,2,SLC52A3,9.2,Severe,Fast Progression,ALS2; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
SAS_01464,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01465,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01466,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01467,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01468,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01469,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01470,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_01471,SAS,2,FUS,9.9,Severe,Fast Progression,FUS; LOC129995449,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01472,SAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; SETX,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,OPTN: Autophagy receptor dysfunction | SETX: R-loop accumulation; genomic instability,Autophagy receptor dysfunction
SAS_01473,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01474,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01475,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01476,SAS,2,SQSTM1,9.2,Severe,Fast Progression,C9orf72; SQSTM1,1,2,C9ORF72; SQSTM1,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SQSTM1: Autophagy receptor dysfunction (p62),1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01477,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01478,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01479,SAS,3,SOD1,7.0,Moderate,Fast Progression,CHMP2B; SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,CHMP2B; SPG11,CHMP2B: ESCRT-III dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01480,SAS,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01481,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01482,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01483,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01484,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01485,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01486,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01487,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01488,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_01489,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01490,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01491,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01492,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01493,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01494,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01495,SAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01496,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01497,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01498,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01499,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01500,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01501,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01502,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01503,SAS,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_01504,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01505,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01506,SAS,2,VCP,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01507,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01508,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01509,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01510,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01511,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01512,SAS,2,TBK1,10.0,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
SAS_01513,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01514,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01515,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01516,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01517,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01518,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01519,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01520,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01521,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01522,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01523,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01524,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01525,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01526,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01527,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01528,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01529,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01530,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01531,SAS,2,FUS,9.0,Severe,Slow Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01532,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01533,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01534,SAS,2,OPTN,7.8,Moderate,Fast Progression,KIF5A; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,KIF5A: Anterograde transport failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01535,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01536,SAS,2,SOD1,7.0,Moderate,Fast Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01537,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01538,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01539,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01540,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01541,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01542,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01543,SAS,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01544,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01545,SAS,2,SQSTM1,6.6,Moderate,Slow Progression,ANG; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,ANG: Ribosomal biogenesis impairment | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01546,SAS,3,SOD1,7.7,Moderate,Slow Progression,ALS2; SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Proteostasis,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01547,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01548,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01549,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01550,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01551,SAS,2,SQSTM1,8.4,Severe,Fast Progression,OPTN; SQSTM1,1,2,OPTN; SQSTM1,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01552,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01553,SAS,2,CHMP2B,7.0,Moderate,Fast Progression,CHMP2B; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),ESCRT-III dysfunction
SAS_01554,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01555,SAS,1,ALS2,6.3,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01556,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01557,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01558,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01559,SAS,2,ALS2,6.5,Moderate,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,Endosome-lysosome fusion failure
SAS_01560,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01561,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01562,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01563,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01564,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01565,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01566,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01567,SAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01568,SAS,2,SPTLC1,6.9,Moderate,Slow Progression,SPG11; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
SAS_01569,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01570,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01571,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01572,SAS,2,SQSTM1,8.4,Severe,Fast Progression,KIF5A; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,KIF5A: Anterograde transport failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01573,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01574,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01575,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01576,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01577,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01578,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01579,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01580,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01581,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01582,SAS,3,SOD1,7.0,Moderate,Fast Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01583,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01584,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01585,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01586,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01587,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01588,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01589,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01590,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01591,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01592,SAS,2,FUS,9.9,Severe,Slow Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01593,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01594,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01595,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01596,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01597,SAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_01598,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01599,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01600,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01601,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01602,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | VCP: Autophagosome maturation failure; TDP-43 accumulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01603,SAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_01604,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01605,SAS,2,VCP,7.7,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01606,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01607,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01608,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01609,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01610,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01611,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01612,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01613,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01614,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01615,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01616,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01617,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01618,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01619,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01620,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01621,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01622,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_01623,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01624,SAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
SAS_01625,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01626,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01627,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01628,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01629,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01630,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01631,SAS,2,TBK1,10.0,Severe,Fast Progression,CHMP2B; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01632,SAS,2,TBK1,9.1,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01633,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01634,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01635,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01636,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01637,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01638,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01639,SAS,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_01640,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01641,SAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01642,SAS,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01643,SAS,1,SOD1,10.0,Severe,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01644,SAS,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_01645,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01646,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01647,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01648,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01649,SAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01650,SAS,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01651,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01652,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01653,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_01654,SAS,1,TARDBP,7.0,Moderate,Fast Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_01655,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01656,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_01657,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01658,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01659,SAS,2,SLC52A3,8.4,Severe,Fast Progression,SLC52A3; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
SAS_01660,SAS,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01661,SAS,1,VCP,7.7,Moderate,Fast Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01662,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01663,SAS,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_01664,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01665,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01666,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01667,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01668,SAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01669,SAS,2,SPG11,7.0,Moderate,Slow Progression,SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
SAS_01670,SAS,1,LOC130001681,8.4,Severe,Fast Progression,LOC130001681,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01671,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01672,SAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01673,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01674,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01675,SAS,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01676,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01677,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01678,SAS,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01679,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01680,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01681,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01682,SAS,2,SOD1,7.7,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01683,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01684,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01685,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01686,SAS,2,TBK1,9.8,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01687,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01688,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01689,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01690,SAS,2,FUS,9.9,Severe,Slow Progression,FUS; HNRNPA1,0,0,,,1,2,FUS; HNRNPA1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA1: Stress granule dysregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | HNRNPA1: Stress granule dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01691,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01692,SAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01693,SAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Endosome-lysosome fusion failure
SAS_01694,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01695,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01696,SAS,1,KIF5A,6.6,Moderate,Slow Progression,KIF5A,0,0,,,0,0,,,1,1,KIF5A,KIF5A: Anterograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,KIF5A: Anterograde transport failure,Anterograde transport failure
SAS_01697,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01698,SAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01699,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01700,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01701,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_01702,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01703,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01704,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01705,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01706,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01707,SAS,2,OPTN,8.4,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
SAS_01708,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01709,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01710,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01711,SAS,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01712,SAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01713,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01714,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01715,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01716,SAS,1,OPTN,9.2,Severe,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01717,SAS,1,ALS2,5.0,Mild,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01718,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01719,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01720,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01721,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01722,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01723,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01724,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01725,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01726,SAS,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01727,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01728,SAS,3,VCP,7.0,Moderate,Slow Progression,PLEKHG5; SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01729,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01730,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01731,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01732,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01733,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01734,SAS,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01735,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01736,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01737,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01738,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01739,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01740,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01741,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01742,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01743,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01744,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01745,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01746,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01747,SAS,2,SOD1,7.7,Moderate,Fast Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01748,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01749,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01750,SAS,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01751,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01752,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01753,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01754,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01755,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01756,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01757,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01758,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01759,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01760,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01761,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01762,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01763,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01764,SAS,2,SQSTM1,8.4,Severe,Fast Progression,CHRNA3; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01765,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01766,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01767,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01768,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01769,SAS,1,SIGMAR1,7.7,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_01770,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01771,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01772,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01773,SAS,2,SQSTM1,8.4,Severe,Fast Progression,SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01774,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01775,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01776,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01777,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01778,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01779,SAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_01780,SAS,1,VCP,7.7,Moderate,Fast Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01781,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01782,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01783,SAS,3,UBQLN2,7.7,Moderate,Fast Progression,FUS; SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_01784,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01785,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01786,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01787,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01788,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01789,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01790,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01791,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01792,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; SIGMAR1,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SIGMAR1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SIGMAR1: MAM calcium dysregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01793,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01794,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01795,SAS,3,SPG11,7.7,Moderate,Slow Progression,SPG11; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Cytoskeletal_Axonal_Transport,SPG11: Lysosome reformation failure; DNA repair defects | TUBA4A: Microtubule destabilization,Lysosome reformation failure; DNA repair defects
SAS_01796,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01797,SAS,1,SETX,4.0,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_01798,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01799,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01800,SAS,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01801,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01802,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01803,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01804,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01805,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01806,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01807,SAS,1,LOC130056973,8.4,Severe,Fast Progression,LOC130056973,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01808,SAS,1,NEK1,8.4,Severe,Slow Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
SAS_01809,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01810,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01811,SAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01812,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01813,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01814,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01815,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01816,SAS,2,SPG11,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01817,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01818,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01819,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01820,SAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
SAS_01821,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01822,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01823,SAS,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01824,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01825,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01826,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01827,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01828,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01829,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01830,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01831,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01832,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01833,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01834,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01835,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01836,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01837,SAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_01838,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01839,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01840,SAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_01841,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01842,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01843,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01844,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_01845,SAS,2,CHRNA3,8.4,Severe,Fast Progression,CHRNA3; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
SAS_01846,SAS,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_01847,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_01848,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_01849,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01850,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01851,SAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_01852,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01853,SAS,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01854,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01855,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01856,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01857,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01858,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01859,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01860,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01861,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01862,SAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01863,SAS,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01864,SAS,2,PRPH,7.8,Moderate,Fast Progression,PRPH; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
SAS_01865,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01866,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01867,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01868,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01869,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01870,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01871,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01872,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01873,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01874,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_01875,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01876,SAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01877,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01878,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01879,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01880,SAS,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01881,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01882,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01883,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01884,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01885,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01886,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01887,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01888,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01889,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01890,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01891,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01892,SAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_01893,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01894,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01895,SAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01896,SAS,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01897,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01898,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01899,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01900,SAS,1,LOC108903148,9.2,Severe,Fast Progression,LOC108903148,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01901,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01902,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_01903,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_01904,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01905,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01906,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01907,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01908,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01909,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01910,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01911,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01912,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01913,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01914,SAS,2,TBK1,9.1,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01915,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01916,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01917,SAS,2,TBK1,10.0,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01918,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01919,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01920,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01921,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01922,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01923,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01924,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01925,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01926,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01927,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01928,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01929,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01930,SAS,1,ERBB4,6.5,Moderate,Slow Progression,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01931,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01932,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01933,SAS,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01934,SAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01935,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01936,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_01937,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01938,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01939,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01940,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01941,SAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01942,SAS,2,CHRNA3,8.4,Severe,Fast Progression,ALS2; CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
SAS_01943,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01944,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01945,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01946,SAS,2,SOD1,7.0,Moderate,Slow Progression,HNRNPA2B1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,HNRNPA2B1: Stress granule dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01947,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01948,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01949,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01950,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01951,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01952,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01953,SAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01954,SAS,1,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_01955,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01956,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01957,SAS,2,SOD1,7.0,Moderate,Slow Progression,ERBB4; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01958,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01959,SAS,2,SQSTM1,6.6,Moderate,Slow Progression,ALS2; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_01960,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01961,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01962,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01963,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01964,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01965,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01966,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01967,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01968,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01969,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01970,SAS,3,SPG11,7.0,Moderate,Slow Progression,SETX; SPG11; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,2,SETX; SPG11,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects,3,DNA_Damage,SETX: R-loop accumulation; genomic instability | SPG11: Lysosome reformation failure; DNA repair defects | VCP: Autophagosome maturation failure; TDP-43 accumulation,Lysosome reformation failure; DNA repair defects
SAS_01971,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_01972,SAS,1,SPG11,7.7,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01973,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01974,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01975,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01976,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_01977,SAS,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01978,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01979,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_01980,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01981,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01982,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_01983,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01984,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01985,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01986,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01987,SAS,1,SETX,5.6,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_01988,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01989,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01990,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01991,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01992,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_01993,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01994,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01995,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_01996,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_01997,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_01998,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_01999,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02000,SAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02001,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02002,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02003,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02004,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02005,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02006,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02007,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02008,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02009,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02010,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02011,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02012,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02013,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02014,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02015,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02016,SAS,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02017,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02018,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02019,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02020,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02021,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02022,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02023,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02024,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_02025,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02026,SAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02027,SAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02028,SAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_02029,SAS,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02030,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02031,SAS,1,LOC124629354,7.8,Moderate,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02032,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02033,SAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02034,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02035,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02036,SAS,3,SOD1,9.8,Severe,Fast Progression,SETX; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02037,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02038,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02039,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02040,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02041,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02042,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02043,SAS,2,VCP,7.0,Moderate,Slow Progression,SETX; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02044,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02045,SAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02046,SAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02047,SAS,2,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02048,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02049,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02050,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02051,SAS,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
SAS_02052,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02053,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02054,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02055,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02056,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02057,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02058,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02059,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02060,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02061,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02062,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02063,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02064,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02065,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02066,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02067,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02068,SAS,3,SPTLC1,6.9,Moderate,Slow Progression,ALS2; SPG11; SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
SAS_02069,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02070,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02071,SAS,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02072,SAS,1,SETX,5.2,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_02073,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02074,SAS,2,LOC130056973,8.4,Severe,Fast Progression,ALS2; LOC130056973,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
SAS_02075,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02076,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02077,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02078,SAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02079,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02080,SAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02081,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02082,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02083,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02084,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02085,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02086,SAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02087,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02088,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02089,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02090,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02091,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02092,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02093,SAS,1,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_02094,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02095,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02096,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02097,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02098,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02099,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02100,SAS,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02101,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02102,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02103,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02104,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02105,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02106,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02107,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02108,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02109,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02110,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02111,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02112,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02113,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02114,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02115,SAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02116,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02117,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02118,SAS,3,SOD1,7.0,Moderate,Slow Progression,SETX; SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,5,Excitotoxicity,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02119,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02120,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_02121,SAS,2,NEK1,8.4,Severe,Fast Progression,NEK1; SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,2,Mitochondrial,NEK1: DNA damage checkpoint failure | SIGMAR1: MAM calcium dysregulation,DNA damage checkpoint failure
SAS_02122,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02123,SAS,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02124,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02125,SAS,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_02126,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02127,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02128,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02129,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02130,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02131,SAS,1,ERBB4,5.0,Mild,Asymptomatic/Low Penetrance,ERBB4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02132,SAS,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02133,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02134,SAS,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_02135,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02136,SAS,1,DCTN1,10.0,Severe,Fast Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_02137,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02138,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02139,SAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02140,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02141,SAS,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_02142,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02143,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_02144,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02145,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02146,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02147,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02148,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02149,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02150,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02151,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02152,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02153,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02154,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02155,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02156,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02157,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02158,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02159,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02160,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02161,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02162,SAS,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02163,SAS,1,SPTLC1,6.9,Moderate,Fast Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02164,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02165,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02166,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02167,SAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
SAS_02168,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02169,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02170,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02171,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_02172,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02173,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02174,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02175,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02176,SAS,1,TARDBP,7.7,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_02177,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02178,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02179,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02180,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02181,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02182,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02183,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02184,SAS,1,ALS2,6.5,Moderate,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02185,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02186,SAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_02187,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02188,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02189,SAS,3,SPG11,7.0,Moderate,Slow Progression,SLC52A3; SPG11; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | SQSTM1: Autophagy receptor dysfunction (p62),Lysosome reformation failure; DNA repair defects
SAS_02190,SAS,2,SPTLC1,6.9,Moderate,Fast Progression,HNRNPA1; SPTLC1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Unknown mechanism
SAS_02191,SAS,2,TBK1,10.0,Severe,Fast Progression,SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02192,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02193,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02194,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02195,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02196,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02197,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02198,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02199,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02200,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02201,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02202,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_02203,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02204,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02205,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02206,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02207,SAS,2,VCP,7.7,Moderate,Slow Progression,ALS2; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02208,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02209,SAS,3,SOD1,7.7,Moderate,Slow Progression,PLEKHG5; SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02210,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02211,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02212,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02213,SAS,2,TBK1,9.1,Severe,Fast Progression,OPTN; TBK1,1,2,OPTN; TBK1,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02214,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02215,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02216,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02217,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02218,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02219,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02220,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02221,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02222,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02223,SAS,2,OPTN,7.8,Moderate,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
SAS_02224,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02225,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02226,SAS,2,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Unknown mechanism
SAS_02227,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_02228,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02229,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02230,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02231,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02232,SAS,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02233,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02234,SAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_02235,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02236,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02237,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02238,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02239,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02240,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02241,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_02242,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02243,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02244,SAS,2,SOD1,7.0,Moderate,Slow Progression,LOC130003372; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02245,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02246,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02247,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02248,SAS,2,SLC52A3,9.2,Severe,Fast Progression,SLC52A3; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Unknown mechanism
SAS_02249,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02250,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02251,SAS,2,TBK1,9.1,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02252,SAS,3,TBK1,9.8,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02253,SAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
SAS_02254,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02255,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02256,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02257,SAS,3,FUS,10.0,Severe,Fast Progression,FUS; SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02258,SAS,3,TBK1,10.0,Severe,Fast Progression,FUS; SPG11; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SPG11: Lysosome reformation failure; DNA repair defects | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02259,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02260,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02261,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_02262,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02263,SAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02264,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_02265,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02266,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02267,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02268,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02269,SAS,2,TBK1,9.1,Severe,Fast Progression,SLC52A3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02270,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02271,SAS,1,PLEKHG5,6.2,Moderate,Slow Progression,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02272,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02273,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02274,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02275,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02276,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02277,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02278,SAS,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_02279,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02280,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02281,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02282,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02283,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02284,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02285,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02286,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02287,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Mitochondrial,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02288,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02289,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02290,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02291,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02292,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02293,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02294,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02295,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02296,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02297,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02298,SAS,1,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_02299,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02300,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02301,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02302,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02303,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02304,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02305,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02306,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02307,SAS,1,OPTN,7.8,Moderate,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02308,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02309,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02310,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02311,SAS,2,TBK1,10.0,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02312,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02313,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02314,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02315,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02316,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02317,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02318,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02319,SAS,3,SOD1,7.0,Moderate,Slow Progression,ALS2; SOD1; UNC13A,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; UNC13A,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Excitotoxicity,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UNC13A: Synaptic transmission defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02320,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02321,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02322,SAS,3,TBK1,9.8,Severe,Fast Progression,ALS2; SLC52A3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02323,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02324,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02325,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02326,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02327,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02328,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02329,SAS,1,ANG,6.0,Moderate,Slow Progression,ANG,0,0,,,1,1,ANG,ANG: Ribosomal biogenesis impairment,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,ANG: Ribosomal biogenesis impairment,Ribosomal biogenesis impairment
SAS_02330,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02331,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02332,SAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02333,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02334,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02335,SAS,2,SQSTM1,9.2,Severe,Fast Progression,CHMP2B; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,2,Proteostasis,CHMP2B: ESCRT-III dysfunction | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02336,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_02337,SAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02338,SAS,1,LOC124629354,8.4,Severe,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02339,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02340,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02341,SAS,3,TBK1,10.0,Severe,Fast Progression,PARK7; SPTLC1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02342,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02343,SAS,2,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2; UNC13A,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,2,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure | UNC13A: Synaptic transmission defects,Ubiquitin-proteasome clearance failure
SAS_02344,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02345,SAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02346,SAS,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02347,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02348,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02349,SAS,2,DCTN1,9.1,Severe,Fast Progression,DCTN1; SPG11,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | SPG11: Lysosome reformation failure; DNA repair defects,Retrograde transport failure
SAS_02350,SAS,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02351,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02352,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02353,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02354,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02355,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02356,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02357,SAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02358,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02359,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02360,SAS,1,PLEKHG5,4.0,Mild,Asymptomatic/Low Penetrance,PLEKHG5,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02361,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02362,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02363,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02364,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02365,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02366,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02367,SAS,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
SAS_02368,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02369,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02370,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02371,SAS,2,TBK1,9.1,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02372,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02373,SAS,2,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1; TARDBP,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Autophagy receptor dysfunction (p62)
SAS_02374,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02375,SAS,2,TBK1,9.1,Severe,Fast Progression,TBK1; UBQLN2,1,2,TBK1; UBQLN2,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | UBQLN2: Ubiquitin-proteasome clearance failure,Autophagy initiation kinase deficiency
SAS_02376,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02377,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02378,SAS,2,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,MAM calcium dysregulation
SAS_02379,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02380,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02381,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_02382,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02383,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02384,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02385,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02386,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02387,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02388,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02389,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02390,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02391,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02392,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02393,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02394,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02395,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02396,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02397,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02398,SAS,2,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02399,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02400,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02401,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02402,SAS,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02403,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02404,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02405,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02406,SAS,2,TBK1,9.8,Severe,Fast Progression,TBK1; VCP,1,2,TBK1; VCP,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagy initiation kinase deficiency
SAS_02407,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02408,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02409,SAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02410,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02411,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02412,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02413,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02414,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02415,SAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_02416,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02417,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02418,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02419,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02420,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02421,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02422,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02423,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02424,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02425,SAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02426,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02427,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02428,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02429,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02430,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02431,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02432,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02433,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02434,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02435,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_02436,SAS,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02437,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02438,SAS,1,CHRNA3,8.4,Severe,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02439,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02440,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02441,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02442,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02443,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02444,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02445,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02446,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02447,SAS,2,SOD1,7.7,Moderate,Slow Progression,SETX; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,4,Proteostasis,SETX: R-loop accumulation; genomic instability | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02448,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02449,SAS,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02450,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02451,SAS,1,ALS2,7.2,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02452,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02453,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02454,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02455,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02456,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02457,SAS,3,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Unknown mechanism
SAS_02458,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02459,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02460,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02461,SAS,3,FUS,10.0,Severe,Fast Progression,FUS; SOD1; SQSTM1,1,2,SOD1; SQSTM1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SQSTM1: Autophagy receptor dysfunction (p62),Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02462,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02463,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02464,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02465,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02466,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02467,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02468,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02469,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02470,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02471,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02472,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02473,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02474,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02475,SAS,2,OPTN,7.8,Moderate,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02476,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02477,SAS,1,UNC13A,6.0,Moderate,Slow Progression,UNC13A,0,0,,,0,0,,,0,0,,,0,0,,,1,1,UNC13A,UNC13A: Synaptic transmission defects,0,0,,,0,0,,,1,Excitotoxicity,UNC13A: Synaptic transmission defects,Synaptic transmission defects
SAS_02478,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_02479,SAS,3,FUS,9.9,Severe,Fast Progression,FUS; SOD1; UBQLN2,1,2,SOD1; UBQLN2,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,2,FUS; SOD1,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,4,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | UBQLN2: Ubiquitin-proteasome clearance failure,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02480,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02481,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02482,SAS,1,FIG4,7.8,Moderate,Slow Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_02483,SAS,2,FUS,10.0,Severe,Fast Progression,FUS; TARDBP,0,0,,,1,2,FUS; TARDBP,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02484,SAS,2,TBK1,10.0,Severe,Fast Progression,SQSTM1; TBK1,1,2,SQSTM1; TBK1,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02485,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02486,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02487,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02488,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02489,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02490,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02491,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02492,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02493,SAS,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02494,SAS,1,SPTLC1,6.9,Moderate,Fast Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02495,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02496,SAS,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02497,SAS,3,SQSTM1,7.8,Moderate,Slow Progression,ALS2; SLC52A3; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02498,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02499,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02500,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02501,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02502,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02503,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02504,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02505,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02506,SAS,2,FIG4,8.4,Severe,Fast Progression,FIG4; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,2,Proteostasis,FIG4: Lysosomal biogenesis failure | TBK1: Autophagy initiation kinase deficiency,Lysosomal biogenesis failure
SAS_02507,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02508,SAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Cytoskeletal_Axonal_Transport,ALS2: Endosome-lysosome fusion failure | TUBA4A: Microtubule destabilization,Endosome-lysosome fusion failure
SAS_02509,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02510,SAS,3,UBQLN2,7.7,Moderate,Slow Progression,CHRNA3; SETX; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_02511,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02512,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02513,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02514,SAS,2,OPTN,9.2,Severe,Fast Progression,ALS2; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02515,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02516,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02517,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02518,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02519,SAS,2,LOC130003372,6.6,Moderate,Slow Progression,ALS2; LOC130003372,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Unknown mechanism
SAS_02520,SAS,2,TBK1,10.0,Severe,Fast Progression,SIGMAR1; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02521,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02522,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02523,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02524,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02525,SAS,2,CHMP2B,7.0,Moderate,Slow Progression,CHMP2B; SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,CHMP2B,CHMP2B: ESCRT-III dysfunction,0,0,,,1,Vesicle_Trafficking,CHMP2B: ESCRT-III dysfunction,ESCRT-III dysfunction
SAS_02526,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02527,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02528,SAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02529,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02530,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02531,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02532,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02533,SAS,2,OPTN,8.4,Severe,Fast Progression,OPTN; SPG11,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SPG11: Lysosome reformation failure; DNA repair defects,Autophagy receptor dysfunction
SAS_02534,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02535,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_02536,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02537,SAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02538,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02539,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02540,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02541,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02542,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02543,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02544,SAS,1,ERLIN1,6.6,Moderate,Slow Progression,ERLIN1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02545,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02546,SAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02547,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02548,SAS,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02549,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02550,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02551,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02552,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02553,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02554,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02555,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02556,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02557,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02558,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02559,SAS,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02560,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02561,SAS,3,FUS,10.0,Severe,Fast Progression,ALS2; FUS; OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | OPTN: Autophagy receptor dysfunction,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02562,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02563,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02564,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02565,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02566,SAS,2,ALS2,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
SAS_02567,SAS,1,SETX,5.7,Mild,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_02568,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02569,SAS,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02570,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02571,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02572,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02573,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02574,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02575,SAS,1,C9orf72,8.8,Severe,Fast Progression,C9orf72,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,DPR toxicity; RNA foci; AMPA receptor dysregulation
SAS_02576,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02577,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02578,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02579,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02580,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02581,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02582,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02583,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02584,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02585,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02586,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02587,SAS,1,SETX,4.6,Mild,Asymptomatic/Low Penetrance,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_02588,SAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
SAS_02589,SAS,1,ALS2,5.0,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02590,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02591,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02592,SAS,1,SOD1,7.0,Moderate,Asymptomatic/Low Penetrance,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02593,SAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02594,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02595,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02596,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02597,SAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02598,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02599,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02600,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02601,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02602,SAS,2,ALS2,7.7,Moderate,Fast Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Endosome-lysosome fusion failure
SAS_02603,SAS,1,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_02604,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02605,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02606,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02607,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02608,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02609,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02610,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02611,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02612,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02613,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02614,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02615,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02616,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02617,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02618,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02619,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02620,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02621,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02622,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02623,SAS,2,TBK1,10.0,Severe,Fast Progression,TBK1; TUBA4A,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,2,Proteostasis,TBK1: Autophagy initiation kinase deficiency | TUBA4A: Microtubule destabilization,Autophagy initiation kinase deficiency
SAS_02624,SAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02625,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02626,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02627,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02628,SAS,2,SPG11,6.5,Moderate,Fast Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02629,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02630,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02631,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02632,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02633,SAS,1,DCTN1,7.7,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_02634,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02635,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02636,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02637,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02638,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02639,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02640,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02641,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02642,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02643,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02644,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02645,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02646,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02647,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02648,SAS,1,UBQLN2,7.7,Moderate,Slow Progression,UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_02649,SAS,2,SIGMAR1,7.7,Moderate,Slow Progression,SIGMAR1; SPG11,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SPG11: Lysosome reformation failure; DNA repair defects,MAM calcium dysregulation
SAS_02650,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02651,SAS,2,TBK1,9.1,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02652,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02653,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02654,SAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1; SPTLC1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02655,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02656,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02657,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02658,SAS,1,HNRNPA2B1,6.0,Moderate,Slow Progression,HNRNPA2B1,0,0,,,1,1,HNRNPA2B1,HNRNPA2B1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA2B1: Stress granule dysregulation,Stress granule dysregulation
SAS_02659,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02660,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02661,SAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02662,SAS,1,ALS2,7.7,Moderate,Fast Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02663,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02664,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02665,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02666,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02667,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_02668,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02669,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02670,SAS,2,SPG11,7.7,Moderate,Slow Progression,ALS2; SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; SPG11,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02671,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02672,SAS,1,SOD1,7.7,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02673,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02674,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02675,SAS,1,SLC52A3,9.2,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02676,SAS,1,SPTLC1,6.9,Moderate,Fast Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02677,SAS,1,SYNE1,9.2,Severe,Fast Progression,SYNE1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02678,SAS,1,SPG11,7.0,Moderate,Fast Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02679,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02680,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02681,SAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02682,SAS,1,CHRNA3,6.0,Moderate,Asymptomatic/Low Penetrance,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02683,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02684,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02685,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02686,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02687,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02688,SAS,2,SETX,5.6,Mild,Slow Progression,ALS2; SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_02689,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02690,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02691,SAS,2,UBQLN2,7.0,Moderate,Slow Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Ubiquitin-proteasome clearance failure
SAS_02692,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02693,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02694,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02695,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02696,SAS,1,CHRNA3,6.0,Moderate,Slow Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02697,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02698,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02699,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02700,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02701,SAS,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02702,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02703,SAS,1,OPTN,9.2,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02704,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02705,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02706,SAS,2,FIG4,9.2,Severe,Fast Progression,ALS2; FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,2,ALS2; FIG4,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure | FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_02707,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02708,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02709,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02710,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02711,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02712,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02713,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02714,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02715,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02716,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02717,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02718,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02719,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02720,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02721,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02722,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02723,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02724,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02725,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02726,SAS,1,SLC52A3,6.6,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02727,SAS,2,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_02728,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02729,SAS,1,TARDBP,7.0,Moderate,Slow Progression,TARDBP,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,2,RNA_Metabolism,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_02730,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02731,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02732,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02733,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02734,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02735,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02736,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02737,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02738,SAS,2,TBK1,10.0,Severe,Fast Progression,TARDBP; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,3,Proteostasis,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02739,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02740,SAS,1,SLC52A3,6.0,Moderate,Slow Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02741,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02742,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02743,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02744,SAS,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02745,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02746,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02747,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02748,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02749,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02750,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02751,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_02752,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02753,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02754,SAS,2,TBK1,10.0,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02755,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02756,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02757,SAS,3,LOC108903148,9.2,Severe,Fast Progression,ALS2; LOC108903148; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Unknown mechanism
SAS_02758,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02759,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02760,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02761,SAS,2,TBK1,10.0,Severe,Fast Progression,FUS; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,3,Proteostasis,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02762,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02763,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02764,SAS,2,ALS2,7.7,Moderate,Fast Progression,ALS2; UBQLN2,1,1,UBQLN2,UBQLN2: Ubiquitin-proteasome clearance failure,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | UBQLN2: Ubiquitin-proteasome clearance failure,Endosome-lysosome fusion failure
SAS_02765,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02766,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02767,SAS,2,TBK1,9.8,Severe,Fast Progression,SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02768,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_02769,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02770,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02771,SAS,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_02772,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02773,SAS,1,SQSTM1,9.2,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02774,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02775,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02776,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02777,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02778,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02779,SAS,1,SQSTM1,7.8,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02780,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02781,SAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02782,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02783,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02784,SAS,2,FUS,10.0,Severe,Fast Progression,ALS2; FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,3,RNA_Metabolism,ALS2: Endosome-lysosome fusion failure | FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02785,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02786,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02787,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02788,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02789,SAS,2,SQSTM1,6.6,Moderate,Slow Progression,SETX; SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02790,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02791,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02792,SAS,1,NEK1,8.4,Severe,Fast Progression,NEK1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,NEK1,NEK1: DNA damage checkpoint failure,1,DNA_Damage,NEK1: DNA damage checkpoint failure,DNA damage checkpoint failure
SAS_02793,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02794,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02795,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02796,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02797,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02798,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02799,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02800,SAS,1,SIGMAR1,6.5,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_02801,SAS,2,VCP,7.7,Moderate,Slow Progression,SIGMAR1; VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Proteostasis,SIGMAR1: MAM calcium dysregulation | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02802,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02803,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02804,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02805,SAS,2,DCTN1,7.0,Moderate,Fast Progression,DCTN1; SIGMAR1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,2,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure | SIGMAR1: MAM calcium dysregulation,Retrograde transport failure
SAS_02806,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02807,SAS,2,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02808,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02809,SAS,2,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02810,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02811,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02812,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02813,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02814,SAS,1,SETX,6.2,Moderate,Slow Progression,SETX,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,1,DNA_Damage,SETX: R-loop accumulation; genomic instability,R-loop accumulation; genomic instability
SAS_02815,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02816,SAS,2,TBK1,9.8,Severe,Fast Progression,SLC52A3; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02817,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02818,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02819,SAS,2,TBK1,10.0,Severe,Fast Progression,ALS2; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,2,Proteostasis,ALS2: Endosome-lysosome fusion failure | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02820,SAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02821,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02822,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02823,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02824,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02825,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02826,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02827,SAS,2,SOD1,7.7,Moderate,Slow Progression,SOD1; SPG11,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,5,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | SPG11: Lysosome reformation failure; DNA repair defects,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02828,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02829,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02830,SAS,2,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02831,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02832,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02833,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02834,SAS,1,FUS,9.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02835,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02836,SAS,1,CHRNA3,8.4,Severe,Fast Progression,CHRNA3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02837,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02838,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02839,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02840,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02841,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02842,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02843,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02844,SAS,1,FIG4,8.4,Severe,Fast Progression,FIG4,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,FIG4,FIG4: Lysosomal biogenesis failure,0,0,,,1,Vesicle_Trafficking,FIG4: Lysosomal biogenesis failure,Lysosomal biogenesis failure
SAS_02845,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02846,SAS,1,LOC124629354,7.8,Moderate,Fast Progression,LOC124629354,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02847,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02848,SAS,2,VCP,7.7,Moderate,Slow Progression,SQSTM1; VCP,1,2,SQSTM1; VCP,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62) | VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02849,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02850,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02851,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02852,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02853,SAS,2,TARDBP,7.7,Moderate,Slow Progression,SOD1; TARDBP,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,TARDBP,TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,2,SOD1; TARDBP,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,0,0,,,0,0,,,4,Excitotoxicity,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TARDBP: Nuclear-cytoplasmic mislocalization; ADAR2 downregulation,Nuclear-cytoplasmic mislocalization; ADAR2 downregulation
SAS_02854,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02855,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02856,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02857,SAS,1,TBK1,7.7,Moderate,Slow Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02858,SAS,1,FUS,9.9,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02859,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02860,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02861,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02862,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02863,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02864,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02865,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02866,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02867,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02868,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02869,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02870,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02871,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02872,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02873,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02874,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02875,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02876,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02877,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02878,SAS,2,UBQLN2,7.0,Moderate,Slow Progression,UBQLN2; VCP,1,2,UBQLN2; VCP,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,UBQLN2: Ubiquitin-proteasome clearance failure | VCP: Autophagosome maturation failure; TDP-43 accumulation,Ubiquitin-proteasome clearance failure
SAS_02879,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02880,SAS,1,SQSTM1,7.8,Moderate,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02881,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02882,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02883,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_02884,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02885,SAS,1,SLC52A3,8.4,Severe,Fast Progression,SLC52A3,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02886,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02887,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02888,SAS,1,DCTN1,7.0,Moderate,Slow Progression,DCTN1,0,0,,,0,0,,,1,1,DCTN1,DCTN1: Retrograde transport failure,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,DCTN1: Retrograde transport failure,Retrograde transport failure
SAS_02889,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02890,SAS,1,SIGMAR1,6.0,Moderate,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_02891,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02892,SAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02893,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02894,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02895,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02896,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02897,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_02898,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02899,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02900,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02901,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02902,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02903,SAS,1,HNRNPA1,6.0,Moderate,Slow Progression,HNRNPA1,0,0,,,1,1,HNRNPA1,HNRNPA1: Stress granule dysregulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,RNA_Metabolism,HNRNPA1: Stress granule dysregulation,Stress granule dysregulation
SAS_02904,SAS,2,OPTN,9.2,Severe,Fast Progression,OPTN; SOD1,1,2,OPTN; SOD1,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,OPTN: Autophagy receptor dysfunction | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Autophagy receptor dysfunction
SAS_02905,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02906,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02907,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02908,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02909,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02910,SAS,1,FUS,10.0,Severe,Fast Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02911,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02912,SAS,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02913,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02914,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02915,SAS,1,TBK1,10.0,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02916,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02917,SAS,1,SOD1,7.0,Moderate,Fast Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02918,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02919,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02920,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02921,SAS,1,SIGMAR1,5.0,Mild,Asymptomatic/Low Penetrance,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_02922,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02923,SAS,2,SOD1,7.0,Moderate,Slow Progression,SIGMAR1; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,2,SIGMAR1; SOD1,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Mitochondrial,SIGMAR1: MAM calcium dysregulation | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02924,SAS,1,SOD1,7.7,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02925,SAS,1,LOC129995449,7.8,Moderate,Fast Progression,LOC129995449,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02926,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02927,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02928,SAS,2,TBK1,9.1,Severe,Fast Progression,SETX; TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SETX,SETX: R-loop accumulation; genomic instability,2,Proteostasis,SETX: R-loop accumulation; genomic instability | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02929,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02930,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02931,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02932,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02933,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02934,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02935,SAS,1,TBK1,9.1,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02936,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02937,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02938,SAS,1,SPTLC1,6.9,Moderate,Slow Progression,SPTLC1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02939,SAS,1,ALS2,7.7,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02940,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02941,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02942,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02943,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02944,SAS,1,VCP,7.7,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02945,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02946,SAS,2,TBK1,9.1,Severe,Fast Progression,C9orf72; TBK1,1,2,C9ORF72; TBK1,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | TBK1: Autophagy initiation kinase deficiency,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,1,1,C9ORF72,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation,0,0,,,0,0,,,3,Proteostasis,C9ORF72: DPR toxicity; RNA foci; AMPA receptor dysregulation | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02947,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02948,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02949,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02950,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02951,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02952,SAS,1,TBK1,9.8,Severe,Fast Progression,TBK1,1,1,TBK1,TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02953,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02954,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02955,SAS,1,ANXA11,8.6,Severe,Slow Progression,ANXA11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02956,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02957,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02958,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02959,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02960,SAS,1,VCP,7.0,Moderate,Slow Progression,VCP,1,1,VCP,VCP: Autophagosome maturation failure; TDP-43 accumulation,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,VCP: Autophagosome maturation failure; TDP-43 accumulation,Autophagosome maturation failure; TDP-43 accumulation
SAS_02961,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02962,SAS,1,SQSTM1,6.6,Moderate,Slow Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02963,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02964,SAS,1,FUS,9.9,Severe,Slow Progression,FUS,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,1,1,FUS,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,0,0,,,0,0,,,0,0,,,2,RNA_Metabolism,FUS: Nuclear-cytoplasmic mislocalization; ATP synthase disruption,Nuclear-cytoplasmic mislocalization; ATP synthase disruption
SAS_02965,SAS,1,SPG11,7.7,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02966,SAS,1,ALS2,5.5,Mild,Asymptomatic/Low Penetrance,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02967,SAS,1,OPTN,8.4,Severe,Fast Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02968,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02969,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02970,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02971,SAS,1,ERLIN1,6.6,Moderate,Slow Progression,ERLIN1,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,Unknown mechanism
SAS_02972,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02973,SAS,1,SQSTM1,8.4,Severe,Fast Progression,SQSTM1,1,1,SQSTM1,SQSTM1: Autophagy receptor dysfunction (p62),0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,SQSTM1: Autophagy receptor dysfunction (p62),Autophagy receptor dysfunction (p62)
SAS_02974,SAS,1,SPG11,7.0,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02975,SAS,1,TUBA4A,6.0,Moderate,Slow Progression,TUBA4A,0,0,,,0,0,,,1,1,TUBA4A,TUBA4A: Microtubule destabilization,0,0,,,0,0,,,0,0,,,0,0,,,1,Cytoskeletal_Axonal_Transport,TUBA4A: Microtubule destabilization,Microtubule destabilization
SAS_02976,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02977,SAS,1,SPG11,6.5,Moderate,Slow Progression,SPG11,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,1,1,SPG11,SPG11: Lysosome reformation failure; DNA repair defects,2,Vesicle_Trafficking,SPG11: Lysosome reformation failure; DNA repair defects,Lysosome reformation failure; DNA repair defects
SAS_02978,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02979,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02980,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02981,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02982,SAS,1,SIGMAR1,6.0,Moderate,Slow Progression,SIGMAR1,0,0,,,0,0,,,0,0,,,1,1,SIGMAR1,SIGMAR1: MAM calcium dysregulation,0,0,,,0,0,,,0,0,,,1,Mitochondrial,SIGMAR1: MAM calcium dysregulation,MAM calcium dysregulation
SAS_02983,SAS,1,ALS2,7.0,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02984,SAS,1,OPTN,6.0,Moderate,Slow Progression,OPTN,1,1,OPTN,OPTN: Autophagy receptor dysfunction,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,Proteostasis,OPTN: Autophagy receptor dysfunction,Autophagy receptor dysfunction
SAS_02985,SAS,1,ALS2,6.5,Moderate,Slow Progression,ALS2,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,1,Vesicle_Trafficking,ALS2: Endosome-lysosome fusion failure,Endosome-lysosome fusion failure
SAS_02986,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02987,SAS,1,SOD1,7.0,Moderate,Slow Progression,SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,3,Proteostasis,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02988,SAS,3,TBK1,9.1,Severe,Fast Progression,ALS2; SOD1; TBK1,1,2,SOD1; TBK1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage | TBK1: Autophagy initiation kinase deficiency,Autophagy initiation kinase deficiency
SAS_02989,SAS,2,SOD1,7.7,Moderate,Slow Progression,ALS2; SOD1,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,0,0,,,0,0,,,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,SOD1,SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,1,1,ALS2,ALS2: Endosome-lysosome fusion failure,0,0,,,4,Proteostasis,ALS2: Endosome-lysosome fusion failure | SOD1: Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage,Protein misfolding; mitochondrial toxicity; glutamate transporter cleavage
SAS_02990,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02991,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02992,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02993,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02994,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02995,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02996,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02997,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02998,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
SAS_02999,SAS,0,,0.0,Unaffected,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,0,,,0,None,No known ALS mechanisms,
